|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/2 ¤W¤È 09:36:27
|
¯E¹©°O¡G 1¡n¯E¹©2015¦~3¤ë¥¿¦¡±q¿³ÂdÂà¤WÂd,«o±q400¤¸¶^¨ì250¤¸ 2¡nÀHµÛ¸Ñª¼®É¶¡±µªñ,¥«³õ¤W°ª«×ªºÃöª`»P°l±·,¿v©³Ãk¤É¨ì750¤¸ªº¤Ñ»ù 3¡n2016/2/21¸Ñª¼«á, ¥Ñ©ó¸Ñª¼¥¼¹F¹w¥ý³]©wªº¥Ø¼Ð, ¦A¥[¤W¦W¼L¥ß©e´CÅé½Ñ¦h¥H³_¶Ç³_,¥H°¾·§¥þ, ¥B¥¼¸gÃҹꪺ«ü±± ÁöµM¤½¥q»¡¯à°÷²£¥Í§ÜÅ骺±Ú¸s´N¯à°÷²£¥ÍÁ{§É¤WªºÀø®Ä,©ó¬O¦³©Ò¿×ªº"¤@ӸѪ¼,¨âºØ¸ÑŪ,¦U¦Ûªíz" ¤@¸ô¤U¶^¨ì350¤¸¥ª¥k 4¡n¦ý¦b2016/3/31²×©óªï¨ÓÀò±oASCO Oral presentationªº®¶¾Ä®ø®§,4¤ë1¤é·M¤H¸`·í¤Ñ,ªï¨Ó¤F¤[¹Hªº¤@¸ôº¦°±ªO 5¡n6¤ëªìªºASCO, ÁÞ¤k§Y±N´¦¶}¦oªº¯«¯µ±¯½ ¨Ì¾Ú²Î¤@§ëÅU±i¥ß¸s¤ÀªR®v¬ã¨s¡G https://www.google.com.tw/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwins9egnPzLAhVikIMKHcc1DN8QFgggMAE&url=http%3A%2F%2Fpcmc.uni-psg.com%2Fvip%2F20160226-01.pdf&usg=AFQjCNHCCWDKl493HzcquFVIcJoolRPgnQ »PµL±¡¤jªº¤ÀªR¡G http://tsjh301.blogspot.tw/2014/08/obipharma.html ¥»µÛªø´Á§ë¸ê, °l®Ú¨s©³ªººë¯«¨Ó±´¯Á¯E¹©ªº§ë¸ê»ùÈ, ¤£¦]µu´ÁªÑ»ùªi°Ê°_¥ñ¦Ó¼vÅT¹ï "¥þ²y²Ä¤@ÁûFirst in class, Best in classªº§ÜÀùÁÞ¤À¤l¥þ·sÃĪ«"§ë¸êªº¼ö±¡ ¨ÃÅé²{¤½¥qÄ@´º: "³Ð³y¥xÆW¥Í§Þ«~µP,¦¨¬°Àù¯gÀøªkªº¥þ²y»â¯èªÌ" "2025¦~¦¨¬°¥xÆW¥Í§Þ²Ä¤@«~µP, 2035¦~¦¨¬°¥þ²yÀù¯gªvÀø»â¾É¤½¥q" Åwªï¤À¨É¥ô¦ó¹ï¯E¹©Ä@´º»P»ùȵû¦ôªº¬Ýªk»P°ª¨£~~ |
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/3 ¤U¤È 09:06:54²Ä 900 ½g¦^À³
|
¥Ø«e¥i¥H½T»{¥u¦³2ӼƦr(2014/8 LR=187, 2015/5 LR=229) ¥[¤W¥i±À½×ªº¤@ӼƦr2014/9 CR=142 ¨Ì¤p©_¤j5Ӥ몺´c¤Æ³t«×¬ù229-187/5=8.4 ±Àºâ «h2014/9 LR=161.8 pºâ¥XLR/CR»~®t12.2% ¨Ì¦¹»~®t¤Ï±À2014/12 CR=164.1 ½Ð°Ý¤p©_¤j ¹ï·Ó²ÕY2014/12 ´c¤Æ92¤H, ¥u³Ó11¤H ³o11¤H³°Äò¨ì5¤ë«e¥þ³¡´c¤Æ ¨º2015/5¤ë«á¥u³Ñ¹êÅç²Õ, ´c¤Æ¼Æ¥i¯à¤Ö¤@ÂI, ·|¼vÅT±zªºpºâ¶Ü? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 08:48:37²Ä 899 ½g¦^À³
|
¥ò´º¤j µ½¤H¤j ®¥³ß°Õ ,¤T²Õ°ß¤@©R¤¤ªÌ ,µ½¤H¤jªº»~´Ó»¡¤]©R¤¤,¨S¦³©R¤¤¤]¨SÃö«Y,¤j®a³£«Ü§V¤O§ä¸ê®Æ,¤]³\¤U¦¸´N©R¤¤, ½Ð§â¤µ¤Ñ¦^µªªº³¡¥÷«Å¥´X¦¸,·|¦³¯S§Oªºµo²{ |
|
|
·|û¡GBRN10139393 µoªí®É¶¡:2015/6/3 ¤U¤È 08:26:01²Ä 898 ½g¦^À³
|
±i¸³¼á²MPD/OTHER=229/37¬O«ü¦b2015/05/25ªº¼Æ¾Ú 2015/01: PD/OTHER¬O187/26¥BPD¬O«üLR«DCR, À³¬O§Q¦h¦ý´CÅé³ø¾É¤£²MÅܦ¨§QªÅ,Y¬O¯uªº¬O¹ê½è§QªÅªº¸Ü, 10:30ªÑªF·|µ²§ô«áÀ³¸Ó´Nn¤j¶^,¬Æ¦Ü¦bªÑªF·|¶i¦æ´Á¶¡,09:40±i¸³¦b»¡©úPD229®É´Nn¤j¶^¤F! 2015/03ªk»¡·|±i¸³»¡´_µo¤H¼Æ142¦ìÀ³¬O«üCR,¬O¥Ñ2015/01ªº187(LR)*30¢H(LR»PCRªº»~®t²v¬ù30¢H)=¬ù143.8¦ì(CR) ¥H¦P¼Ë±ø¥ópºâ2015/05/25 : 229(LR)*30¢H=176¦ì(CR) ¤]´N¬O2015/05/25 ´_µo¤H¼Æ=176¦ì ¤µ¤È´CÅé³ø¾É´_µo¤H¼Æ=229¦ì,§ë¸ê¤H»~»{¬°3¤ë¥÷¤~142¤¤ë¥÷«o§Ö³t¼W¥[¨ì229¦ì,¯uªºÀ~¨ì¤F,©Ò¥H¦b12:30¤£²z©ÊºÆ¨g±þ¥X ! ªÑªF·|µ²§ô«á,Å¥¨ì¦³¦ì¤p©j¥´¹q¸Üµ¹¥LªB¤Í»¡,¦ª¾¹D¬Q¤Ñ¤£À³¸Ó½æ¥X¤F ! ¥»¤H·|«á¤]»P¤@¦ì¹ï·sÃÄ«D±`¦³²`¤J¬ã¨sªº³Õ¤h¤¬°Ê,¤]¸ò¥L¥æ´«¤F¦W¤ù(¤£¤è«K³zº|¥LªºªA°È¤½¥q¤Î©m¦W,¦ý«Ü¦h¤HÀ³¸ÓÅ¥¹L¥L),¥L»¡¦³¨Ç¤H§âPFS°ª¦ô¤F,25,30³£¤Ó¿E±¡¤F,OBI-822n¹F80,90¤À¥i¯à©Ê¤£°ª,¦ý¦Ü¤Ö¦³70¤À¡CTFDAÃÄÃÒn®³¨ì¨S°ÝÃD,¦ýnª½±µ¥Ó½ÐFDAÃÄÃÒ¥i¯à©Ê¤£°ª,¦ýn¥Ó½ÐBTÁÙ¦³¾÷·|¡C¥LÓ¤H¦ôPFS¬ù15,Áö«D¥P¤¦,¤]«D§®ÃĦý¤w¸g¬O«D±`¤F¤£°_ªº¨}ÃĤF ! ²z¥Ñ:»P¹Ç§AÅó±ø±ø¤jªº¬Ýªk¦³¬Û¦ü PLACEBO + Herceptin + docetaxe, M PFS =12.4 PERJETA + Herceptin + docetaxe, M PFS =18.5 (12.4 + 49%) Herceptin PFS=6 OBI-822YPFS=9¥H¤W´N¥i¥H¨ú±oTFDAÃÄÃÒ,¤]¦³¥i¯à»P¨ä¥LÃļt·f°t¥ÎÃÄPFS¤@©w¤ñ15§ó°ª 1.°Æ§@¥Î¤Ö,OBI822¤£¥i©¿µøªºÀu¶Õ,¤]¬OFDA®ÖãÃÄÃÒªº°Ñ¦Ò(¦pªG¦³¤@ºØÃÄ¥i©µªø¹Ø©R5¦~,¦ý°Æ§@¥Î¤j¨ìÅý§A¥Í¤£¦p¦º, ¥t¦³¤@ºØÃÄ¥i©µªø¹Ø©R3¦~,¦ý°Æ§@¥Î¤p¨ìÅý§A¯à§ïµ½¥Í¬¡«~½è,¬¡±o¦³´LÄY,¨º±z·|¦p¦ó¿ï¾Ü©O?) 2.¶Pº¸»X/Her 2/¤T³±©Ê³£¾A¥Î 3.822³æ¤@¥ÎÃÄPFS=15ÁÙ¬OÀu©ó²{¦³ÃĪ«PFS=6 4.¦³¨Ç¦]¬°Globo H¤ÏÀ³²v§C¼vÅTM PFS, ¦pªG¥¼¨Ó²ÎpÀù²ÓMGlobo H²v»PÀø®Ä¡A¥ÎÃÄIgG,IgM¤ÏÀ³²v¬ÛÃö©Ê«á¯à§ó²M·¡Àø®Ä 5.833 ¥|ºØÀù¯gn¶}©l¶i¦æ...µ¥µ¥ §Ú¤]»{¦P±Û«a¤jªº¬Ýªk: ¡i¤µ¤Ñ¤£¤Ö¤H°Ý§Ú´_µo229¤H¬O«ç»ò¦^¨Æ¡H§Ú·Q쥻¤£©ú¨s²zPD229¬O«ç»ò¦^¨Æªº§ë¸ê¤H¡A½L¤¤¬Ý¨ì°OªÌ¤£°÷²`¤Jªº³ø¾É¡A¥H¬°5¤ë¯uªº¤w¸g´_µo229¤H¦Ó·P¨ìÅ宣¤£¤w¡A³y¦¨«á¨Óªº±þ½L´N¤£Ãø²z¸Ñ¡A©Ò¥H¡A¤@ª¾¥b¸Ñ¥[¤WÄw½X±ªº¦]¯À¾ÉP¤µ¤Ñªº«®À¡A§Ú·Q¤F¸Ñ¯u¥¿ªºì¦]«á¡Aµu½u¤Wªº¯ÉÂZ¥i¼È®ÉÂ\¤@Ãä¡A«¤ß±Mª`¦b«áÄò°ò¥»±µo®i¡A¤ß±¡ªº°_¥ñ¸û¯à±±¨î¡A¦U¦ì¤j¤j¡A©¼¦¹¥[ªo¡I¡j §ÚÓ¤H«Øij¤j®a§âOBI822 PFS³]©w¦b15~20¶¡´N¤w±µªñ§®ÃĤF! ©ú¤ÑªÑ»ùÀ³·|º¥º¥¦^äF! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 08:19:09²Ä 897 ½g¦^À³
|
¤p©_¤j 1§A´£¨ì¹êÅç²Õ²Ä90¦ì¤j¬ù¦b2015¦~2¤ë²£¥Í¡A©Ò¥H¦ô¤¤¦ì¼ÆPFS¤j¬ù20Ó¤ë,¨ì¤µ¤Ñ6¤ë3¤éªÑªF·|±i¸³ÁÙ¬O»¡¤K¤ë¤~n¤½§i¸Ñª¼®É¶¡,¨Ì§Aªº¸ÑŪ¬Ý¬O¤£¬OnÅý¹êÅç²Õ´c¤Æ¤H¼Æ¦A¦h¤@ÂI¥H¹F¨ì«GÄRªºPFS? 2¤ë¥i¯à¹F¨ìK-M ¨ç¼Æªº0.5¤ô¥½u¬°¦ó¨S¤½§i¸Ñª¼? 3 central read »P Local Read ¬O§_»Ýn¨Ì»~®t¤ñ²v´«ºâ¦n«á¦A¤ñ¸û¤ÀªR? ÁÂÁ¸Ѵb |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/3 ¤U¤È 08:18:13²Ä 896 ½g¦^À³
|
¤p©_¤j¡A©M§A¤Á½R¤@Ó½×ÂI¡A«ö§Aªººâªk¡Aª½¦Ü¥h¦~©³LR:CR¬°187:172¡A¨âªÌ¶¡ªº®t¶Z¶È8%¡A®Ú¾Ú¥ò´º¤j±Ä³XLÂå®v«ü¥X¨âªÌ¥§¡»~®t¦b20%-40%¶¡¡A°ê¥~½×¤å³ø§i¤]«ü¥X22%-25%¡AÁö»¡CR¦^¶Çµ¹±i¸³¥i¯à¦³2.5Ó¤ë®É¶¡®t¡A¦]§Ú̬O±Ä«O¦u¦ô¨ì¥h¦~9¤ë©³¥¼¹F142¤H¡A¦ý¬O¥¼¹F142¤Hªº·Q¹³ªÅ¶¡¤]³\¤£¤p¡A¦pªG¬O110-120¤H¤§¶¡©O¡H©Ò¥H§Ú¨p¤ß»{¬°LR187¤H´î±¼³Ì§C20%®t¶Z(37¤H)CR¬°150¤H¥H¤U¡A¤]³\¤ñ¸û¶KªñLÂå®v©M°ê¥~½×¤åªº»¡ªk¡A¨Ì¦¹Ãþ±À¡A¤µ¦~5¤ëªºLR229¤H´î¥h®t¶Z20%(45¤H)CR¬°184¤H¥H¤U¡C |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/3 ¤U¤È 07:32:03²Ä 895 ½g¦^À³
|
¥xÁÞ¤j¡A ²Ê§ì¤@¤U ³Ì«á²Îp¤ÀªR¥Hcentral read¬°·Ç 2014¦~9/30¡Acentral read=142 2014-12 Local Read= 187 2015-05 Local Read= 229 Local Read¦b³o5Ӥ몺´c¤Æ³t«×¬ù229-187/5=8.4 2014¦~9/30~2014¦~12/31Á`Á{§ÉÆ[¹î¤H¼Æ¸û2015¦~¤W¥b¦~¦h¡A´c¤Æ³t«×À³¸û§Ö¤@ÂI ©Ò¥H¦ô2014¦~9/30~2014¦~12/31´c¤Æ³t«×=10¤H/¨C¤ë ©Ò¥H2014¦~12/31ªºcentral read=172 2014¦~12/31¤¤³~Â÷¶}¤H¼Æ¦@26¤H¡A´N¦ô¹êÅç²Õ©M¹ï·Ó²Õ¦U¤@¥b=13¤H ¹ï·Ó²Õ¤@ª½¦bÁ{§É¸ÕÅ礤ªº¦³116-13=103¡A¥H9¦¨´c¤Æ²v¨Ó¦ô=92¤H ¦]¦¹¹êÅç²Õ¦b2014¦~12/31ªº´c¤Æ¤H¼Æ=172-92=80 ¹êÅç²Õ¦b2014¦~12/31´c¤Æ¤H¼Æ=80¤H ¹êÅç²Õªº´c¤Æ«ç»ò¤À¥¬«ÜÃø²q¡A80¤H´c¤Æ¤]¥i¯à¹F¨ìK-M ¨ç¼Æªº0.5¤ô¥½u ©ÎªÌ90¤H´c¤Æ¹F¨ì©ÎªÌ100¤H´c¤Æ¹F¨ì¡A¦ýµ´¹ï¤£»Ý¨ì116¤H´N¥i¥H½T©w¤¤¦ì¼ÆPFS ´N¦ô¤¤¶¡È90¤H´c¤Æ®É¹F¨ì0.5¤ô¥½u ¦]¦¹²Ä90¦ì¤j¬ù¦b2015¦~2¤ë²£¥Í¡A©Ò¥H¦ô¤¤¦ì¼ÆPFS¤j¬ù20Ó¤ë ¦UºØ¤£¦Pªº°²³]·|³y¦¨PFS¦ôpȦb¤W¤U10%ªº»~®t½d³ò ³Ì«á¸Ñª¼µ²ªG·|¤£·|¤j©ó20Ó¤ë¡Aµª®×¨ä¹ê¥u¦³¤@Ó¦r¡A¡§¬O¡¨©ÎªÌ¡§§_¡¨¡A¨S¦³¸Ñª¼¬O¨S¦³¿ìªk½T»{ªº¡C ¥H¤Wpºâ¡A°Ñ¦Ò´N¦n¡C |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/3 ¤U¤È 07:31:25²Ä 894 ½g¦^À³
|
¦U¦ì²{¦b·Q·Q,¸ÕºâªºPFS¤¤¶¡¯uªº¦³«Ü¦h°²³]·|»P¨Æ¹ê¦³®t¶Z.§Ú¦b·Q³o¦¸ªº¨Æ¥ó,¦³¤H¤@©w·|ª¾¹D¦~©³ PD 187¤H,ÀH«K¤@ºâ´Nª¾¹D¥²´Iºôªº¼ÖÆ[ªÌ¼Æ¾Ú°ª¦ô¤Ó¦h¤F.¦]¦¹¦³¤H·|±q400¦h¤@¸ô¥X¨ì300,ÁöµM¦³¤H¤@ª½´£¥X«O¦u¬Ýªk.Áö¬OÄw½X±¦ý«o¤]¥i¥H¬Ý¥X¤@¨ÇºÝÙ.²{¦b³oºØpFS³Ì¦n¬O15-20,¨º½Ð±Ð¦U¦ì¤j¤j¦³¥ô¦ó³Ì·sªº·Qªk? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 07:21:13²Ä 893 ½g¦^À³
|
¼·¤j 1¤£n³QÁபº¥~ªí(local read ´_µo¤H¼Æ)©Ò鳬¡A«ÂI¬On¬Ý¤º¦b(º}«Gªº¼Æ¾Ú),¤µ¤Ñ§A¯àÂI¹º¥XnÂI,µ¹§A«öÓÆg ±i¸³¤w¸g´£¨ì«ÂI>>>¥Hcentral read ¬°¥D,¨ä¥L¤£ºâ,822ªº³]pprimary endpoint PFS¬°¥D,central read »PPFS»¡¤F¤~ºâ¼Æ ¨ä¥¦¤£ºâ 2´¼¼z¤ñª¾ÃÑ«n,FDA®ÖãÃÄÃҳ̰ª¦Ò¶q¬O¯f¤Hªº§Q¯q¡A¤º¦bº}«Gªº¼Æ¾Ú´N¬OProgression Free Survival (PFS) 3 ¹êÅç²Õ´c¤Æ¤H¼Æ¤Ó¤Ö©Î¤Ó¦h¹ï Progression Free Survival ·|¦³¼vÅT,¤Ó¤Ö©È¥X²{·¥ºÝÈ,¤Ó¦hªí¬O¥ÜÃÄ®Ä ¤£ÅãµÛ,¾A¤¤³Ì¦n,¥i¯à§Ú¤Ñ¥÷¤ñ¸û®t,§Ú¤£À´¬°¤°»ò¹êÅç²Õ¾A«×´c¤ÆPFS´N·|©¹¤U°? 4 PERJETA® +trastuzumab +docetaxeln=402,¨Æ¥óªº¯f±w¼Æ, 191 (47.5%),¤¤¦ì¼Æ¯e¯fµL´c¤Æ¦s¬¡´Á18.5Ó¤ë(¿W¥ß¼f¬d) OBI822 233X47.5%= 110¤H 5 «ö·Ó±Û«a¤j±À¦ô5¤ë©³Local read¬°229¤H¡A¦©°£®t¶Z24.06%(¬ù55¤H)¡A²Ê¦ôcentral read¬ù174¤H¥H¤U¡C¦pªG ¹ï·Ó²Õ´_µo¤H¼Æ¬°100¤H¡A¹êÅç²Õ¥Ø«e´_µo¬ù74¤H¥H¤U 6 °²³]±Û«a¤j±À¦ôcentral read 174¤H¬O¦X²zªº±À¦ô,Ó¤H»{¬°¥¼¨Ó´XÓ¤ë¨â²Õn´c¤Æ¨ì220¤H®É¶}ª¼·|¸û¦³§Q,§Úªº ¬Ýªk¤]³\¦³°g«äÁٻݦU¦ì¤j¤j¤À¨É¬Ýªk,¹êÅç²Õ¾A«×´c¤ÆPFS´N·|©¹¤U°¶Ü?§Ú¯uªº¤£À´ ¹Ç§AÅó±ø±ø¤j: 8.5»õ¬ü¤¸¬O¤é²±§ëÅU±i¬ã¨sûªº±À¦ô ¤£¬O§Úªº±À¦ô,¹ïOBI822¨Ó»¡²Ä¤@ÁûÃÄ,¦b©|¥¼Áp¦X¥ÎÃĤU¦p§A±À¦ô¤w¸g±µªñ¶P ÀùÂù¼Ð¹vÃĪºPFS18.5Ó¤ë,¤]¹L°÷¦n¤F §C°Æ§@¥Î¬O¨ä³Ì¤jÀu¶Õ |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/3 ¤U¤È 07:18:13²Ä 892 ½g¦^À³
|
¦ý«eÃD¬O¯E¹©ªºÁ{§É¸ÕÅ礣¥i¥H¥u¬D¹ï¡uGlobo H¡v§Ü즳¤ÏÀ³ªº¯f¤H°µ¹êÅç |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/3 ¤U¤È 07:09:09²Ä 891 ½g¦^À³
|
½Ð±Ð¯ä¹«¤j,¤µ¤Ñ¯E¹©µo¥X³o¼Ëªº°T®§½T©w¤F.¤j®a¤§«eªºPFS¹w´ÁÀ³¸Ó¬O¤j´TÁY¤p¤F.²{¦b¤p§Ì·Q½Ð±Ð±z»{ÃѪº¤j¤á·|¤£·|¤ß²D¤F¤@¥b,nµ¥¾÷·|¥X¤F? |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/3 ¤U¤È 07:08:26²Ä 890 ½g¦^À³
|
¤j®a¤]³\©¿²¤¤F¤@¥ó¨Æ: "¯E¹©ªºÁ{§É¸ÕÅçµo²{¦³70~80%¥H¤Wªº¨ÅÀù¯f¤H³£±a¦³¡uGlobo H¡vªº§Üì" ¤]´N¬O¬ù¦³25%ªº¹êÅç²Õ¬I¥´822ªº±¡ªpµ¥©ó¹ï·Ó²Õ,¤]´N¬O¦³¥´©M¨S¥´¬O¤@¼Ëªº, °²³]ºâ¶i°h¥X¤H¼Æ¦n¤F¹êÅç²Õ°²³]ÁÙ¦³200¤H,¹ï·Ó²Õ100¤H(¹êÅç²Õ©M¹ï·Ó²Õ¤´¬°2:1) , «h200¤H¤¤ªº25%¬O50¤H¬O¬I¥´822«á¬O¨S®Äªº, ¬G¬I¥´«á¦³®Ä¤H¼Æ¬°150¤H, ¬Û¹ï©óµL®Ä¤H²Õ¬°50+100=150¤H ¦Ó¤µ¦~5¤ëªºlocal PD 229¤H,Y¥H20%»~®tpºâ¬° center PD 183¤H ¦ÓY°²³]µL®Ä²Õ¤w¥þ¼Æ´_µo,¨Óºâ¬I¥´«á¦³®Ä²Õ´_µo¬°33¤H (¦³¥i¯à³Ì¦¬I¥´¸g¹L3~4¦~¦Ó´_µo),822¤´¥iÂk¬°¥P¤¦µ¥¯Å¦Ó ¦p¦¹¨Ó¬Ýlocal PD 229¤H«D±`¦X¥G¹w´Á. ¦ý¦pªG¥H¤W¬°¯u¦bÀù´¹¤ù©|¥¼°Ý¥@¤§«e¯E¹©³Ì¦n¦³§Ö³tÅç¡uGlobo H¡vªº§Üì"ªº³]³Æ,¥iµû¦ô¯f¤H¥i§_¾A©ó¬I¥´,´N¹³¶PÀù¥n¥ýÅç°ò¦]¤@¼Ë ¥H¤W²L¨£¶È¨Ñ°Ñ¦Ò,§Æ±æ¦U¦ì¤j¤j¥i¥H«ü¥¿ |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2015/6/3 ¤U¤È 07:00:52²Ä 889 ½g¦^À³
|
¤Ñ°¨¦æªÅªºJ¶Ã«÷´ê ¤H¦b²§¶m¤ß¦b822 ©ú¦~¤¤³Ì¨Î¸Ñª¼®É¾÷,¦ý´_µo¤H¼Æ¤Î®É¶¡°Ï¶¡¥²¶·ºCºCªº©Ô¥X¤@±ø¶V¨Ó¶V²Óªºªø§À¤Ú~ |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2015/6/3 ¤U¤È 06:45:31²Ä 888 ½g¦^À³
|
±i¸³¤§«e¨ü³X¤º®e: ¤j®a³£¥H¬°¬O¥§¡ÂI,°²³]»¡¦³3Ó¤H,³o¤H¬¡3Ó¤ë,³o¤H¬¡5Ó¤ë,¨ºÓ¤H¬¡3¦~ ¨º¥¦¤¤¶¡È´N¬O5Ó¤ë ¤]´N¬O¬Ý¤¤¶¡³oÓ¤H¬¡´XÓ¤ë´N¬O´XÓ¤ë. ©Ò¥H¤£¬O»¡¤H¼Æ¶V¤Ö¶V¦n,¦AÁ|Ó¨Ò¤l °²³]§ÚÌnªº284Ó¤H,´_µoªº¦³60Ó¤H,¥i¬O¨º60Ó¤H¸Ìªº¤¤¶¡ÂI¦³31Ó¤H³£¬O5Ó¤ë ³Ñ¤Uªº³£«Üªø,¥i¬O¤¤¶¡ÈÁÙ¬O5Ó¤ë ©Ò¥H¦bÁ{§É¸Ñª¼«e§ÚÌ«ç»ò¥i¯àª¾¹Dµ²ªG,¥~¬É¹ï¨ä¤¤³ø§iªºµ²ªG³£¬O²q´ú,¤£¨ì³Ì«á¤@¨è¬O¤£·|¦³µª®×ªº. ´_µo¤H¼Æ¤£°÷¤£¨ã²Îp·N¸q¡A²{¦b´_µo¤H¼Æº¥¼Wµ´¹ï¬O¦n¨Æ¡A¦ý´_µo®É¶¡»Ý©Ôªø¦Ó¥BºCºCªº´_µo~ Åý¤¤¶¡È¸¨¦b¬ù48¡Ò2ªº¦±½u(«e«á·|¦³¸¨®t)»Ý¬Ý¤¤¶¡ÂI°ª®p¸¨¦bþ,©Ò¥H¥Ø«e¬Ý¨Ó¨ÌµM¶¶§Q ¤§«e229¦³µo¤å½Ð±Ð¦U¦ì¤j¤j¡A§P©wºÃ¦ü´_µo¯f¾ú¡A¨ì½T©w´_µo¯f¾ú»Ý¦h¤[®É¶¡~ ©Ò¥Hpfsn¹L25¥H¤WÀ³¦³Ãø«×,¦ýn¦b¥«³õ¤W³q±þ©Ò¦³ÃĪ«À³¸Ó¤£Ãø ¦ý¨Æ±¡¨M¤£¬O²Â¤H·QªºÂæ(§Ú.§Ú.§Ú)§Ú¤@ÂI±M·~ª¾ÃѤ]¨S,¥u¯à¤Ñ°¨¦æªÅ«÷´ê3¤£5®É¥X¨Ó¶Ã¤@¤U~¦U¦ì¤j¤j´N§Ô@¤@¤U§a~ |
|
|
·|û¡GYunyun10140355 µoªí®É¶¡:2015/6/3 ¤U¤È 06:29:57²Ä 887 ½g¦^À³
|
¥H«e«Ü¦h¤H³£»{¬°¤ý³·¬õ©Î±i©¾¿Ñ¤£¬O¥Õè ¦ý¨Æ¹êÃÒ©ú ¤ý³·¬õªº¦Ût³y¦¨©Ò¦³ªÑªF·l¥¢¤]¬O¨Æ¹ê¤µ¤é(¤E¤G¦@ÃÑ) ¦Ó±i©¾¿Ñ¦b«D¥»·~ªº§ë¸ê¤]¬OÁë¦Ð¦ÓÂk. ¯E¹©¤w¸g¬O¤W¥«¤½¥q ´_µo¤H¼Æªº¼Æ¾Ú§óÀ³¸Óºë·Ç¦p¹ê¤½¥¬ ª¾¹Dº}«Gªº¼Æ¾Ú¬°¦ó?§óÀ³¸Ó³z¹LªÑ¥«Æ[´ú¯¸¦p¹ê¤½§i §_«h¤£¬O¦¨¤F¤º½u¥æ©ö¶Ü? ¥Ø«e¯E¹©¨S¦³¸ê¨÷ ´«¨¥¤§ §ë¸ê¤j²³ ®Ú¥»µL±qÁ×ÀI ´²¤á³Ì¤£¨ü«OÅ@ ¤]¬O¥D¤O ª÷¥D °]¹Î Ây±þªº¹ï¶H §ÚÌ·íµM¤£¯à§_©w¬ãµo¹Î¶¤ªº¥I¥X»P¨¯W ¦ý¤]¤£¯àÅý¯S©w¤H¤hª±§Ë©óªÑ´x³y¦¨¶Ë®` .¦A»¡ ¦¨ªG¤§«á ¬O§_¤À¨Éµ¹¤pªÑªF©O? ¨º´Nn¬Ý¥ø·~¨}¤ß¤F ²¦³ºªÑªF¨Mµ¦Äw½X¦hªº»¡¤Fºâ¼Æ . |
|
|
·|û¡G£~£~10134649 µoªí®É¶¡:2015/6/3 ¤U¤È 06:07:51²Ä 886 ½g¦^À³
|
LOCAL:229,°²¦pÅÜCentral´î13%¨Óºâ,«h¬ù´î¤Ö30¤H, Central:199 Other:37 Á`¨ü¸Õ349-199-37=113,³o113¤H¦³¥i¯àNED, ¸ÕÅç²Õ232¤H,¨ä¤¤¦³¥i¯à113¤HNED,¤ñ²v¬°113/232=48.7%, ¤@´Á¸ÕÅçNED:10/27=37%, ¦]¦¹,¥Ø«e±¡ªp¨Ã¥¼¥¢±`,Y¥¼¨Ó´_µo¼W¥[¤H¼Æ¦b29¤H¥H¤U, «h¤G´Á¸ÕÅ礴¤ñ¤@´Á¸ÕÅç¶i¨B¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/3 ¤U¤È 05:56:01²Ä 885 ½g¦^À³
|
¤wª¾822Áö«D¥P¤¦¡A¦ý¤]ºâ¬O§®ÃÄ PLACEBO + Herceptin + docetaxe, M PFS =12.4 PERJETA + Herceptin + docetaxe, M PFS =18.5 (12.4 + 49%) 822³æ¿W¥ÎÃĦpªG´N¯à¤ñ¹ï·Ó²Õ¹w¦ô6Ӥ몺M PFS + 150% ~ 250%,¤]¬O¤£±o¤F ¦pªG¯uªº822 M PFS>18.5§ó¨ã¦³«ü¼Ð·N¸q¡A©Ò¥HÁÙ¬O¼ÖÆ[¬Ý«ÝªÑ»ù4¦ì¼Æªº¨Ó¨ì 1.°Æ§@¥Î¤Ö 2.¶Pº¸»X/Her 2/¤T³±©Ê³£¾A¥Î 3.822³æ¤@¥ÎÃÄPFSÁÙ¬OÀu©ó²{¦³ÃĪ« 4.¦³¨Ç¦]¬°Globo H¤ÏÀ³²v§C¼vÅTM PFS, ¦pªG¥¼¨Ó²ÎpÀù²ÓMGlobo H²v»PÀø®Ä¡A¥ÎÃÄIgG,IgM¤ÏÀ³²v¬ÛÃö©Ê«á ¯à§ó²M·¡Àø®Ä 5.833 ¥|ºØÀù¯gn¶}©l¶i¦æ...µ¥µ¥ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/3 ¤U¤È 05:49:14²Ä 884 ½g¦^À³
|
¤µ¤Ñ¤£¤Ö¤H°Ý§Ú´_µo229¤H¬O«ç»ò¦^¨Æ¡H§Ú·Q쥻¤£©ú¨s²zPD229¬O«ç»ò¦^¨Æªº§ë¸ê¤H¡A½L¤¤¬Ý¨ì°OªÌ¤£°÷²`¤Jªº³ø¾É¡A¥H¬°5¤ë¯uªº¤w¸g´_µo229¤H¦Ó·P¨ìÅ宣¤£¤w¡A³y¦¨«á¨Óªº±þ½L´N¤£Ãø²z¸Ñ¡A©Ò¥H¡A¤@ª¾¥b¸Ñ¥[¤WÄw½X±ªº¦]¯À¾ÉP¤µ¤Ñªº«®À¡A§Ú·Q¤F¸Ñ¯u¥¿ªºì¦]«á¡Aµu½u¤Wªº¯ÉÂZ¥i¼È®ÉÂ\¤@Ãä¡A«¤ß±Mª`¦b«áÄò°ò¥»±µo®i¡A¤ß±¡ªº°_¥ñ¸û¯à±±¨î¡A¦U¦ì¤j¤j¡A©¼¦¹¥[ªo¡I |
|
|
·|û¡GTony10139281 µoªí®É¶¡:2015/6/3 ¤U¤È 05:48:33²Ä 883 ½g¦^À³
|
¤µ§¡»ù335½æ¤F, ÁöµM½ß¤F,¦ý¸U¤@©M°ò¨È¤@¼Ë §ó¦å¥»µLÂk¤F, »{¦Pªü©vªº»¡ªk "¤@ª½Ä±±oª©¤Wªº®ðª^¤Ó¹L¼ÖÆ[¡AÅ¥¤£¶i°f¦Õªº©¾¨¥ ¶X³oÓ¾÷·|§â´²¤á³£¬~¥X³õ¤]¦n¡A§ë¸ê·sÃĪѡA¥»¨Ó·ÀI´N«Ü°ª |
|
|
·|û¡G³\¤j10137169 µoªí®É¶¡:2015/6/3 ¤U¤È 05:24:22²Ä 882 ½g¦^À³
|
©I¥s~¤ý£«¬Â¤j! ··«B«B¤¤ ¤p§Ì·QÅ¥°±§Aªº·N¨£ ¤è«K²{¨´£¨Ñ·N¨£ ·P®¦! |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/3 ¤U¤È 05:22:49²Ä 881 ½g¦^À³
|
©Ò¥H¤é²±ªº³ø§ipfs 16.5Ó¤ë³Ì±µªñ¨Æ¹ê |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/3 ¤U¤È 04:33:48²Ä 880 ½g¦^À³
|
¦^À³¥xÁÞ¤j°ÝÃD¡A 2015/6/3ªÑªF·|¡A¥~¦æ¤H¬Ý¼ö¾x¡A¤º¦æ¤H¬Ýªù¹D¡A ¤µ¤Ñ¨£¨ì¯Q¾~µo¨¥»¡²×©ó¬Ý¨ì¯E¹©¸õ¤ô¡A¦b¨ºùض}¤ßªº©ç©ç¤â¡A¯u¦n¯º~~ ¤×¨ä¬O¦b12:30·í¥X²{¡¨´_µo¤H¼ÆPD=229¤H®É¡¨Åý¤£²z¸Ñªº¤H½T¹êÀ~¨ì¤F ¦ý822¨s³º¥«³õ»ùȦbþ¸Ì¡APFS·|¬O¦h¤Ö? ®e§Ú¹D¨Ó: 2014/8 LR142(CR142©¹«e±À4Ó¤ë) 2014/12 LR187,O26 2015/5 LR229,O37 §Ú¥Î¼Ò«¬ºâ¤F¤@¤U¡A ³Ì®tªº±¡ªp¡AOthers¤j¦h³£¬O¹ï·Ó²Õ®É¡AY¹ï·Ó²ÕPFS=6, 822 PFS¬ù¦b15¥ª¥k ³Ì¦nªº±¡ªp¡AOthersÀH¾÷¤À¥¬¦b¹êÅç²Õ»P¹ï·Ó²Õ¤¤¡AY¹ï·Ó²ÕPFS=6, 822 PFS¬ù¦b20¥ª¥k ¥ý«e¤j®a(¥]§t§Ú)·Q±o¤Ó¼ÖÆ[¡A142´_µo[¤H¼Æ³oӼƦrÀ³¸Ón©¹«e±À3~4¤ë¡A¬Æ¦ÜÁÙ¥Î120ºâ¡A·íµMPFS 24+, ¦ý°È¹ê¦a¨Ó¬Ý¡A°Æ§@¥Î¤p¥BPFS15~20¹ï©ó¨ÅÀù¥½´Á±wªÌ¨ÓÁ¿¤]¬O¤@¤jºÖµ¡A§Ú»{¬°¥ú²{¦b¤w¸gÈ500¤¸ªº»ùÈ¡A¦¨¥\¤W¥«®É¤]À³¸Ó·|»·¶W¹L1000¤¸ªº»ùÈ(©IÀ³±z©Ò»¡ªº¥ú¼Ú¤é±ÂÅvª÷¬ù8.5»õ¬ü¤¸, ¨CªÑ°^Äm=150 NT) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 04:21:16²Ä 879 ½g¦^À³
|
¯E§b¤j ¥i¥H°²³]9¤ë¡A10¤ë¡A11¤ë¡A12¤ë¥|Ӯɬq¸Ñª¼®ÉªºPFS¬ù¦h¤Ö |
|
|
·|û¡Gbill10135881 µoªí®É¶¡:2015/6/3 ¤U¤È 04:10:50²Ä 878 ½g¦^À³
|
¤j¤j ¤@Ó²{¶¥¬q¥H¬ãµo·sÃÄ¡A¬°¥þ¤O§ëª`ªº¤p¤½¥q¡Aû¤u¤£¨ì¦Ê¦W¡A¤½¥qªv²z¥i¥H¥[±jÀ³¸Ó¸É±j¡A¦ýµ´«D²{¶¥¬q¤½¥q¥þ¤ß§ë¤Jªº«ÂI! |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/3 ¤U¤È 04:08:45²Ä 877 ½g¦^À³
|
¤£¦n·N¦ü, ¥xÁÞ¤j §Úºâ¹êÅç²Õ120¤H ¹ï¨ìªº¬O¦b10¤ë ¥i¯à¬O§Ú°Ñ¦Ò¤p©_¤j§â®É¶¡®t¦Ò¼{¶i¥h²£¥Íªº®t²§? ÁÙ¬O§Ú¥u¦³¤p¾Çµ{«×¥u·|µ¥¤ñ, ¹ê»Ú¨Ã«Dµ¥¤ñ¼W¥[? |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/3 ¤U¤È 03:29:07²Ä 876 ½g¦^À³
|
³o»ò«nªº¼Æ¾Ú¡A³Ì²×µª®×¬O»~´Ó ³oª±¯º¶}¤j¤F ¹ï¤½¥q«e´º¨S·N¨£ ¦ý¹ï¤½¥qªºªv²z¡AÓ¤H»{¬°µ´¹ï¬O¤£¤J¬yªº ¤½¥qµo¨¥¤H¬O¦Yxªº |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/3 ¤U¤È 03:20:57²Ä 875 ½g¦^À³
|
¦pªG¦³®É¶¡®tªº°ÝÃD ¨º12¤ëCR=142, ¹ï¨ìªºÀ³¬O9¤ëLRªº½T»{ ¦p¦¹CR/LR»~®t¥i¯à¥u¦³13-14% (¹w¦ô9¤ëLR=165) |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/6/3 ¤U¤È 03:08:13²Ä 874 ½g¦^À³
|
¯E¤ÍÌ ¤p§Ì¤µ¤é¨ÃµL¥X®uªÑªF·|,¦b¦¹,¥ý·PÁ¦U¦ìªº¤À¨É ¤p§Ì¦³¨Ç·Qªk¤]»P¤j®a¤À¨É 1.´N§ë¸ê¤Hªº¨¤¦â¦Ó¨¥,¤p§Ì»{¬°¨S¦³¯S§O¤£¦n©Î¦n,«O«ù¤¤¥ß·Qªk 2.´N¯f±w¦Ó¨¥,¤p§Ì»{¬°"¦n",¥un¤ñì¥ý¹w©wÁÙ¦n³£¥s¦n,³Ì«nªº¬O¯f¤Hªº¥Í¬¡«~½è±o¥H§ïµ½ Àù¯g¯f¤H³Ì§Æ±æªº¬O¥ÎÃÄ,³Ì®`©Èªº¤]¬O¥ÎÃÄ,°Æ§@¥Î¤pªºÃĤS¯à§ïµ½¥Í¬¡«~½èªºÃĥثe¯uªº¨S¦³ 3.n¥[½X»P´î½X¤p§ÌÓ¤H»{¬°¦Û¤v°µ¦Û¤vªº¥D¤H,¦Û¤v§PÂ_ ¦A¦¸·PÁ¤j®aªº¤À¨É,¦³¯E¤Í̯u¦n |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 03:01:54²Ä 873 ½g¦^À³
|
¬ü°ê¤@¦~¨ÅÀù¦º¤`¬ù¥|¸U¤H¡AYK¤@ª½强½Õ¬ü°ê¤G´Á¬O¥H¤T´Á³W®æ¨Ó¶i¦æ¡AÁÙ»¡¦³¤@¨ÇÃĤG´Á¼Æ¾Ú¤½§i«á«Kª½±µ¥Ó½ÐÃÄÃÒ¡AFDA®ÖãÃÄÃҳ̰ª¦Ò¶q¬O¯f¤Hªº§Q¯q¡AÓ¤H·Pı¯E¹©·Qª½±µ¥H¥xÆW¤T´Á¥[¬ü°ê¤G´Á¼Æ¾Ú¥Ó½ÐÃÄÃÒªº¥ø¹Ï¤ß»á¬°强¯P¡A¥t¥~¤]´£¨ì¤@Áû¤p¤p§Ü¥Í¯ÀÃÄ¥H2.5»õ¬ü¤¸±ÂÅv¼Ú¬w¡AÃø©Ç¤é²±µû¦ô¨ÅÀùÃÄ ¼Ú¤é±ÂÅvª÷¬ù8.5»õ¬ü¤¸ ¥H¤W¶È¨Ñ°Ñ¥[¡A¦p¦³»~½Ð§ó¥¿ |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/3 ¤U¤È 02:40:36²Ä 872 ½g¦^À³
|
¯}300¥[½X §Ú´N»¡µ¥6¤ë3¤é ¦nÀI¨S½ä |
|
|
·|û¡G°ß±©10140520 µoªí®É¶¡:2015/6/3 ¤U¤È 02:37:16²Ä 871 ½g¦^À³
|
¤µ¤ÑªºÃz¶qÁÙ¥´¤£¨ì¶^°±¡A¬Ý¨Ó¬Û«H¤½¥q¬£ªº¤HÁÙ¬O¤£¦b¤Ö¼Æ¡C |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/3 ¤U¤È 02:36:15²Ä 870 ½g¦^À³
|
rabbit¤j, «D±`·PÁ±z«ÈÆ[ºëÅPªº¸Ñ»¡. 2014-12 Local Read: PD 187 / Others 26 2015-05 Local Read: PD 229 / Others 37 ¦pªG¥Î³o¤GӼƦr¨Ó¦ôºâ, median PFS¤]¦³21Ó¤ë¥H¤W, P< 0.001 ÁÙ¬O¤£¥Î¤Ó¥¢±æ. ¤µ¤Ñ±þ¥Xªº¤H, ¹L´X¤Ñ¤Sn«á®¬. ¯E¹©¤£¬Oµu½u§ë¾÷ªÑ. µ¥«Ý¬O¦³»ùȪº. ¯E¹©ªº®Ö¤ß¤Hû, ¤µ¤Ñ³£°Ñ¥[ªÑªF·|, ³£«Ü¯u¸Û¼ö¤ßªº¦^µªªÑªFªº°ÝÃD. ¥L̹ï¤G/¤T´ÁÁ{§É¸ÕÅ礴©ê«ù¼ÖÆ[ªº¤ß±¡. ·Q·Q ¥LÌÓ¤H¤Î¿Ë±ªB¤Íªº«ùªÑ·|¤ñ§Ṳֶ́Ü? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 02:28:04²Ä 869 ½g¦^À³
|
¤p©_¤j¡A¥ò´º¤j¡A²q·Q¤j¡A±ø¤j¡Aµ½¤H¤j ¥i¼ÒÀÀ¤@¤U¡A¨ì¤µ¦~12¤ë°²³]¹ï·Ó²Õ110¤H Central read,¹êÅç²Õ120¤Hcentral readªº±¡ªp¤U¶}ª¼,PFS¬ù²¤¼Æ¾Ú¡AÁÂÁ |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2015/6/3 ¤U¤È 02:16:17²Ä 868 ½g¦^À³
|
±i¸³¦³"»¡ªñ´Á§Æ±æ¤Þ¶i¥~¸ê ©Ò¥H¥Ñ¤¸´I¨ó§U¿ì¦n¥~ªk»¡ ®ü¥~ªk¤H»¡«Ü«á®¬²{¦b¤~ª¾¹D¦³³oÃħ_«h¦§ë¸ê¤F" ¥H¤W¬O¤j·N ¥t¥~¦pªGPFS¤£¿ù¤T´Á¸Ñª¼«á·|±ÂÅv ³Ìªñ¦³®aXX¤½¥q(¤p§Ì§Ñ°O)±ÂÅv¼Ú¬w ÀH«K´N2.5»õ¬üª÷ (¤p§Ì²q ¦óªp¬O¯E¹© À³¸Ó¦³¼Æ¿»ùÈ ¦ý¤@¤Áµ¥¸Ñª¼) ¶}§¹·|«Ü¦w¤ß¶}¤ß¦a¥h¦Y¶º ¦Y§¹¶º¤@¬Ý½L ¥H¬°²´ªá ¯uªºÄw½X³£n´«¨ì¥~¸ê¤â¤W? ¦ý¦Ò¶q¦³³\¦h§ë¸ê¤H³£¬O¥HªÑ²¼»ù®tºû¥Í ©Ò¥H¤]¨S¤°¦n³dÃø¥LÌ ¤j®a¦U¨ú©Ò»Ý ¤p§Ì¥i¬O«H¤ß¤Q¨¬! |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/3 ¤U¤È 02:12:35²Ä 867 ½g¦^À³
|
·PÁ¤p©_¤jªº²Ó¤ßªÈ¥¿¡Aªº½T«O¦u¦ô¨ì9¤ë©³¬°©y¡C |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/3 ¤U¤È 02:03:46²Ä 866 ½g¦^À³
|
±Û«a¤j¡A¥xÁÞ¤j¡A ±i¸³3/3»¡¤£¨ì142¤H¬O¹ïªº ´N¬Ocentral read¨ì2014/12/31¤£¨ì142¤H ¦ý¦³®É¶¡®t¡A³o¸ê®Æ¶×Á`¨ì¬ü°ê¿W¥ß¤¤¤ß§PŪ«á¦A¦^¶Çn2.5Ó¤ë ´N§ì«O¦u¤@ÂI¡A§ì¤@Ó¾ã¼Æ3Ó¤ë¡A ©Ò¥Hcentral read¤£¨ì142¤H³oӨƹê¬O2014¦~9¤ë©³ªº¨Æ ±q¤Ñ¤Wªº¥P¤¦ Åܦ¨¤H¶¡³Ì¦nªº¨ÅÀùÃÄ ´N¬Ý¥xÆWªº§ë¸ê¤H«ç»òµû»ùÅo ¤£·|µû»ùªº¸Ü´Nµ¥¸Ñª¼«á¥æµ¹¥~¸ê¨Óµû§a¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 01:59:02²Ä 865 ½g¦^À³
|
¦U¦ì·Q¤@·Q ¹êÅç²Õ¦bcentral read ¦b 50 75 100 120³o¥|ӼƾڸѪ¼¡A ¨º¤@Ӽƾڷ|²£¥Í³Ì¦nªºPFS,nÅý§Ú¦^µª§Ú·|»¡³Ì«á ¤@Ó¡A¤H¼Æ¤Ó¤Ö¸Ñª¼PFS·|¤£°÷«GÄR ¡A¥Ø«e¦ôp¹êÅç²Õ©|¯Ê45¤H¡A²q´ú³oÀ³·|¨Ó¦Û¦´Á¦¬®×ªº°í±j°ü¤k¡A¦o̼µ¨ì³Ì«á¤@¨è¤~´c¤Æ¡A¦]¬°¥h¦~¤K¤ë¨ì¤µ¦~12¤ë ¤w¸g¾ú¤F16Ó¤ë¡AµL®Äªº¦´N´c¤Æ±Æ¶¤±Æ«e±¡A¯E¹©¦bµ¥°í±jªº°ü¤k´c¤Æ±Æ¶¤±Æ¤¤¶¡¡A¦´Á¨º66¤H¤w¸g¾ú ¤F34_46Ó¤ë |
|
|
·|û¡Gbill10135881 µoªí®É¶¡:2015/6/3 ¤U¤È 01:49:55²Ä 864 ½g¦^À³
|
¦³«H¤ß¡A¤p§Ì¤µ¤é¬O¶X¶Ã§½§À½L¥[½X¡A¤p¤p¦A¶R¤T±i! |
|
|
·|û¡Gwison3710140346 µoªí®É¶¡:2015/6/3 ¤U¤È 01:42:52²Ä 863 ½g¦^À³
|
¤£¸g¤@µf´H¹ý°© ²j±o±öªá¼³»ó»..@¤ßµ¥«Ý§a |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/3 ¤U¤È 01:39:22²Ä 862 ½g¦^À³
|
¦³¤H»¡§Ú̳£¤Ó¼ÖÆ[¡A§Ú¦Û¤v¤]±`ÀË°Q¬O¤£¬O¥Ç¤F«ÜÄY«ªº¦Û§Ú·Pı¨}¦n¿ù»~¡HµS°O±oPD229ª§½×¤£¥ð¡A§Ú¦Û»{¨S¦³¨º¼Ë°ª«×´¼¼z¥h¤À¿ë¦óºØª©¥»¬°¥¿½T¡A§Ú¥u¦³¤@Ó¤¤¤ß«ä·Q¬°¨Ì¾Ú¡A¨º´N¬O±i¸³»¡¥h¦~©³´_µo¥¼¹F142¤H¡A¦Ó³o¶µ¼Æ¾Ú¬OCRµ¹ªº¡A¤µ¤ÑªÑªF·|¤W¤]¦A«×ÃÒ©ú³o¤@ÂI¡A¨º´N°÷¤F¡A¨º´N¤ßµLÄa©Àµ¥¨ì²Ä¥|©u¡C |
|
|
·|û¡G¤p®æ10136562 µoªí®É¶¡:2015/6/3 ¤U¤È 01:37:00²Ä 861 ½g¦^À³
|
¤~´XÓ¤ë®t¶Z¦n¹³«Ü¤j,¤§«e¤Ó¼ÖÆ[¤F¶Ü? ӪѡG¯E¹©(4174)¨ÅÀù·sÃĤT´Á´_µo¼Æ229¤H¡A8¤ë¶}±M®a·|ij©w¸Ñª¼®É¶¡ 2015/06/03 12:41 °]°T§Ö³ø ¦ó¬ü¦p ¡i°]°T§Ö³ø¡þ¦ó¬ü¦p³ø¾É¡j¥xÆW¯E¹©(4174)¤µ¤éÁ|¦æªÑªF·|¡A¤pªÑªF»EµJ¨ÅÀù·sÃÄOBI-822¡A¸³¨Æªø±i©À·Oªí¥Ü¡A¤w³W¹º8¤ë¥l¶}±M®a·|ij¡A¨M©w¸Ñª¼®É¾÷¡FºI¦Ü5¤ë25¤é¤î¡A¤T´ÁÁ{§Éªº¯f¤H´_µo¤H¼Æ¬°229¤H¡A±©¦¹¼Æ¾Ú¬°Âå¥Í§PÂ_¡A¥i¯à·|¦³®É¶¡®t¤Î»~®t¡A³Ì²×ªk³W±N¥H¿W¥ß§PŪ¤¤¤ßªº¼Æ¾Ú¬°·Ç¡C ¡@¡@OBI-822¬O¥þ²yºÓÀù¯g¥D°Ê©Ê§K¬ÌÀøªk¡Aº¶µ¾AÀ³¯g¬°¨ÅÀù¡A¤µ¦~5¤ë349Ó¦¬®×±N¥þ¼Æ§¹¦¨Àøµ{¡A8¤ë³Ì±ß¥[¤JӮפ]¤w©¡º¡¤@¦~¡C±i©À·Oªí¥Ü¡AºI¦Ü5¤ë25¤é¤î¡A´_µo¤H¼Æ¬°229¤H¡A¦ý¦¹¼Æ¾Ú¬°40¦ìÂå¥Í©Ò§PÂ_¡A«D¿W¥ß§PŪ¤¤¤ßªºµ²ªG¡A¦s¦b2.5Ӥ몺®É¶¡®t¡A»~®tȤ]¥i¯à¹F20%¡C¥Ø«e³W¹º8¤ë¥l¶}±M®a·|ij¡A¨M©w¸Ñª¼®É¾÷¡A¦Ó³Ì²×ªk³W¤´¥H¿W¥ß§PŪ¤¤¤ßªº¼Æ¾Ú¬°·Ç¡C ¡@¡@¬ü°ê¤Î¥þ²y¤T´ÁÁ{§É¸ÕÅçpµe¡A±N«Ý¥xÆW¤T´ÁÁ{§É¸Ñª¼µ²ªG¡A¦A¶i¤@¨B³Wµe¤j³°Á{§É¸ÕÅç®Éµ{«h´Á«Ý¤U¥b¦~¯à¶¶§Q®i¶}¡C²Ä¤G¶µ¾AÀ³¯g§Z±_Àù¡A¦b2013¦~11¤ë»P°¨°ºÂå°|¦X§@®i¶}¤G´ÁÁ{§É¸ÕÅç¡A³Ì§Ö¦~©³¥i±æ§¹¦¨110¤H¦¬®×¥Ø¼Ð¡A²{§óµÛ¤â³W¹ºOBI-822¯ØŦÀù¾AÀ³¯g¤G´ÁÁ{§É¸ÕÅçpµe¡C ¡@¡@Globo¨t¦Cªº·s¥@¥NªvÀø©Ê¬Ì]OBI-833¡A¥h¦~12¤ë¤wÀò¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)³q¹L¤HÅéÁ{§É¸ÕÅç¼f¬d(IND)¡A¤]ÀH§Y¦V¥xÆWTFDA´£¥XIND¥Ó½Ð¡A¦pÀò³q¹L¡A¤U¥b¦~±N®i¶}Á{§É¤@´Á¸ÕÅç¡C ¡@¡@§Q¥ÎÁÞ¬ì§Þ¶}µoªºÀù¯g¶EÂ_¸Õ¾¯¢wÁÞ´¹¤ùOBI-868pµe¡A¹wq2016¦~®i¶}Á{§É¸ÕÅç¡C¦×¬r±ìµß¯ÀOBI-858¡A¥h¦~¥ç¤w§¹¦¨Á{§É«e¸ÕÅç¡Aµ²ªGÅã¥Ü²£«~¨ã¨}¦n¬¡©Ê¡A¹wp¤µ¦~¤º§¹¦¨¬r²z¸ÕÅç¡AÀH§Y¥Ó½ÐÁ{§É¸ÕÅç³\¥i(IND)¡C |
|
|
·|û¡G³Í¤l³Í10140178 µoªí®É¶¡:2015/6/3 ¤U¤È 01:35:57²Ä 860 ½g¦^À³
|
½æ±¼¤F¡AªÑªF·|"Ó¤H"ªº·Pı ¸Ñª¼À³¸Ó¨S°ÝÃD(ÁÙ¬O¤@®a¦n¤½¥q)¡A¦ý¬O¥i¯à¤£·|¯S§O¦n ·Pı«D±`¤¤©ÊªºµûÂ_¡C «áÄòÁÙ¦³FDAÃÄÃÒ¡A³q¸ô¡A¾P°â n¤W1000¦nÃø¡A¦³¤j¤j¦ô500ªº»ùÈ¡A¦ý¬O²{¦bªÑ»ù¤w¸g340 §Q¼í(160)Vs·ÀIVs®É¶¡(2¦~) |
|
|
·|û¡GWang10139528 µoªí®É¶¡:2015/6/3 ¤U¤È 01:32:20²Ä 859 ½g¦^À³
|
¨Ó¨Ó¨Ó¡A°µÓ²Îp¡A¤µ¤Ñ¬Ý¨ì³o¼Ëªºªk»¡·|¡A§âªÑ²¼½æ±¼¶]±¼ªº¦³´XÓ¡HÁÙ¬O¤@±i³£¨S½æ°f¶Õ¥[½Xªº¦³´XÓ¤H¡H |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/3 ¤U¤È 01:15:55²Ä 858 ½g¦^À³
|
¤j®a³£¤Ó¼ÖÆ[ ¥¢±æ©Ê½æÀ£¤£ª¾n¨ì¤°»ò®ÉÔ¤F |
|
|
·|û¡G¨}ÃÄW¤f10139639 µoªí®É¶¡:2015/6/3 ¤U¤È 12:59:15²Ä 857 ½g¦^À³
|
2014/12 LR187,O26,CR¤£¨ì142, 2015/5 LR229,O37 822«D¥P¤¦¡A¤j®a¥¢±æ¡A¤µ¤Ñ¥X²{¥¢±æ½æÀ£ 822 PFS 12-18±z¥¢±æ¶Ü¡A§Ú¬O¼f·V¼ÖÆ[¡AÁÙ¬OÈ500¥H¤W»ùÈ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/3 ¤U¤È 12:55:55²Ä 856 ½g¦^À³
|
¥xÁÞ¤j¡A¹êÅç²Õ´_µo¹F110¤H¡A§Ú§PÂ_²Ä¥|©u¦³¾÷·|¹F¨ì³oӼзǡC¥ý«e¦³°µ¹Ú¡A¹Ú¤¤¦³¤O¤H¤h»¡¡Aµ¥¨ì²Ä¥|©u¡A¤@¤Á²×±N©ú®Ô¡C²{¦b¡Aר¾i©Ê¡A¥R¹êÂåÀø¤º²[¬°¤Wµ¦¡C |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/3 ¤U¤È 12:49:01²Ä 855 ½g¦^À³
|
©Ò¥HY¦~©³¸Ñª¼,©ú¦~¥Ó½Ð¥xÆWÃÄÃÒ,2016¶}½æ,¦³topline ¬O¥i¯àµo¥Íªº |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 12:43:19²Ä 854 ½g¦^À³
|
±Û«a¤j §A¦ô¨ì¥Ø«e¹êÅç²Õcentral read ¬O74¤H¡A§Ú»{¬°¦b³oӼƦr¤U¶}µPPFS·|¤£°÷«GÄR¡A¹êÅç²Õ¶W¹L110¤HPFS¤~·|«GÄR¡A¤~¯à´ç¹L¶Â´ËªL¡A¬Ý¨ì¬üÄR±mi¡AªÑªF·|°Ñ¥[¤H¼Æ«Ü¦h¡A¯u¥¿¬ÝÀ´ªù¹Dªº¤H¡A¤S¦³´X¤H?ª¾µÃø´M |
|
|
·|û¡Grabbit10136567 µoªí®É¶¡:2015/6/3 ¤U¤È 12:33:46²Ä 853 ½g¦^À³
|
Hi §Q¯A¤j¤t¤j/¥ò´º¤j/µ½¤H ¥H¸~½FªºÁ{§É§Þ³N«ü¾É¸ê®Æ¦Ó¨¥¡A¦b 1970s¡¦ FDA ³q±`¬O°ò©ó ORR ªº¼Æ¾Úµ¹¤©ÃĪ«»{ÃÒªº¡A ¦ý¦b 1980s¡¦ ¤§«á FDA ¤£¦A¥H ORR ¬°¥Dn±ø¥ó¨Ó»{ÃÒÃĪ«¡A¦Ó¬O¥[¤J¤F§ó¦h¦³Ãö©ó "¸ÓÃĪ«¦³¯q" ©ó¯f±wªº±ø¥ó¡C OS DFS ORR CR PFS ªº¼Æ¾ÚÅã¥Ü¦U¦³¨äÀu¯ÊÂI¡A³oÃäµL¶·ÂØz¡A¦³¿³½ìªÌ¥i¥H¥Î "Object Response Rate"¡A §A¥i¥H§ä¨ì FDA ªº¤@¨Ç¸ê®Æ¨ä¤¤ªº Tabel1. ¼g±o«D±`²M·¡¡C 1. ¤@¯ë¥½´Á¸~½FÁ{§É³]p¬O¥H PFS ¬°¥DnÆ[¹î¼Æ¾Ú¡A¦ý¥½´Á¯f±w±µ¨üÁ{§É«á¡A Y OS µLªk»P¹ï·Ó²Õ¦³«Ü©úÅ㪺©Ôªø¡A«h PFS ´Nºâ¤ñ¹ï·Ó²Õªø¡A¨ä·N¸q¬O¤£°ªªº¡C PFS ¦b¼Æ¾Ú¤W¥i¸ÑÄÀ¬°ÃĪ«¹ï¸~½F§í¨îªº®ÄªG¡C 2. ORR ªº¸~½F«ÈÆ[½w¸Ñ²v´N¥i¥H¦õÃÒ¦¹ÃĪ«¦b "ªvÀø" ¤WªºÃĮįà¤O¡A Y¯f±w¬° SD ¡A±µ¨üÀøµ{«á«ùÄòºû«ù SD ªºªí²{¹ï PFS ¦³¥[¤À¡A¦ý¹ï ORR ¬O¨S¦³·N¸qªº¡A ORR ¬O¥²¶·©w¸q¸~½FÁY¤p«á¨Ãºû«ù¤@¬q®É¶¡¡A©Ò¥H ORR ¤ñ°_ PFS ¨Ó»¡¡A¹ï "Àø®Ä" ¦³§ó«ÈÆ[ªº¸ÑÄÀ¡C Q1: ©Ò¥H¡AYÃD¥Ø¬O¡A822 ¥HPFS > 20¬°±ø¥ó¥i¥H®³¨ìÃÄÃÒ¶Ü? A1: ¥i¥H¡A¦ýÁٻݦҶq OS »P¹ï·Ó²Õªº¤ñ¸û¡C Q2: PFS n¦h¤[? OS n¦h¤[? ¤~¯à§K¥h©Î´î¤Ö¼Ë¥»¼Æ FDA Phase3? A2: ·f°t§ó¦h¸ÓÃĪ«¦³¯q©ó¯f±wªº¼Æ¾Ú¡A¨Ò¦p ORR ©Î QOL ¥H¤W¬O¤p§Ì¹ï§A̪º°Q½×©Ò§ä¥Xªºµª®×¡A¨S¦³n§ïÅܧĄâ³yªº·Qªk¡A¶È¨Ñ°Ñ¦Ò ³Ì«á¡A¥O¤HÃø¹Lªº¬O¡AÓ¤H¥H¯E¹©¬°«e¤¥xÆW¥Í§Þ¤½¥q¡A¦ý³ºµM¦b¥¼¸Ñª¼«e¦]¬°§@·~²¨¥¢¦Ó³zÅS¤F Local Read PD¡A ³o¦b§Ú©M§Úªº®aÂå°Q½×®É¡A¥Lªº½T¤]¬Oº¡Áyªº¤£¥H¬°µM¡A¦Ó³Ì²³æªº»¡ªk´N¬O¡A¤µ¤Ñ¦³¤F³oÓ²¨¥¢¡A¤U¦¸©O? ³oÓ PD ¼ÆY¬O¥uµ¹ª£ªÑªº¦³¤ß¤H¤h©O? ¸Ñª¼¸ê°T¦³µL¥i¯à¤U¦¸¤½¶}«e´N¤w¸g¦³¥~³õ¯S©w¤H¤h®³¨ì¤â©O? ÁÙ¦³¡A¹ï PD ¼Æ¤£²z¸Ñªº¯f±w¡A·|¦³¬Æ»ò¸ÑŪ? ¯E¹©¯uªº¬O¥Ç¤F¤j¿ù¡A»~´Óªº¤½¥qû¤u¡AÁÙ¦³¼f½Zªº¡A³£ÃøÃã¨ä©S¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤U¤È 12:12:58²Ä 852 ½g¦^À³
|
¥ò´º¤j ¤½¥q¦^µªn¬Ýcentral read, ½Ð§Aµû¦ô¤@¤U¨ì¤¤ë®Écentral read ¬ù¦h¤Ö¤H¡A ¤@¤ë¬O¤p©ó142¡A°²³]¨ì12¤ë central read ¬O230¤H¨Ó¶}ª¼¡APFS¦p¦ó¡A¤½¥q¤µ¤Ñ©ú½T¦^µªFDA ÃÄÃÒ¬ÝPFS¡C |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/3 ¤U¤È 12:11:37²Ä 851 ½g¦^À³
|
ÁÂÁÂ¥xÁÞ¤j»¡©ú, ¤j®a³£¨S²q¹ï ¥»¨Ó¸£³U¦³°{¹L·|¤£·|©ñ¿ù¤ë¥÷, ¥i·Q·Q¯E¹©C, ¤S¤£¬O§ÚÌ®a²Â¯µ®Ñ ¨S¦³¤Uª`, ¤£µM¥i¿W±o4.9»õ ³Ì±µªñªº¬Oµ½¤H¤jªº¡¨¥´¿ù»¡", ¥h»â¼ú§a (¤£¹L§Ú¬Ý¥L²q±o¦³ÂI¤ßµê) |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/3 ¤U¤È 12:05:01²Ä 850 ½g¦^À³
|
¤£¬O¥P¤¦¬O¨}ÃĤ]¤£¿ù Y¬O¥P¤¦¶}ª¼®É¶¡·|µ¥¦º§A,¬O¨}ÃÄ«h¹w¦ô¦~©³¶}ª¼¤]¤£¿ù,²L¨£¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡Gªü©v10140551 µoªí®É¶¡:2015/6/3 ¤W¤È 11:48:53²Ä 849 ½g¦^À³
|
²Ä¤@¦¸µo¨¥... ¤µ¤Ñ°Ñ¥[ªÑªF·|¤F¡A·P·Q´N¬O ¤½¥q¹ï822ªº¸Ñ»¡ºâº¡¤¤©Êªº¡A±qPD¼Æ¾Ú¨Ó¬Ý¡A¥h¦~©³187¡A¤µ¦~¤¤ëªk»¡«e229 ±µªñ¤Ó¤ëªº®É¶¡¦³42¦ì´_µo¡A¥§¡¤@Ó¤ë¬O9Ó¤W¤U ¦Ò¼{¨ì°h¥Xªº¤H¼Æ37¡A¥Ø«e¥u¦³312¦ìÄ~ÄòÁ{§É¡AµM«á¡A229.... ³oÓÃĦü¥G¤£¬O¨º»òªº¥P¤¦¡APFSì¥ýª©¤W¼ÖÆ[¦ô¨ì300%¡A®£©Èn¤U×........ ·íµM¡A³o¬O§ÚÓ¤Hªº·Qªk ¥t¤@¤è±¡A±q¦n³B¨Ó¬Ý¡A³o¨Ç³£¬O±ß´ÁªºÂಾ©Ê¨ÅÀù¯f¤H¡A¥»¨Ó´N«ÜÃøªv¤F ¦Ó822¡Aì¥ý³]©wªº¾ãÅéPFS¥Ø¼Ð¬O+50%¨ì¤EÓ¤ë¡A¬O¦³¾÷·|ªº Á|¨Ò»¡¡AMerckªºPD-1ÃĪ«Keytruda¡A¹ï¤K¦Ê¦h¤Hªº¶Â¦â¯À½F¶i¦æ¤T´ÁÁ{§É µ²ªG¯f¤H¹ïKeytruda¦³¤ÏÀ³ªº¤ñ¨Ò¬O33%¡A°Æ§@¥Î¤ñ¸û¤p¡A¤@¦~¦s¬¡²v´£¤É30%¡A®³¨ìFDAÃÄÃÒ ©Ò¥HOBI-822¹êÅç²Õ¦pªG¯à¦³50%ªº¤ÏÀ³²v¡A´N·|¬O«D±`¦nªº¼Æ¾Ú ¨ÅÀù±ß´Á¯f±w¡A¤£¬O¨CÓ¤H³£¯à²£¥Í¨¬°÷ªº IgG¸òIgM ¤]¤£¬O¨CÓ¨ÅÀù²ÓM³£¦³Globo H series §Ú¥»¨Ó´Á«ÝªÑªF·|¥i¥H¦³§Q¦h¡A¤£¹LÅ¥§¹¾ã³õªº·Pı¬O¡A¤½¥qªº»¡ªk°¾¤¤©Ê ¤@ª½Ä±±oª©¤Wªº®ðª^¤Ó¹L¼ÖÆ[¡AÅ¥¤£¶i°f¦Õªº©¾¨¥ ¶X³oÓ¾÷·|§â´²¤á³£¬~¥X³õ¤]¦n¡A§ë¸ê·sÃĪѡA¥»¨Ó·ÀI´N«Ü°ª¡A¤Á°O!! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤W¤È 11:41:36²Ä 848 ½g¦^À³
|
¯E§b¤j ¤@¤ëªº¸ê°T¦¨¥ß¡A¤p©ó142¨ÌµM¦³®Ä¡A¸Û¹ê¬O¬ü°êºë¯«¡A¯E¹©È±o«H¥ô¡A¤£¦¨¼ô±À¦ô°²³]11¤ë«e¥i¹F¨ìPD220 Central read,À³¸Ó¬O¬Û·í¦nªº¶}ª¼®É¶¡ÂI |
|
|
·|û¡G¥ú¼v10031538 µoªí®É¶¡:2015/6/3 ¤W¤È 11:36:54²Ä 847 ½g¦^À³
|
³Ìªñ¦³¿Ë¤H¦]Àù¯gÂ÷¥@...ÃÀ¤H¦w¶vÀö¤]¬O¦]¬°¨xÀù¡A¦~¬ö»´»´´NÂ÷¶}¤F...ü ¦³¸g¾ú¹Lªº¤H¡Aª¾¹D¯E¹©ªºÃĦ³¦h«n¡A§Æ±æ·sÃįuªº¥i¥HÀ°§U«Ü¦h¤H~ ¦³©_ÂÝ°Á{¦bs¤p©j¨¤W¤F... Hi all! So my trip to MDACC was once again successful!!I even had my yearly MRI and everything is clear. I dared to ask my oncologist what the chances of recurrent disease is for me...... She said that ¡¦normally¡¦ at this point I would typically already have a reaccurence but that I have already passed that time frame and she doesn¡¦t really know because I have had the vaccine as well. She said the farther I get out without having a reaccurence the harder it is to predict when or if I will even have a reaccurence! I am so blessed. Thank you God. |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/3 ¤W¤È 11:31:57²Ä 846 ½g¦^À³
|
«z, ¤µ¤Ñ³zº|ªº½u¯Á¥i¯u¦h Áo©úªº¯E¤Í·|«Ü¦£ ·PÁ§Y®É§â°T®§±aµ¹¤j®aªº¤j¤jÌ ·q§A̤@ªM |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/3 ¤W¤È 11:30:19²Ä 845 ½g¦^À³
|
·|±þ¤U¨Ó´N¬O¦]¬°ÁÙnµ¥,µu´Á¤º®Ú¥»¤£·|¦³¤°»ò¯S§Oªº§Q¦h. |
|
|
·|û¡Gkenken10138351 µoªí®É¶¡:2015/6/3 ¤W¤È 11:27:00²Ä 844 ½g¦^À³
|
ªÑªF·|¦³¤°»ò§QªÅ¶Ü?«ç»ò¬ðµM¦³¤H¥X¨Ó¬å? |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/3 ¤W¤È 11:26:00²Ä 843 ½g¦^À³
|
ºI¦Ü¥h¦~©³PD:187/others:26¤è¬°¥¿½T¸ê°T¡APD«üªº¬OLocal read¡A¦Ü©ó¥ý«e©ÒPOªºPD229¤H¡A¹ê»Ú¤W¬O¤µ¦~5¤ëªº³Ì·sLocal read¼Æ¦r¡C±i¸³©Ò»¡¥h¦~©³¥¼¹F´_µo142¤H¬Ocentral readªº¥¿½T¼Æ¾Ú¡A¦U¦ì¤j¤j¥i¤ñ¸û¥h¦~©³Local read:central read¬°187¤H:¥¼¹F142¤H¡A¨âªÌ®t¶Z²Ê¦ô¬°24.06%¥H¤U¡A§k¦X¯E§b¤j©ÒPOªº°ê¥~½×¤å³ø§i22-25%¡AµM«á¦A¹ï·Ó5¤ë©³Local read¬°229¤H¡A¦©°£®t¶Z24.06%(¬ù55¤H)¡A²Ê¦ôcentral read¬ù174¤H¥H¤U¡C¦pªG¹ï·Ó²Õ´_µo¤H¼Æ¬°100¤H¡A¥ÎÃIJմ_µo¬ù74¤H¥H¤U¡C¥H¤W¼Æ¦r¬°¦Û§Ú±À´ú¹w¦ô¡A¶È¨Ñ°Ñ¦Ò¤£¥i²`«H¡C |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/3 ¤W¤È 11:24:24²Ä 842 ½g¦^À³
|
·|¤¤¤]¦³»¡local read®Úcentral ¥i¯à·|¦³¨âÓ¥b¤ëªº¸¨®t.¦]¦¹¦pªG¤j®an¦ôºâPFS¦n¹³¬O¥i¥H¥ÎLR,§Úı±o¬O¤ñ¸û«O¦uªº.¦]¬°µoÁnªº®É¶¡ÂI¬O¤ñ¸û±µªñ¨Æ¹êªº.·íµMLR»PCR¤]·|¦³»{©w¤Wªº»~®t. |
|
|
·|û¡G¥ú¼v10031538 µoªí®É¶¡:2015/6/3 ¤W¤È 11:22:57²Ä 841 ½g¦^À³
|
«ç»ò¬ðµM¤j®a³£¨S¦³Ãö¤ßs¤p©jªºÅÜ¤Æ ¦o³o´X¤Ñ¦³©_Âݵo¥Í¦b¦o¨¤W...§Ú¬Ý¤F³£¦n·P°Ê!!! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/3 ¤W¤È 11:22:48²Ä 840 ½g¦^À³
|
¦n®ø®§¡A¤T¤ëªk»¡PD¤p©ó142¬O¥¿½Tªº¡A±i¸³¨S»¡ÁÀ ³o¥y¸Ü³Ì«n |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/3 ¤W¤È 11:19:52²Ä 839 ½g¦^À³
|
ÁÂÁ¤À¨É ì¨Ó¬O§â5¤ëLR ¶K¨ì12¤ë¥h ¨º2015/1 CR <142 ¬O§_ÁÙ¦¨¥ß? §Ú·Q³o¬O¤j®a³ÌÃö¤ßªº |
|
|
·|û¡Gªü¤å10138375 µoªí®É¶¡:2015/6/3 ¤W¤È 11:16:54²Ä 838 ½g¦^À³
|
©Ò¥H¬O2014/12E Local Read PD:187, 2015/5 Local Read PD:229? ÁÙ¬O2015/5 Local Read PD:187? |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/3 ¤W¤È 11:11:35²Ä 837 ½g¦^À³
|
·íµM¬OLocal read,¤j®a³£·d¿ù¤F.¦Ó¥B¬O¤¤ëªº. |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/3 ¤W¤È 10:49:56²Ä 836 ½g¦^À³
|
ÁÂÁ¦h¦h ¨º187¬OLR ©Î CR? ¦³»¡¶Ü |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2015/6/3 ¤W¤È 10:44:33²Ä 835 ½g¦^À³
|
¸³¨Æªø»¡229¡þ37¬O»~´Ó ¥h¦~12¤ëÀ³¸Ó¬O 187¡þ26 SAE¥u¬OÄY«¹L±Ó¦í°|¤@¤Ñ ¦U¯E¤Í¦w¤ß |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/3 ¤W¤È 06:22:18²Ä 834 ½g¦^À³
|
§ó¥¿PO ¤å( ì¤å±Ôz¦³»~) : ì¤å : ¦]¬° ORR ¤Ó°ª®É, PFS ¥²µM§C, ©Ò¥H¬ÝPFS ´N¥i ; ¦ÓORR °ª®É, ¦pªGOS ¤]«Ü°ª, ³o®Éªº °ªORR ¤S¨S¤Ó¤j·N¸q¡C À³§ó¥¿¬° : ¦]¬° ORR ¤Ó§C®É, PFS ¥²µM§C, ©Ò¥H¬ÝPFS ´N¥i ; ¦ÓORR §C®É, ¦pªGOS ¤]«Ü°ª, ³o®Éªº §CORR ¤S¤Å»Ý²z·|¡C ·í 822 ªºPFS ³£¤w¸g±µªñ ¶PÀù¥ªºOS ®É ( ª½±µ±N¶PÀù¥¥´w¤F) , ORR ªº°ª§C ¹ï±wªÌ»P ¦VFDA¨úÃÄÃÒ ¬O¨S¦³·N¸qªº |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/3 ¤W¤È 12:48:17²Ä 833 ½g¦^À³
|
¥ò´º¤j, ¤p§Ì»{¦P±zªº¬Ýªk. §Q¯A¤j¤t¤j, ¯à§_½Ð±zÁ|¨Ò»¡©ú "PFS¨Ã¤£¯à·í¦¨¬Oµ¹ÃÄÃÒªºprimary point¡A¤@©wn¦³OS"? ªü®¶10139782 µoªí®É¶¡:2015/6/2 ¤U¤È 12:32:06 1. ¯E¹©¤G´Á¬O¥þ²yªºÁ{§É,¤T´Á¤~¬O¥xÆW 2. ¹L¥h°µ§¹¥þ²y¤G´Á«áª½±µ®³ÃÄÃÒªº¦³³\¦h«e¨Ò:¦p¿ÕµØ..½÷·çªº¨ÅÀù¥ÎÃÄ(¦³¥[¤J²üº¸»XÀøªkPFS20.2Ó¤ë,¥B°Æ§@¥Î¤j)¡K. ¦p¨S°O¿ù¦³5.6®a,³£¬O¦b¥þ²yÁ{§É¤G´Á´Nª½±µ¥Ó½Ð¬ü°êÃÄÃÒ,½÷·çªºÃÄÃÒ¦b¥h¦~12¤ë¤w¸g³q¹L¤U¨Ó ¯E¹©ªº822¦pªGPFS¤ñ20.2Ó¤ë¦h.¨ä¾÷Âà¤è¦¡¯f¤H°Æ§@¥Î·¥¤p,¥Í¬¡«~½è´£°ª,±z¤´µM»{¬°¤´¶·µ¥«Ý¬ü°ê¤T´Á°µ§¹¤~¯à®³¨ìÃÄÃÒ¶Ü? ½÷·çªº Ibrance¤G´Á Ibrance + Letrozole median PFS 20.2 Ó¤ë vs Letrozole median PFS 10.2 Ó¤ë, ¾Ì¦¹¤G´Á¼Æ¾ÚÀò±o FDA¬ð¯}©ÊÀøªk©M§Ö³t¼f¬d¸ê®æ, ¥Ó½Ð NDA¨Ã´£«eÀò±o FDAÃÄÃÒ, ¨Ã¤£»Ýn§¹¾ãªº OS¼Æ¾Ú. °O±o Ibranceªº OS 37Ó¤ë¦h, Letrozoleªº OS 34Ó¤ë¦h, ¨S¦³²Îp¤Wªº©úÅã®t²§. |
|
|
·|û¡G¤ý¤p¤å10140500 µoªí®É¶¡:2015/6/2 ¤U¤È 11:58:44²Ä 832 ½g¦^À³
|
¤µ¦~¤U¥b¦~«Ü¦³¾÷·|½Ä¤@ªi¦æ±¡¡AOTC¥Í§Þ«ü¼Æ×¥¿¤@¦~¡A¶g½u¤W¤ÉÁͶսu¶^¯}¤S¯¸¦^¨Ó¡A¤ë½u¤W¤ÉÁͶսu¤]¨S¶^¯}¡A¾ã²z¤F¤@¬q®É¶¡¡A·Pı¬O¾ã²z§¹¤F¡A´N¬ÝªÑ¤ý¯E¹©¦ó®É¤Ï§ð¦æ±¡´N¦ó®É·¶³¦A°_±a°Ê¥Í§Þ¤F¡C¬Ý¦n¤U¥b¦~¡C |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/2 ¤U¤È 11:33:28²Ä 831 ½g¦^À³
|
ªÑªF·|¦³¾÷·|ªº¸Ü¤]°Ý°Ý¨º¤@¦ìserious side effect ªÌ |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/2 ¤U¤È 11:08:03²Ä 830 ½g¦^À³
|
§Q¯A¤j¤t¤j: ¤p§Ì¹ï§A¼gªº¤U±³o¬q¸Ü¦³¤£¦P·N¨£ ( ¸òªk»¡·|µLÃö ): [ ¨ä¹ê§Ú¤£¤Ó½T©w¬°¤°»ò¼ÒÀÀPFS¨º»ò«nC¡K¡K§Ú¬Ý¹L«D±`¦h¸Ñª¼«áPFSªºK-M curve¡Aºâ¥X¨Ó¸òì¥ýªO¤Í¼ÒÀÀ§¹¥þ¤£¤@¼Ëªº¨Ò¤l¡A¦Ó¥BPFS¨Ã¤£¯à·í¦¨¬Oµ¹ÃÄÃÒªºprimary point¡A¤@©wn¦³OS¡]³o¤]¬O¥Ø«e§K¬ÌÀøªk¹J¨ìªº¬D¾Ô¡A¸U¤@ORR¦]¬°¸~½FÅܤj¦Ó¤í¨Î¡A¨º«D±o¬ÝOS°Z¤£¬O©Ôªø¹êÅç®É¶¡¡HFDA¦³n°w¹ï§K¬ÌÀøªkקï¡A¦ý³on¥t¥~±M¤å°Q½×¤F¡^¡C¨º·F¹À´¢´úPFS¡H? ] ²§·N¦p¤U: 1> ¹w¦ôPFS ·íµM«n : ¦]¬°³o¬O§ë¸êªº«n°Ñ¦Ò¼Æ¾Ú, ´N¦n¹³¹w¦ô¬ì§ÞªÑ EPS ¤]±`·|»~®t»á¤j, ¦ý¤£¹w¦ôEPS ªº¸Ü, ¤ß¤¤¨SÓ©³ , ¤£´±¤U¤â§ë¸ê; ´N¹³¬O¤Úµá¯S¹w¦ô¤½¥qªºªø´Á²{ª÷¬y¶q, ¤]±`·|»~®t«Ü¤j, ¦ý¤£¹w¦ô¦æ¶Ü? ·íµM¤£¦æ! ¨ä¦¸, ¹w¦ôK_M¦±½u³oºØ²Ó¸`, ·íµM·|®t²§«Ü¤j, ¦ý¹w¦ôPFS ®É( ¥u¬O³Ì²×ªºµ²½×) , ¦b¦³³¡¤À¼Æ¾Úªº±¡ªp¤U, ¨ä»~®tÀ³¤£P¶W¹Lªø´Á§ë¸ê¤H ©Ò¯à±µ¨üªº½d³ò¡C 2> ¤p§ÌÁÙ¬O»{¬°µ¹ÃÄÃÒªºprimary point À³¬O PFS¡A ¦ÓOS¬Osecondry point ( ¥xÁÞ¤j ¦³¤å³¹), ¦ýORR µ´¤£¬O¥Dnªºµû¦ôÂI : ¦]¬° ORR ¤Ó°ª®É, PFS ¥²µM§C, ©Ò¥H¬ÝPFS ´N¥i ; ¦ÓORR °ª®É, ¦pªGOS ¤]«Ü°ª, ³o®Éªº °ªORR ¤S¨S¤Ó¤j·N¸q¡C 3> ©Ò¥H§A®³ Herceptin ¸òOBI822 ¬Û¤ñORR , ¤p§Ì»{¬° PFS ®t²§¤j®É, ¨âªÌªº ORR ¬O¤£¯à®³¨Ó¬Û¤ñªº¡C PFS´X¥G¤@¼Ë®É, ¤~¯à¤ñ¸ûORR: Àù¯gÃĪ«n¤ñªº¥Dn´N¬O PFS ¸òOS (¨ä¥L¬O¦¸n) , ¦]¬°³o¹ïÀù¯g±wªÌ¤~¦³¤j·N¸q¡C ¦Ó¥BOS ¬O¥i¥H¦b®³¨ìÃÄÃÒ¤§«á, ¦A°µ«áÄòÆ[¹î²Îpªº, ¦]¦¹, ¤]¤Å»Ý¦p§A©Ò¤ª, DMC «Øij´£«e¸Ñª¼®É, ¤½¥qÁÙn¤p¤ßÁlÁl§â¾ãÓÁ{§É¨«§¹¡C ¦]¦¹¤p§Ì»{¬°¥un822 ªºPFS ¦³§â´¤¹F¨ì 24~30Ó¤ë, ¤p§ÌY¬O¸gÀçªÌ, ·íµMn´£«e¸Ñª¼ , ¦]¬°³o¼Æ¦r³£¤w¸g»P¶PÀù¥ªºOS ( 30Ó¤ë) ¬Û·í¤F , ¶PÀù¥¤w¸g¨S±o¤ñ¤F( ´Nºâ¶PÀù¥ORR ¦n«Ü¦h,, ¤S¦³¦óÃö«Y) , ³o®ÉÁÙnµ¥OS ¥X²{«á, ¦A¨Ó¤ñ¸ûOS ¶Ü? ·íµM¤£¥Î¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 07:47:32²Ä 829 ½g¦^À³
|
§Q¯A¤j¤t¤j 1¦³Ãöprimary endpoint ,secondary endpoint ½Ð°Ñ¦Ò5¤ë22¤é¤U¤È¶K12ÂI38¤À¶K¤å 2 topline¥»¤H»{¦P§Aªº¸ÑŪ¡A(Á{§Éªì¨B¼Æ¾Ú) |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/2 ¤U¤È 07:45:04²Ä 828 ½g¦^À³
|
¦pªG¡A¤µ¦~¤@¤ëPD 229¬°¯u, ¦Ó¥BLR, CR ¬Û¶Z¤£¤j, À³¸Ó±i¸³´N¤wµo²{something wrong ±i¸³3¤ë®É«ù¥½×z´N¦n, §Ú¬Û«HÁÙ¬O¤Wªº¤FÂd, »Ýn°µ¤U¦C¸Ø±i½×zÅý¥¼¨Ó·S³Â·Ð¶Ü? (1)·íªì¹w©w´Á¤¤¤ÀªR¬O¥H´_µo¤H¼Æªº¤@¥b142¤H¬°¤ÀªR¼Ð·Ç¡A«e¨âÓ¤ë´_µo¤H¼Æ¤´¥¼¹F´Á¤¤¤ÀªR¼Ð·Ç¡A¦Ó¥B¤w¸g¦¬§¹©Ò¦³ªº¯f¤H¡A¦]¦¹´Á¤¤¤ÀªR¤w¸g¨S¦³·N¸q¡A¨ú®ø¤F (2)¦bÁ{§É¹êÅ礦~«áµo²{¡A´_µo¤H¼Æ¸û·íªì¹wpªºn¤Ö«Ü¦h (3)¬ü°ên¶}©l¤T´Á»Ýn¨Ì¾Ú¥xÆW¤T´Áªºµ²ªG×¥¿Á{§É³]p¡A©Ò¥H¦³¨Ç©µ»~(¤]´N¬O»¡©µ«áì¦]¬O¦]¬°ÃĮĤӦn) µ²½×: ªü§Ú´N¬Û«H¥Lªºrecord¤Î¬°¤H°Ú, ·å²«©Î¦³, ¤£¦Ü©ó´ÛÄF |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/2 ¤U¤È 07:17:00²Ä 827 ½g¦^À³
|
§Q¯A¤j: ½Ð±Ð2 ±M·~°ÝÃD ( ¥H¤U¬O¤p§Ìªº·Qªk, ·Ð½Ð«ü±Ð¬O§_¦³»~ ? ) 1>> ORR ªºpºâÀ³¸Ó¬O¥Î Central Read ªºPD ¨Ópºâ , ¤p§Ìªº»{ª¾¥¿½T§_? Y¥¿½T, 1 ¤ëPD229 ¥u¬O Local Read , ©|¤£¯à¥Î¨Ópºâ, §_«h , 1¤ëORR¥u¦³26.60% ( °²³]SD= 0 ) ,¨º»ò, PFS ¤]¤£¥i¯à¤Óªø¡C ( 349 ¡V 229 ¡V 37 = 83 ; 83 / (349-37) = 26.60% ) 2>>ORR ³o¼Æ¦rªº¤º²[, «ö²zÀ³¤w³¡¤À¤ÏÀ³¦b ´_µo/ ´c¤Æ¤H¼Æ¤¤¤F , ¦Ó´_µo/´c¤Æ¤H¼Æ¤§ÁͶիhª½±µ¤ÏÀ³¦bPFS¤W , ¥ç§Y, PFS ¦P®É¥]§t´_µo¤H¼Æ¤§ÁͶջP®É¶¡, ¦bÃÄÃÒµû¦ô¤W , PFS ¦ü¥G¤ñORR «n±o¦h? 3>>ORR ¤ñ¸û°ª©³®É , À³¸Ó¦b PFS ¤@¼Ë®É¤ñ¸û¤~¦³·N¸q: Ä´¦p: Herceptin , PFS=6 , ORR=38% ( 38% ¬O°²³]È) OBI822 ,¦bPFS ¹F¨ì6 ®É, ORR ¥i¯à°ª¹F90% |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 06:40:55²Ä 826 ½g¦^À³
|
§Q¯A¤j¤t¤j 1¥ò´º¤j°Ý§Aªº°ÝÃD¦n¹³¨S¦³¦^µª¨ì«ÂI 2 822ªºprimary endpoint ¬OPFS,¤£¬Ý³oӬݨº¦ìÓ?secondly endpoint ¬OOS,¥u·í¬°¥¼¨Ó¬ã ¨s¤è¦V¡A³oÓ°ÝÃD§Ú¤¤ë¦^µªFaith¤j®É¤w¦³»¡©ú 3«Øij·í¤@Ó°²³]©Ê°ÝÃD©|¥¼¼á²M«e¤£À³¦³¤Ó¿E±¡°Ê§@ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 06:01:44²Ä 825 ½g¦^À³
|
§ó¥¿ ¬Ýª¼>¶}ª¼ ¤µ¤Ñ>¤µ¦~¤¤ë |
|
|
·|û¡G§Q¯A¤j¤t10022029 µoªí®É¶¡:2015/6/2 ¤U¤È 05:57:56²Ä 824 ½g¦^À³
|
¬Ý¨ì¦U¦ì¤j¤jªºµ½·N¦^À³¡A¯u¬O¥O§Úµ~ºF¸U¤À......¦b¯E¹©ªº¾Þ§@¤W¡A§Ú¬O¤@¸ô¸òÀHµÛCliff/Rabbit/«¼C/¥xÁÞ/²q·Q¤jªº¸}¨B¡AÃä¦YÂû±ÆÃä¶ß¥Ê¤l§ë¸êªø¤jªº§r¡I¦U¦ì¤j¤j½Ð§Ö§O§é±þ¤pªº¤F¡A§Ú¬O³f¯u»ù¹êªº¡A¥¿´ä©`¦Ì¯Å´²¤á°Ú......¡]®t¤@ÂIÂI´N§Ô¤£¦í¼g¦¨©`¦ÌÀJ Orz......¦bMobile01·í¶m¥Á²V¤Ó¤[¡A«á¿ò¯g´N¬O·|J¶Ã¨¥»y XD¡^ ¦]¬°«Ü¤Ö«Ü¤Ö¨Ó³}¥²´Iºô¡A¥»¨Ó·Q´N¤£¦^À³¤F......¦ý¦A·Q·Q¡A¯E¹©©ú¤Ñ´N¥l¶}ªÑªF·|¡A§Ú¦A«ç»ò§¯¨¥´b²³ÄA˶¥աA¤£¨ì¤G¤Q¥|¤p®É¤º¦U¦ìª©¤Í´N¥i¥HÀò±o¤½¥q¸Ñµª¤F¡C©Ò¥H¡A´NÁÙ¬O§Ô¤£¦í¦A«pÁy¥ÖAA¼L¤l¤@¤U¡C §Ú§Ô¤£¦í¸H¼L¡A·íµM¬O¦]¬°PD 229³o¨Æ¡C¬Q±ß¬Ý¨ìì¨Ó¥X¤F³o»òÀɤl¨Æ¡AÀ~±o§Ú»°ºò±qÀY°l³o¯d¨¥ªO¬Ý¨ì¤µ±á2.30am¡A®tÂI»~¤F§Ú±á°_°e³ø½æ¦À\ªº¦æµ{¤F¡Iì¦]¦³¤T¡G (1) ¤½¥q³ºµM¤½¶}³zÅS¥¼¸Ñª¼¹êÅ窺¯f±w´_µo¤H¼Æ¡H¤@¥y¸Ü¡A³o¨Æ ¡§¥Ç¤Ñ±ø¡¨ ªº¡CLÂå®v¦ó³\¤H¤]¡H³ºµMÁÙ¸ò¦h¦ìªO¤Í¼á²M¡A ¡§³o´N¬OPD¡B³o´N¬Oothers¡¨......§Ú¯u¬OµL»y¤F¡AÃø©Ç¥xÆW¥Í§Þ¥i¥H°µ¤º½u¡C¦pªG¯E¹©¥H¬°PD ¬Osafetyªº¤@³¡¤À¡A¨º§Ú§óµL»y¡C¦³ÃöPD³o¨Æ¡A¯E¹©¼á²M¤]¤£¬O¡B§ó¥¿¤]¤£¬O¡B§ó·s§ó¤£¹ï¡A¦]¬°³o³¡¤Àªº¸ê°T®Ú¥»´N¤£¸Ó¬y¥X¨Ó¡CLocal read©Îcentral read¤]®Ú¥»´N¤£¬O«ÂI¡A½Ö´±»¡¥uncentral read¤£¬ªº|¡Blocal read´N¥i¥H®³¥X¨Ó»¡¼Lªº¡H©ú¤Ñµ¥µÛ¬Ý³Á§J±i«ç»ò¶ê§a¡C (2). ¦pªG¡A¤µ¦~¤@¤ëPD 229/others 37¦¹¨Æ¬°¯u¡A¨º»ò¾ãÓgame plan³£ÅܤF¡I§Ú¥»¨Ó¬O¸òÀH¦U¦ì¤j¤jªº¸}¨B¡A¶ß¥Ê¬Ý³øµ¥µÛ822¥Î·¥Àu²§ªºORR¸òPFS/OSÁ{§É¼Æ¾Ú¡Aª§¨ú¬ü°ê¤Î¦¤W¥«ªº¡C²{¦b¡H¦pªG¤@¤ë¤w¸gPD 229/ others 37¡A³o³Ñ¤U¥¼³øªº¯f±w¦³´X¦¨¡H·í¤¤¡AÃø¹D¨S¦³Stable Disease¡H´Nºâ¹®¤Ñ¤§©¯¡A³Ñ¤Uªº³q³q¬OPR/CR¡AORRºâºâ¤]¤w¸g¶^¯}¤T¦¨¡A¦óªp¥H³oPD¬ðµMÃz¼Wªº±¡ªp¡A¦©±¼SD¡A³Ì«áµ²ºâ¥X¨ÓORR·|¤£·|»·¤ñ·Q¹³ªº§C¡Hª`·N¡A¶PÀù¥ªºORR¤£§C³á¡C (3). ©µÄò(2)¡A¦pªGORR¤£°ª¡A¦ýPFS¦³¼W¥[¡]°²³]¬O21Ó¤ëvs.¶PÀù¥/µµ§ü¾J18Ó¤ë¡^¡A¨º·íµMÁÙ¬O¦³¾÷·|®³¬ü¼ÚÃÄÃÒ°Ú¡C¦ý´N¬O¡Apivotal trialºCºC°µ...... ¤S©ÎªÌ¡A¦pªG¶D¨D«ÂIÅܦ¨¬O§K¬ÌÀøªkªºlong tail survival + low SAE¡A¤ñ¦p¶D¨D¯f¤Hªºsurvival «Üªø¡A¸~½FÁöµMÅܤj¡A¦ý¨ä¹ê¸Ì±Àù¯g²ÓM³Q±þ±o®t¤£¦h¡B¦Ó¥B¯f¤HªºQoL¦³©úÅã¶i¨B¡A¨º¤]¥i¥H¡C¦ý¬O³o³q±`¬O¾A¥Î©ó´c©Ê¸~½F¡A¤ñ¦ppancreatic/NSCLC/GBM³oºØOS¦b¤@¦~¥ª¥k©Î¥H¤ºªºÂಾÀù¯g¡A³o¼Ë¹êÅç¤~¤£·|¥ÃµL¤F¤é¡C¨ÌmBC¨Ó»¡¡A¹ï¤âOS¦n¹³¤Ó¤[¤F¤@ÂI¡An¤ñ¹ï¤â®i²{¨}¦nªºOS¡A¥i¦³±oµ¥¤F......¦Ó¥B¡A¯E¹©³o¹êÅç±Ò°Ê±o¦¡A·íªì¤]¨S¦³nÆ[¹î¸~½FÀù¯g²ÓM¡]¥Îbiopsy¨ú¼Ë¡^©Î¬O°lÂܯf±wQoL¡A³Ì«á´N¥u¯àµw¸Iµw¡A«÷OS¤F¡]§ó¥¿¡A¨ä¹ê´Nºâ¦³Æ[¹î¸~½FT²ÓM®û¼í¡A¤]ÁÙ¬OnOS¡^¡C§Ú¬Ý¬Ý²{¦b§K¬ÌÀøªkªº±¡ªp¡An«h¹³CI/CART¡ASAE¥i©Æ¦ýORR«Ü¦n¡A¦]¦¹´`¦Ñ¸ôÁÙ¬O¥i¥HÁ{§É¤G´Á§¹´Nª½¨úÃÄÃÒ¡F¤£µM¹³dendritic cell therapy¡Alow-to-none SAE¥Blong survival¡A´N¥²¶·¥ÎOS¨Ó¶D¨D¡C¦ý³o¥i«Ü¤Ö¦]¬°low SAE¥B¦s¬¡¨}¦n¡AFDA´Nª½µoÃÄÃÒªº°Ú¡I³£¬O©ì«Ü¤[¤§«á¡A¤½¥q¤½¥¬¼Æ¾Ú¡AµM«á«Üź¶Æªº»¡¡G§A¬Ý§A¬Ý¡A§Ú̪º¯f±w¦³¤H¹L¤F¡]Á|¨Ò¡^48Ӥ뤧«á¡BºI¦Ü¥Ø«e³ø§i¬°¤î³£ÁÙ¬¡µÛ¡C«Ü±j§a¡I¦pªG¬O³o¼Ë¡K¡K¨ºÁÙ¤£¦p¦b¬ü¼ÚÄ~Äò¿ìpivotal trialºâ¤F¡C ©Ò¥H§Ú¹ï©ú¤ÑªÑªF·|¤]«ÜÃö¤ß¡APD 229¤@¨Æ¦P®É²o¯A±M·~/¹D¼w¦M¾÷»Pgame plan change¡A«Ü´Á«ÝªO¤Í¤À¨É¤½¥q¨ì®ÉªºÁ¿ªk¡C ¥t¥~²²¤¦^¨â¦ì¤j¤j¡G ¥xÁÞ¤j¡A¦pªGtopline¤£¬O§Ú»¡ªº·N«ä¡A¨º§Ú·|»¡¯E¹©³s^¤å³£¦³°ÝÃD¡I¡]©êºpª½±µ¤FÂI¡^ ¥ò´º¤j¡A¨ä¹ê§Ú¤£¤Ó½T©w¬°¤°»ò¼ÒÀÀPFS¨º»ò«nC¡K¡K§Ú¬Ý¹L«D±`¦h¸Ñª¼«áPFSªºK-M curve¡Aºâ¥X¨Ó¸òì¥ýªO¤Í¼ÒÀÀ§¹¥þ¤£¤@¼Ëªº¨Ò¤l¡A¦Ó¥BPFS¨Ã¤£¯à·í¦¨¬Oµ¹ÃÄÃÒªºprimary point¡A¤@©wn¦³OS¡]³o¤]¬O¥Ø«e§K¬ÌÀøªk¹J¨ìªº¬D¾Ô¡A¸U¤@ORR¦]¬°¸~½FÅܤj¦Ó¤í¨Î¡A¨º«D±o¬ÝOS°Z¤£¬O©Ôªø¹êÅç®É¶¡¡HFDA¦³n°w¹ï§K¬ÌÀøªkקï¡A¦ý³on¥t¥~±M¤å°Q½×¤F¡^¡C¨º·F¹À´¢´úPFS¡H¨Ì§Aªº°ÝÃD¡A1).¦pªG¯E¹©°ª¼h´¿¸g¿E¯P°Q½×¬O§_n´£«e¸Ñª¼¡A³oÀ³¸Ó¬O·íªìPDÁ٫ܧCªº®ÉÔ§a¡HªÑ·¾»¡early termination¦³¤T±¡ªp¡Asafety, benefit, frutility¡C822 SAE«Ü§C¡A·íµM¤£¬O¦]safety concern·|¦Ò¼{early termination¡C·íªì¦pªGPD«Ü§C¡A¦³¥i¯à¹³§Ṳ́§«e¹w´Áªº¡A822¦]¬°ÃĮĥX²³¦Ó°µearly halt for efficacy¡A¦ý²{¦bYPD 227¬°¯u¡A¥i¯à´N¤£¬O³o±¡ªp¤F¡C¦pªG²{¦bÁÙ¦³early halt, ¨º´N¬O²Ä¤TºØ±¡ªpfruitility¡A¹ï·Ó¹êÅç²ÕÃĮĵLÅãµÛ®t²§¡A¦¦¦¬¤u§K±o®ö¶O¯f¤H¥Í©R¤F¡C§Ú·Q²{¦b¤j®a³£¤£·Q§a¡H 2).§AÁ¿¨ººØ¶WªøPFS/OSªºÃÄ¡A¦pªG¬O¦b´c©Ê¸~½F¡A¨º´N¬O§Ṳ́@ª½´Á«Ýªºearly halt for efficacy ¥X²{¡FCRC¦^³øDMC¡Aµ²ªGµo²{event³q³q¬O¡B©Î¤j³¡¤À¬O¹ï·Ó²Õ¡A¹êÅç²Õ¦n±o«Ü¡I¦]¦¹DMC³qª¾¤½¥q«Øij´£«e¸Ñª¼¡A·íµM¡A¤½¥q¦Ò¼{FDAµ¹ÃÄÃÒªºprimary endpoint¡A¤]¦³¥i¯à¿ï¾Ü¤£´£«e¡B¦Ó§â¹êÅ稫§¹¡A²Ö¿n¨¬°÷¼Æ¾Ú«á¦A´£ÃÄÃҥӽСC²¦³º¼f®Ö¸ê®Æµ¹µoÃÄÃÒªº¬OFDA¡A¤£¬ODMC¡F¦]¦¹DMC´Nºâ«Øij¤½¥q¥i¥H´£«e¤¤¤î¡A¤½¥q¤]¤£¨£±on¤¤¤î¡C ¡§¦ý¬O¡¨¡A¤½¥q»Ýn¤½§iDM |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 05:51:45²Ä 823 ½g¦^À³
|
µ½¤H¤j ¥h¦~²Ä¤G¦¸ªÑªF·|¦³¤H°Ý¬Ýª¼¬O§_·|´£«e¡A¤½¥q¦^µªn»P¬ÛÃö³æ»P¤Î±M®a°Q½×¡A¶ÀÁ`¤]»¡nµ¥¨ì284¤HXX¤£ª¾¦³¨S¦³¨º¤@¤Ñ³£¤£ª¾¹D¡A©Ò¥H¦o¤]µLªk¦^µª¡A¬JµM¤µ¤Ñ¤w¤½§i¤K¤ë·|¨M©w®É¶¡¡AÁ¿¥Õ¤F´N¬O·|´£«e¡A ©ú¦~ªìªº¥i¯à©Ê«Ü§C¡A¦pªGn©ú¦~ªì¶}µP¤µ¦~©³¤½§i ´N¥i¥H¡A¤£¥²´£¦¥|Ӥ뤽§i¡A§Úªº·Qªk¥²¸û¥tÃþ¡Aťť´N¦n¡A¥i¯à¦³»~ |
|
|
·|û¡Gªü¤å10138375 µoªí®É¶¡:2015/6/2 ¤U¤È 05:47:20²Ä 822 ½g¦^À³
|
ü!¥úÀY¶Ã§¿§¿¦Ã¬Vªe¤t³Q§ì¨ì,Åý§Ú¹ï¥Lªº¸Û«H¤Î¹ïªÀ·|¸Ó¦³ªº³d¥ô¦³¨Ç³\¦sºÃ |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/2 ¤U¤È 05:39:06²Ä 821 ½g¦^À³
|
§Æ±æ©ú¤éªÑªF·|¦³¤H§Y®É¶Ç°e°T®§ |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/2 ¤U¤È 05:15:24²Ä 820 ½g¦^À³
|
±aÀY¤jô¥»¶gÁÙ¬O¨C¤Ñ¥[½X50±i¡A«ùÄò¬Ý¦n¯Eô¤¤ ~~ ¥t¥~°Q½×°Ï¤W¦U¦¡¦U¼Ëªº¸ê°T¥R¥¸¡A¤£½×«~½è¬O§_¦nÃa¡A³£»Ýn¯E¤Í¦n¦n§â¯ß§PÂ_¤@¤U ©ú¤ÑªÑªF·|¸g¹L¤õ·Ò«á«á´N·|ª¾¹D¥ý«e³\¦h¤H°Q½×¤¤¨ì©³¯uª÷¨s³º¬O½Ö¥H¤Î¦bþ¸Ì ~~ µ²ªG¥i¯à·|¥O©Ò¦³¯E¤Í·|¤ß¤@¯º ~~ ²î¹L¤ôµL²ª ~~ «·sÂk©ó·¥®öÀRµ¥¸Ñª¼ |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/2 ¤U¤È 03:56:27²Ä 819 ½g¦^À³
|
¥xÁÞ¤j, §Ú¬Ý¤£¥Î³Â·Ð, ¥un§ÚÌÁA¸ÑPFSªº©w¸q¬O¥]§t´c¤Æ(´_µo)©Î¦º¤`, ´N¥i¥H¤F. «öCliff¤jªº¶K¤å, PFS¥Hp¹º®Ñ¬°·Ç :¬O±q¡u¨ü¸ÕªÌ³QÀH¾÷¤À°t¶}©l¤@ª½¨ì´c¤Æ©Î¦º¤`ªº®É¶¡¬°¤î¡v¡F¤£¬O±q¥´²Ä¤@¾¯¶}©lºâªº¡C °Ñ¥[ªÌ·|¥ýµn°OÓ¤H¸ê®Æ¤Î¦w±Æ¦UºØÀˬd, «Ø¥ßÓ¤HÀÉ®×, ½T©w²Å¦X°Ñ¥[Á{§É¸ÕÅ窺±ø¥ó«á, ³QÀH¾÷¤À°t¨ì¸ÕÅç²Õ©Î¹ï·Ó²Õ, ¤~µ¹¤©¥´°w¥ÎÃÄ, ©Ò¥H¹ï¥H«á²ÎpPFS OS, ¤£·|¼vÅT. «D±`·PÁ§Q¯A¤j¤t¤jªº±M·~¤ÀªR. ¯E¹©©ó104/05/19 13:45:20¦bÃÒ¥æ©Ò«¤j°T®§¤½§i: .... ¦³Ãö¸Ñª¼®É¶¡¡A¤@¦p104¦~¤T¤ë¦b¥»¤½¥q¤WÂd«eªk»¡·|»¡©ú¡A³Ì§Ö¦~©³©Î©ú¦~ªì¡A±N«S¸ÕÅç¹ï¶H´_µo²v¨M©w¡C ¥»¤½¥q¥ç±N¦b¤K¤ë¥l¶}±M®a·|ij¡A¨M©w¸Ñª¼®É¾÷¡C³o¤]¬OÁ{§É¸ÕÅç±M·~µ{§Ç¡A¥»¤½¥q¦b¿í¦æÁ{§É¸ÕÅç±M·~³W½d¤U¡AÁn©ú¸ÕÅçpµe©M¤½¥qÀç¹B¶i®i¤@¤Á¶¶§Q¡C ±i¸³¦b3¤ë3¤éªk»¡·|¤w«Å¥¬: ¤£°µ´Á¤¤¤ÀªR, ±N©ó¦~¤¤¹L«á, ¥J²Ó¦Ò¼{µû¦ô³Ì¦³§Qªº¸Ñª¼®É¾÷, ½Ð¤j®a¬Û«H§Ú̪º¸gÅç. ÁöµMÁÙ¨S¸Ñª¼, ¦ý¬O¯E¹©ªº¦³Ãö¤HûÀ³¸Óª¾¹D¸ÕÅç²Õ©M¹ï·Ó²Õªº"¥ÎÃÄ"¤H¼Æ, ©M¤G²Õªº´c¤Æ¤H¼Æ¤j¬ù¦U¦h¤Ö¤H, ©M¨ü¸ÕªÌªº¸~½FÅܤƱ¡ªp(CR, PR, SD, PD). ©Ò¥H¥Ø«e¬O¦bµ¥«Ýµû¦ô³Ì¦³§Qªº¸Ñª¼®É¾÷. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 03:45:31²Ä 818 ½g¦^À³
|
Cliff¤j ì¨Ó¬OÀH¾÷¤À¬£¤é°_ºâ¡A»P¥´°wµLÃö¡AÁÙ¦n¦³§A´£¿ô¡A¥æ¬yÅý¥ý«e¿ù»~»{ª¾¯à¤£Â_§ó¥¿¡A¤]Åý¨ä¥L¤j¤j¦A½Æ²ß¤@¤U¡A·P®¦·PÁ |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/2 ¤U¤È 03:25:29²Ä 817 ½g¦^À³
|
¥xÁÞ¤j¡G ±z¤w¸g³Q§Úªº¤W¤@½g¶K¤å·d²V¤F¡A½Ð§â¥¦§Ñ¤F¡A¥un°O¦í¤U±³o¬q´N¦n¡C PFSpºâªº°_©lÂI¨Ì¨CÓÁ{§É¸ÕÅçpµe³]pªº¤£¦P·|¦³¤@ÂI¤p®t²§¡A¦³ªº±q¥´²Ä¤@¾¯ºâ°_¡A¤]¦³ªº¸ÕÅç¬O±q¦¬®×¤éºâ°_¡A¡]¥ý¼f¾\¨ü¸ÕªÌ¯f¾ú¸ê®Æ¡A²Å¦X¦¬®×«áÁÙnÄò°µ¤@¨ÇÀËÅç/´ú¶q/«ØÀÉ¡A¦AÀH¾÷¤À²Õ¡AµM«á¤~ª¾¹D¸Ó¥´¯uÃÄÁÙ¬O¦w¼¢¾¯¡A©Ò¥H¤£¤@©w¦¬®×·í¤Ñ´N¥´²Ä¤@¾¯¡^¡C ¦Ó«¥ÌªºOBI-822 ¤G/¤T´ÁÁ{§É¸ÕÅçpµe¡A½T©w¬O±q¦¬®×«á¡A§¹¦¨ÀH¾÷¤À°tªº¤é´Á¡]randomization¡^ºâ°_¡A¦Ó«D¿ð¦Ü²Ä¤@¾¯ªº¤é´Á¤~¶}©lpºâPFS¡C ³o¬O¥»Á{§É¸ÕÅ窺©w¸q¡A¥u¯à±µ¨ü¡A¤£¥i¯à°Ó¶q©Î§ïÅÜ¡A§ó¤£»Ýn±À´ú©ÎÃhºÃ¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 03:06:29²Ä 816 ½g¦^À³
|
µ½¤H¤j 1¦pªG§ï¬°¹ï·Ó²Õµo¥Í110Óevents (¸~½F´c¤Æ©Î¦º¤`)³o¼Ë¥i¥H¶Ü? 2¦bÁÙ¥¼µo¥Í³o¨âÓ±ø¥ó«ePFS·íµMÄ~Äò²Îp¡A´Nºâ¸~½F¥u¦³15%´c¤Æ¤]¤£ºâ¡Aª½¨ì¹F¨ìì¨Ó¹w©wªº´c¤Æ¼Ð·Ç 3±q¯f±w¦¬®×°_ºâ¦ü¥G¤£¤Ó¦X²z¡A¨Ò¦p1¤ë10¤é¦¬®×¡A ¥i¬O¯u¥¿¶}©l¥´°w¬O1¤ë20¤é¡A 4¥´°wÀ³¸Ó¬O«ü¥´¤ÆÀøÃĶ}©lºâ¡A ¤£¬O¥´OBI822/821¤~¶}©lºâ¡A§Ú¦³¨S¦³»¡¿ù? |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/2 ¤U¤È 02:45:08²Ä 815 ½g¦^À³
|
§Q¯A¤j¤t¤j, ±z¬O°ª¤H¡A¦³±z¯u¦n~~ ¥xÁÞ¤j, ¨Ì¾Úù¤ó(Roche) Understanding Clinical Trials endpoints,¨Ñ±z°Ñ¦Ò¤@¤U PFS: The proportion of patients who continue to live with a disease that is not getting worse. (i.e. not progressive disease (PD)) For example: PFS-6 is the rate. or the proportion of patients given a treatment that survive without their disease worsing at six months after treatment began. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 02:26:57²Ä 814 ½g¦^À³
|
Cliff¤j ¥H«e¹³¤p©_¤j¡A±ø¤j¡Aµ½¤H¤j¤Î§Ú¥»¤H¡A¨ä¥L¤j¤j½Í¨ìªº´c¤Æ©Î´_µo¨ä¹ê¤w¥]¬A¸~½F´c¤Æ©Î¦º¤`¡A§ÚÌn¤£n²Î¤@»¡©«:¨Ò¦p¹ï·Ó²Õµo¥Í110¤H´c¤Æ§ï¬° ¹ï·Ó²ÕPFS events(µo¥Í¸~½F´c¤Æ©Î¦º¤`)110¤H §A¦³¨S§ó²³æ¦ý¤£¥¢¨ä¤º²[ªº»¡ªk¡AÁÂÁ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤U¤È 02:03:09²Ä 813 ½g¦^À³
|
Cliff¤j §A´£¨Ñªº¸ê°T§Úª¾¹D¡A¥Î¥Õ¸Ü¤åÁ¿´N¬O PFS event¬O«ü 1±q¨ü¸Õ¥´²Ä¤@°w°_ºâ¨ì¨ü¸Õ¦º¤`ªº®É¶¡ªø«× 2±q¨ü¸Õ¥´²Ä¤@°w°_ºâ¨ì¨ü¸Õ¸~½FÅܤj¨ì¶W¹Lì¥ý©wqªº¼Ð·Ç¬°¤îªº®É¶¡ªø«× ³oºØ»¡right?) |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/2 ¤U¤È 01:55:53²Ä 812 ½g¦^À³
|
«Ü¦h¤j¤j(§t¤p§Ì)³£§Æ±æ, §KÁ{§É¤T´Áª½±µ³q¹L¬ü°ê¤W¥« ¤p§Ì»{¬°¾÷·|¥i¯à«Ü¤p ¬ü°ê2´Á+°Ï°ì3´Á -> ¥Ó½ÐBTD -> ¸É°µ¤p¶q¬ü°ê3´Á -> ÃÄÃÒ ©Î³\¥i¯à¤@¨Ç (¤p§Ì·MÄø¤@ª½»{¬°2,3´Á¤£À³¦X¨Ö¶i¦æ, À³¥þ²y(§t¬ü°ê)2´Á§@§¹, ®³2´Á¼Æ¾Ú¤@Ãä¥Ó½ÐBTD, ¤@Ãä¥xÆW3´Á, ³o¼Ë¤£¬O¸û§Ö¶Ü? Å޿観»~¶Ü? ) ¥t¥~¦³¨Ç¤j¤j½èºÃ¤@¨Çµo¨¥±M·~«×¤£¨¬, ¨¥«¤F, ¤p§Ì¦Ûº¬O¯ó¥]¤@Ó, ¨ä¹ê¥un¤£¬O¬G·N»~¾É, ³yÁÁ, ¥Õ¥Ø, ðã½|, À³¸Ó³£¥i¥]®e, ²¦³º³o¸Ì¤£¬OÂå¾Ç°Q½×°Ï, Y¾ã¥»¤p»¡¥u¦³ªF¨¸¦è¬r«n¦a¥_¤¢¹ï¸Ü, ¯à¬Ý¶Ü? |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/2 ¤U¤È 01:33:34²Ä 811 ½g¦^À³
|
¥xÁÞ¤j¡G PFSpºâªº°_©lÂI¡G ¤¤¤åªº¡G ¡u¡KPFS©w¸qªº¨Æ¥ó¥]¬A¡u¸~½F惡¤Æ¡v©M¡u¦º¤`¡v¡A¥HPFS¬°µû¦ô«ü¼Ðªº臨§É¸ÕÅç¡AÆ[¹î¨ü¸ÕªÌ±q¶i¤J¸ÕÅç¨ì¸~½F µo¥Í惡¤Æ©Î¦º¤`ªº®É¶¡ªø度¡A¨ü¸ÕªÌ¥un¡u¸~½F惡¤Æ¡v©Î¡u¦º¤`¡v¤GªÌ¨ä¤@¥ýµo¥Í¡A«h¹F¨ì¬ã¨sªº²×ÂI¡A¦¹¤@Æ[¹î®É¶¡ªø度§Y¬O¸ÕÅç©Òn¦¬¶°¤ÀªRªº數¾Ú¡F¡K¡v¡]http://www2.cde.org.tw/Data/CDEDoc/Documents/%E7%99%8C%E7%97%87%E8%97%A5%E7%89%A9%E8%87%A8%E5%BA%8A%E8%A9%A6%E9%A9%97%E5%B8%B8%E7%94%A8%E4%B9%8B%E6%99%82%E9%96%93%E8%AE%8A%E6%95%B8%E8%A9%95%E4%BC%B0%E6%8C%87%E6%A8%99.pdf ¡^ ¤Wzªº¡u±q¶i¤J¸ÕÅç¡v¤Ó¦r»¡±o¤£²M·¡¡A«Øij°Ñ¦Ò¤U±^¤åªº»¡©ú¡C ^¤åªº¡G ¡uProgression-free survival (PFS) is a measure of the activity of a treatment on a disease. It is the time that passes from a certain date (generally the first day of treatment, or the day in which a patient is enrolled in a clinical trial) and the date on which disease "progresses" or the date on which the patient dies, from any cause.¡v¡]http://en.wikipedia.org/wiki/Progression-free_survival ¡^ ¥Hp¹º®Ñ¬°·Ç¡G ¡uThe duration between the date of randomization to either the date of documented disease progression¡Kor the date of death from any cause.¡v¬O±q¡u¨ü¸ÕªÌ³QÀH¾÷¤À°t¶}©l¤@ª½¨ì´c¤Æ©Î¦º¤`ªº®É¶¡¬°¤î¡v¡F¤£¬O±q¥´²Ä¤@¾¯¶}©lºâªº¡C |
|
|
·|û¡Gªü®¶10139782 µoªí®É¶¡:2015/6/2 ¤U¤È 12:32:06²Ä 810 ½g¦^À³
|
DEAR §Q¯A¤j¤t ¤j¤j¤j ·PÁ±z±M·~ªº¤À¨É! §A©Ò´£¤Î¡¨ ¦U¦ìı±oFDA¦³¥i¯à®³¥xÆW¹êÅç¸ê®Æ§KÁ{§É¤T´Áª½±µ³q¹L¬ü°ê¤W¥«¶Ü¡H¡¨ 1. ¯E¹©¤G´Á¬O¥þ²yªºÁ{§É,¤T´Á¤~¬O¥xÆW 2. ¹L¥h°µ§¹¥þ²y¤G´Á«áª½±µ®³ÃÄÃÒªº¦³³\¦h«e¨Ò:¦p¿ÕµØ..½÷·çªº¨ÅÀù¥ÎÃÄ(¦³¥[¤J²üº¸»XÀøªkPFS20.2Ó¤ë,¥B°Æ§@¥Î¤j)¡K.¦p¨S°O¿ù¦³5.6®a,³£¬O¦b¥þ²yÁ{§É¤G´Á´Nª½±µ¥Ó½Ð¬ü°êÃÄÃÒ,½÷·çªºÃÄÃÒ¦b¥h¦~12¤ë¤w¸g³q¹L¤U¨Ó ¯E¹©ªº822¦pªGPFS¤ñ20.2Ó¤ë¦h.¨ä¾÷Âà¤è¦¡¯f¤H°Æ§@¥Î·¥¤p,¥Í¬¡«~½è´£°ª,±z¤´µM»{¬°¤´¶·µ¥«Ý¬ü°ê¤T´Á°µ§¹¤~¯à®³¨ìÃÄÃÒ¶Ü? ½Ð±Ð±zªº°ª¨£ ÁÂÁÂ! ·P®¦! |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2015/6/2 ¤U¤È 12:32:05²Ä 809 ½g¦^À³
|
¸É¥R¥ò´º¥S´£¦¸Ñª¼ ½÷·çIbrance¥Ó½ÐÃÄÃÒªº¤å¥ó¤W(APPLICATION NUMBER:207103Orig1s000) 2.2 Study Design and Changes PALOMA-1 was originally designed to enroll 150 patients randomized 1:1 between a Palbocicib + letrozole (P+L) arm and a letrozole only (L) arm. While enrollment was underway, the sponsor altered the original protocol a total of 7 times. Major changes to the statistical analysis plan (SAP) were included in protocol amendments 3, 5, 6, and 7. Table 2 describes these amendments. Additional details on the study design follow in Section 3. The original protocol was finalized on March 27, 2008. 2013¦~7/11²Ä7¦¸protocolÅܧ󤺮e¬O°w¹ïstatistical analysis plan (SAP) ªí®æ¼gµÛ Changed the final analysis time of PFS from 114 PFS events to 95 PFS events based upon slower than expected event rate. |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/2 ¤U¤È 12:31:50²Ä 808 ½g¦^À³
|
¦P·N Biwin ©Ò¨¥ ~ ~ ¯«ÀJ«L«Q ²Ä¥|¶° ²Ä¥|¤Q¦^ µØ¤s¤§Åq : ¤@¸sªZ¤Ò´§¼C»¡¹D¡AªZªL¬Û¶Ç¦³ ¡§µØ¤s½×¼C¡¨ ªºÃý¨Æ¡A«¥Ì¤µ¤é«K¨Ó½×¥L¤@½×¡A ¥B¬Ý·í¥@^¶¯¡A¨ì©³½Ö©~º ? ¡K ¡K ¡K ¡K ³o¤@µÛ¨Ï¶ÀÃÄ®vµ¥ºÉ¬Ò´jµM ¡K ¡K Ãø¹D·í¯u ªø¦¿«á®ö±À«e®ö¡A¤@½ú·s¤H³Ó¤H? ¡K ¡K ¡K Á@¨Ó¤£¹L¬O¦¿´ò¤Wªº¤@§å¤H¡A¤£ª¾±q¨º¸ÌÅ¥¨ì ¡§µØ¤s½×¼C¡¨ ¥|¦r¡A©~µM¤]¨Óªþ±e·¶® ¡C ¡K ¡K ¶ÀÃÄ®v¹Ä¹D:´Û¥@¡K ¡K ¡K¡A©Ò¦³¦h¦³¡A¦ý·Q¤£¨ì¦b³oµØ¤s¤§Åq¡A©~µM¤]±o¨£¦¹½ú¡C «¢ ~ ½L¤ÓµL²á¡A À°Biwin©Ò¨¥¡A¥Îª÷±e¤p»¡³¹¸`¡A»´ÃP¤@¤U ~ ~ ~ |
|
|
·|û¡GBiwin10140217 µoªí®É¶¡:2015/6/2 ¤U¤È 12:27:49²Ä 807 ½g¦^À³
|
ÄY®æºÊ·þ¯E¹©¸gÀç¹Î¶¤¡A6/3½Ð¥LÌ»¡©úPD229¨ÓÀs¥h¯ß¡A¬°¦ó¦bpptÀɤW§R°£¡H¦Ò¶q¬°¦ó¡H...¦³µL¥ø·~¹D¼w·ÀIªº°ÝÃD¡H ¤é«e¤½¥q¤º³¡¦^µª§ë¸ê¤Hªºµª®×¡A¬O§_¦³¬»Ä²ªk³W(Á{§ÉÁÙ¦b¶i¦æ¤¤¡A¬O§_´¿³zÅS¤£¸Ó³zÅSªº¸ê°T¡H)¡H ¦Ü©óÂåßÓ±M·~ªº¬ì¾Ç¡AÁÙ¬O¥H¤½¥q©x¤èªº¦^µª¬°¨Ì¾Ú§a¡I ·L¦ÌªÑªFªº¬Ýªk¡A¦p¦³±o¸o½Ð¨£½Ì¡I |
|
|
·|û¡GBiwin10140217 µoªí®É¶¡:2015/6/2 ¤U¤È 12:15:35²Ä 806 ½g¦^À³
|
PD229¨Æ¥ó¤w¸g³y¦¨¡y¿ß©ü˦b¿ûµ^¤W¡z²{¶H¤F... ¦b¤£§¹¥þ½T©wªº¸ê°T«e´£¤U¡A¥[¤W³\¦h¨S¦³¦X²z¨Ì¾Úªº°²³]¡B±À½×¡A¤£±M·~ªº¤ÀªR¥R¥¸¦b°Q½×°Ï¡A... ¹ê¦b«D§ë¸êªÌ¤§ºÖ¡I |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/2 ¤W¤È 11:51:18²Ä 805 ½g¦^À³
|
§Q¯A¤j¤t¤j: ¨âÓ°ÝÃD·Q½Ð±Ð¤j¤j±z: 1> §AºÙ: ²{¦b¨S¦³´£«e¸Ñª¼³o¨Æ ¡C 1.1¦ý¾Ú¤p§Ì©Òª¾ , ¯E¹©¤½¥q°ª¶¥·|ij¤¤, ´¿¬°¤F¬O§_´£«e¸Ñª¼ÅG½×³\¤[ , Y¯u¦p§A©Ò¤ª, ¨S´£«e¸Ñª¼¥i¯à, ¨º»ò, °ª¼h©Ò¬°¦ó¨Æ? ¥O¤H¯Ç´e¤F 1.2 Y¦³¤@ºØÃĪ«, PFS ¥iªø¹F8 ¦~ , OS ªø¹F25¦~( ¤¤Âå²z½×: ¤HÃþ¥¿±`¥i¬¡¨ì120·³ , ¦èÂå¤]¦p¬O»¡ ) , ¨º»ò, ¬O§_¤]n¤G´ÁÁ{§É 15¦~, ¤T´Á¦AÁ{§É15¦~, Á`¦@30¦~, ¦¹ÃĪ«¤~¯à°Ý¥@? ³o¦ü¥G©ó²z¤£³q, §ó¦óªp¤§«e ¯E¤Í¦³´£¥X¤w¦³2ºØÃĪ«´£«e¸Ñª¼¹L¡C¤£ª¾§Q¯A¤j¤t¤j ¹ï¦¹¦³¦ó¬Ýªk? 2> §A»{¬°¤£¥i¯à¥Î¥xÆW¤T´Á¥hFDA ¥Ó½ÐÃÄÃÒ, ³o¬O·íµM¡C ¦ý¯E¹©ªº¥xÆW¤T´Á, ¦P®É¤]¬O¬ü°ê¤G´Á, ³o¸ò§A©Ò¤ªªº«e´£¬O¤£¤@¼Ëªº , ¦óªp¤½¥q¦bªk»¡¤W¤]ºÙ ¦³¾÷·|ª½±µ¥Ó½ÐFDA ÃÄÃÒ, §Ú¬Û«H¯E¹©¤½¥q¾ãÓ¸gÀ綥¼h¬O¤£·|¦bªk»¡·|¶°Åé½s³y¬üÄRªºÁÀ¨¥ªº¡C ¹ï¦¹, ¥i§_½ç±Ð¤@¤G? |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/2 ¤W¤È 11:43:25²Ä 804 ½g¦^À³
|
¥|ºØ±¡¹Ò (1) 2015/1 , Central Read ¯u¬O < 142 ¤u§@¤Hû¤@®É²¨¥¢§â¤£¸Ó¤½¥¬ªºLR post¥X, ¬Ý¦bÃĮĨôµÛ, ¹ª´x³q¹L (2) 2015/1, 142< CR < 229 (160,180,200? ¥i¯à¤]¤£·|Á¿¥¿½TÈ) ¤W¦¸3¤ëªk»¡, ¤f»~»¡2015/1 CR <142 , Åý¤j®a»~·|²£¥Í´Á±æ¹L°ª, ¤@Áù°`, ¥þ³õµL¨¥ (¥i¯à»Ýn¤¯¸q¤§¤h¹G°Ý, §_«h¤j®an¦Aåx«Ü¤[) (3) 2015/1 CR=229 (¾÷·|¤£¤j§a, ®t87¤H, ¦Ó¥B8 ¤ë¦¬®×§¹<142) ¸³¨ÆªøÁ{®É¨{¤lµhµLªk°Ñ¥[·|ij, «x, «ç»ò·|³õ®à¤l,´È¤l³£°v¦º¤F (4) 2015/1 CR=? ê©óÂå¾ÇÛ²z, µLªk¤½¥¬ ¦³¤H³Û: Ãöªù©ñª¯ ¤p§Ì¼h¦¸¤£°ª, »y¦h²Ê«U, ©êºp |
|
|
·|û¡Gªü¤å10138375 µoªí®É¶¡:2015/6/2 ¤W¤È 11:37:47²Ä 803 ½g¦^À³
|
¤j¤á¤H®a, ¥H§A³]©wªº±ø¥ó,§Ú¦Û¤v±ÀºâPFS·|¤p©ó12 ¦ý§Úªº¸ÑŪ,§Q¯A¤jªº·N«ä¨Ã¤£¬O§A»¡ªº³o¼Ë |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤W¤È 11:28:29²Ä 802 ½g¦^À³
|
§Q¯A¤j¤t¤j ·PÁ´£¨Ñ¤À¨É¡A¤å¤¤¦³´£¨ìtopline¡A³o¤]¦³¤TºØª©¥»¡A§Ú´£¨ìªºÀY±ø·s»DÀ³¸Ó¤£¹ï¡A¤]¦³¤H´£¨ìÀ禬¡A¥[¤W¤µ¤Ñ²Ä¤Tª©Á{§Éªì¨B¼Æ¾Ú¡A§Ú·Q¤]¬O±i¸³»¡¤F¤~ºâ¼Æ¡A²³ø¬O¯E¹©¥´ªº¡A¯u¥¿·N¸qÀ³¥Ñ¯E¹©¨Ó¸ÑŪ¡A§Úè¤~¬Ý°ê¥~Á{§ÉÂå¾Ç³ø§i¦³¥Î¨ìtopline data Ó¤H»{¬°§Aªº¸ÑŪ©R¤¤¾÷·|³Ì¤j ¥ò´º¤j:¦L¶H¤¤PFS¬O¥H¥´²Ä¤@°w°_ºâ |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/2 ¤W¤È 11:26:59²Ä 801 ½g¦^À³
|
¯à§_½Ð¥ò´º¤j±N229¤H¥þ³¡³£¬O³Ì«ácentral ªº¸ê®Æ,¥t±N37¤Hªº°h¥XY¬O¤j³¡¤À³£¬O¹ï·Ó²Õ ¨Ó°µpFSªº¹w¦ô.³o¼Ë¦ü¥G¤ñ¸û±µªñ§Q¯A¤jªº»¡ªk.ÁÂÁ±z. |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/2 ¤W¤È 11:16:42²Ä 800 ½g¦^À³
|
Åwªï§Q¯A¤j¡I¦n¤[¤£¨£¡A¥@¬É¯u¤p¡C ¯u¥¿ªº±M®a¨Ó¤F¡A§Æ±æ¥¼¨Ó¦b¦¹¦h¦hµÛ¾¥¡A¦¹¤D¯u¥¿¯E¤Í¤§ºÖ¡C ´N¸ê®Æ©Ò¸ü»P¤p§Ì©Òª¾¡A822¨Ã¨S¦³¦b¨ü¸ÕÓ®×°lÂܹLµ{¤¤¥[¤Wbiopsy °µ¸~½F©â¼Ë¡F¥B¥¼¦CQOL¬°°lÂÜ«ü¼Ð¡F¦ý¦³©w´Á¦^°|Åç¦å¬Ýanti-GH Ab response ¤Îcell mediated responses¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤W¤È 11:05:57²Ä 799 ½g¦^À³
|
¥ò´º¤j 21Ó¤ë¤w¸g¤ñ²{¦³ªºÃÄÀu¨q¤F¡A·Q·Q822Áp¦X¤@ÓPFS¤p©ó4Ӥ몺¤ÆÀøÃÄ¡A¦³¥[¨S¥[¼vÅT¦³¡A»¡822¬O³æÃĪvÀø¤]¤£¬°¹L¡A¶PÀù¥Âù¼Ð¹v¥[¼Ú¬wµµ§ü¾J¡A PfS¤]¤~18.5Ó¤ë¡A¦pªG822¦AÁp¦X¦n¤@ÂIªºÃÄ¡A¤S·|¦p¦ó |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/6/2 ¤W¤È 10:54:33²Ä 798 ½g¦^À³
|
§Q¯A¤j¤t ¤j¤j¡A±j ! ±M·~ ! ¨ØªA ! ª©¤W¤j¤j¤j¤j±M·~ªÌ²³¡A¥O¤H¨ØªA¦Û¹Ä¥±¦p±æ¹Ð²ö¤Î¡B¡B¡B¡B ©Î³\¤j®a·|«Ü©_©Ç¡A«ç»ò §Ú³o¤ä¶w¼C¡A³£Á¿¤@¨Ç ¦³ªº ¨Sªº¡A ¦n¹³±q¨Ó¤£¥h°Q½× PFS ¡B¡B¡BÔ£ªº ¡§Âå¾Ç°ò¥»±¡¨ ?? ¥H«e§Ú¤]°¸º¸·|µoªí¤@¨Ç ¡§Âå¾Ç°ò¥»±¡¨ Ô£ªº ~ «á¨Ó´X¦¸¶}·|¡A¤~ª¾¹D¡A ¡§¦Û¤v¦bÂå¾Çªºª¾ÃÑ¥u°÷AÄ_¡Aª±®a®a°s¡¨ ¡A´N¤£¦A½Í¨º¨Ç ¡§²`¿D¡¨ ªºªFªF¡C (¥»©P¤»¡B¤é¡A¦³¥xÆWÀù¯gÂå¾ÇÁp¦X¦~·|¡A¦³´X¦ì¸~½F¬É¤j¦Ñ·|»P·|¡A·|°Ý°Ý½Ð±Ð¤@¤U¥L̪º·Qªk) ¸Õ·Q¡A¥x¤j¡BºaÁ`¡B¶§©ú¡B¡BÀH¤â§ì´N¤@°ïªº³Õ¤h¡B±Ð±Â¡B¥Dªv¥D¥ô¡B¡B¡A §Ú̦A«ç»ò¥hÆp¬ã ¡§Âå¾Ç¡¨ ¡A¤]ÁÙ®t¤H®a ¤Q¸U¤K¤d¨½¡C (³oÁÙ¥u¬O¦b¤p¤p¤p¥xÆW¡A¦a¹Ï¬Ý¤£¨ìªº ¼u¤Y¤§¦a¡A©ñ²´¥þ²y¡AÂå¾Ç±M·~¤H¤h§ó¦h) ©Ò¥H°£¤F ¡§°ò¦Âå¾Ç¡¨ ¥~¡A¤]n ´L·q®Ä²v¥«³õ¡A¶ÉÅ¥¥«³õªº¯ß°Ê ¼K ~ ¤]¤£n ¦k¦ÛµáÁ¡¡A¦pªG©M¨º¨Ç ³Õ¤h¡A¤ñÁÉ §ë¸ê¡B³Ð§ë¡B¡B¡A»¡¤£©w´N¦³Ä¹ªº¾÷·| ~ ~ ? |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/2 ¤W¤È 10:47:18²Ä 797 ½g¦^À³
|
Y¬O²Ä¤Gªº±¡ªp¦³¥i¯à ªí¥Ü,822 Àøµ{§¹«áÁÙ¬On¨C3Ó¤ë¦A¥´¤@¦¸, ¥i½T«O¤£´_µo, |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/2 ¤W¤È 10:41:44²Ä 796 ½g¦^À³
|
§Q¯A¤j¤t¤j «Ñ¤l¤ºªº¶}¤f´N¬O®ð¶Õ¤£¤Z, ID³o»ò«e±, ±z¤]ÁÙ¯u¨Iªº¦í®ð, ²{¦b¤~¥X²{ ·q§A¤@ªM, ¥i¤£¥i±`±`¥X¨ÓÅý§Ú̽¤«ô¤@¤U |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/2 ¤W¤È 10:35:45²Ä 795 ½g¦^À³
|
PFS ªº¦Û§Ú×¥¿ : 1> °²³]±i¸³©ÒºÙ 2015/1 ´_µo¤H¼Æ¤Ö©ó142¤H («Ü¦h¤H§@¹Ú¹Ú¨ì¬O120¤H¥ª¥k) , ¥B¦p¥ý«e©Ò°²³]ªº, ¨ä¤¤¥u¦³20%´_µoªÌ¬°¹êÅç²Õ(24¤H) : ¹êÅç²Õ³oºØ«ÜºCªº´_µo³t«×, ªí¥ÜÀø®Ä±µªñ¤@´ÁÁ{§É, ¦]¦¹,, ¥H«e¤~¥Î¹êÅç²Õ¤H¼Æ´_µo¹F¤@¥bªº³o¤@¦ì («á±¥b¼Æªº¤H¦ü¥G³£¶W¹L4¦~¥H¤W¤~´_µo? ) ¨Ó·í§@¤¤¦ìPFS , ¦p¦¹¤@¨ÓPFS ·|«Ü°ª 2> ¦ý¦pªG´_µo³t«×«Ü§Ö( ¤@´ÁÁ{§É¤£¨ã°Ñ¦Ò©Ê), ¦b2015/1 Central Read PD ¤w¹F160¤H , ¥B°²³]¨ä¤¤¹êÅç²Õ´_µo¤H¼Æ¬°64¤H(¹ï·Ó²Õ96¤H~~»P²Ä1ÂI°²³]¬Û¦P) ¤µY¤S°²³]¨ì¦~©³´_µo¤H¼Æ¦@¹F284¤H(¹êÅç²Õ174¤H) , ³oªí¥Ü«á±¥b¼Æ´_µoªº¹êÅç²Õ¨Ã¤£¹³¤@´ÁÁ{§ÉªÌ¨ã¦³¯S§OÀø®Ä, ¦Ó¥u¬O«½Æ«e±¥b¼Æªº¼Ë¥»¦Ó¤w, «h «e¤éÓ¤H©ÒpºâªºPFS=30Ó¤ë À³¬O¿ùªº, ³o®ÉPFS ´£«e·§¦ôªº±Àºâ, À³¬O¥H«e¥b¼Æ¹êÅç²Õ´_µoªÌªº¤¤¦ì¼Æ ¨Ó°µ¬°PFS¹w¦ôÈ, ¦p¦¹¤@¨Ó, ¹êÅç²Õ«e¥b¼Æ´_µo¤§¤¤¦ì¼Æ ( ²Ä58¦ì, 233/2=116 , 116/2=58 ) ±N¸¨¦b2014/12 , ³o¼ËªºPFS ¬ù¬O21Ó¤ë ( ¤U±ªº23+19 °£¥H2=21) (¹êÅç²Õ«e¥b¼Æªº¤¤¦ì°_ÂI2013/1, ¦Ü~2014/12 =23Ó¤ë; «á¥b¼Æ¤¤¦ì°_ÂI 2014/11, ¦Ü~2016/ 6 =19 Ó¤ë ~~ ³o¬O°²³]¦Ü2016/6 ¥þ³¡´_µo, ¦]¥§¡¨C¤ë´_µo10¤H) ¦Ó«D«e¤épºâªº30Ó¤ë , ¦ýP Ȥ£¦]¦¹§ïÅÜ, ¯S¦¹×¥¿¤§ 3> ªG¦p¦¹ PFS=21 ¤@¼Ë¬Û·í¨ã¦³µ´¹ïÄvª§¤O , ¥u¤£¹LÅý¤H¯Ç´e ¬°¦ó¤@Ó¤£±þ¥¿±`²ÓM ¥u±þÀù²ÓMªºÁÞ¦X¦¨ÃĪ«¨äÀø®Ä¤]¥¼¨ìÅå¤Hªº¦a¨B ¡C ¦ý¦pªG ©ú¤Ñ±i¸³½T»{ 2015/1 ªºÁ`´_µo¤H¼Æ¯uªº¤Ö©ó 142¤H , ¨º»ò¤j®a¬O¤£¬On¹³¬Ý§¹ ¿½Ã®Q¹q¼v¤@¼Ë °_¨Ó¹ª´xÓ¤T¤ÀÄÁ©O? ( ¤p§Ì¦Û±q¤Q´X¦~«e¦³¯f¤£¬Ý¦èÂå ±Ä¥Î¦ÛµMÀøªk ©Î¬Ý¤¤Â大«á ¥H«e¬Ý¦èÂ帨¤Uªº¯f®Ú¡Bªø¦~ªº¤ò¯f ³vº¥®ø¥¢ ºë¯«¤]¤ñ¥H«e¦n«Ü¦h µ¹°µª½¾PªºªB¤Í¥Î»ö¾¹´ú¥Í²z¦~ÄÖ ©~µM¤ñ¹ê»Ú¦~ÄÖ¤p¤F ¡§ 15 ¡§ ·³ ³oªB¤Í»¡§Ú¬O°ß¤@ªº¨Ò¥~ ) ¥H¤W±Àºâ ¦p¦¹¿ù»~ ½Ð¤£§[«ü±Ð |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/2 ¤W¤È 10:16:59²Ä 794 ½g¦^À³
|
·PÁ§Q¯A¤j¤t¤j¤À¨É¡I |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/2 ¤W¤È 10:16:53²Ä 793 ½g¦^À³
|
¬Ý¨Ó¹ïpFSªº´Á«Ý´N¬O¯à¶W¹L10´Nºâ¬O¤£¿ù¤F.¤°»ò¬ð¯}©ÊÀøªk¤]¤£¥Î¥ý°µ¹Ú¤F.¤@±À¤H¤§«e¬Ýªº¤j¦n,¦n¹³¥þ³£³Q¥´¤F¤@Ó¦Õ¥ú. |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/2 ¤W¤È 10:07:57²Ä 792 ½g¦^À³
|
«ôŪ§Q¯A¤j¤t¤j¤jµo¨¥«á¡A¤~²`·P¦Û¤v±M·~ª¾ÃѪº¤£¨¬¡A·P®¦¤À¨É¡C |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/2 ¤W¤È 09:51:03²Ä 791 ½g¦^À³
|
§Q¯A¤j¤t¤j ¯E¹©ª©¤S¥X£¸¦ì¯«¤H¯Å ·P®¦ |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/6/2 ¤W¤È 09:47:19²Ä 790 ½g¦^À³
|
§Q¯A¤j¤t¤j ·PÁ ³o¤@¦¸±z¯uªº¸ÑÄÀªº¬Û·í²M·¡¤F «¢«¢«¢ ¦ÂI¥X²{¹À~~~ ÁÂÁÂÅo |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/2 ¤W¤È 09:46:08²Ä 789 ½g¦^À³
|
ÃØ»PªÑ²¼ªº¹ï¶H³q±`¬O°t°¸©Î¤l¤k¡A¥Dn¬O¦³§ó¦h¸`µ|ªÅ¶¡ªº¦Ò¶q¡A°t°¸¤l¤k½æ¥X¤@¼Ën¥Ó³ø¡C½è³]ªº¹ï¶H¬°»È¦æ¡AªÑ²¼©è©ã¦b»È¦æ¡A¨âªÌªºªÑ²¼³q±`¤£·|¬y¨ì¥«³õ¡C¦Ü©óœU¦ón½è³]¡H5¤ë¬Oúµ|©u¸`¡A¤S¦³ÃÒ©Òµ|«á¿ò¯g¼vÅT¡Aû¤u»{ªÑ³¡¤À¡A¥un¤½¥qÂà¤WÂd©Î¤W¥«¡Aû¤u¾¨ºÞ¨S¦³³B¤À¤â¤¤«ùªÑ¡A´N·|³Q¥H±¾µPº¤éªº¤W¥«Âd¥§¡»ù®æ¦©°£»{ªÑ¦¨¥»¡A©Ò±o»ù®t¦Û°Ê¦C¤J·í¦~ºî¦X©Ò±opµ|°ò¦¡C½Ð°Ý¥LÌúµ|ªº¿ú±q¨º¸Ì¨Ó¡A©Ð«Î©è©ã©Î½è³]ªÑ²¼É´Úúµ|³£¤£¥O¤H·N¥~¡C |
|
|
·|û¡Grabbit10136567 µoªí®É¶¡:2015/6/2 ¤W¤È 09:40:36²Ä 788 ½g¦^À³
|
Hi §Q¯A¤j¤t!!! ©|¥¼Åª§¹§Aªº¤å³¹¡A¥ý¦æ«ô§¡A«Ü°ª¿³ ª×Às(Cliff) »ñÂú(§Q¯A) ³£¦b¦¹ª©! XD |
|
|
·|û¡G¤ý£«¬Â10136621 µoªí®É¶¡:2015/6/2 ¤W¤È 09:37:07²Ä 787 ½g¦^À³
|
¤¨¸³»¡:¥Í§Þ¿ï¹ï¤H(±i©À·O.¯Î±Ò´f)°µ¹ïªº¨Æ,¦A§â®É¶¡©Ôªø¨º´N¹ï¤F. |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2015/6/2 ¤W¤È 09:35:00²Ä 786 ½g¦^À³
|
³]½è¥X¥h´N¬O§â¿ú®³¤@¨Ç¦^¨Ó =>¿ú®³¦^¨Ó«á,ªÑ²¼©Ò¦³Åv¤HÁÙ¬O¥h³]½èªº¤Hªº,ªÑ²¼»ùȤU¨Ó,n¹ÀÂ_ÀYn¹À¸É¿ú,¬O§a?? ÃØ»P¥X¥h ¥H«áªÑ²¼ªº¬y¦V´N¤£¥Î¥æ«Ý¤F =>§Ú»{¥i, |
|
|
·|û¡G§Q¯A¤j¤t10022029 µoªí®É¶¡:2015/6/2 ¤W¤È 09:34:52²Ä 785 ½g¦^À³
|
²Ä¤@¦¸¦b¯E¹©ª©µo¨¥¡A¬Ý¨ìPD 229³o¸ÜÃD³o»ò¼öªù¡A§Ô¤£¦í·Q¦bªÑªF·|«e´ê´ê¼ö¾x¡C ´XÂI·Qªk¡A - PD 229/ others 37 ´N¬O¤@¤ëªº´_µo¤Î°h¥X¯f±w¼Æ¥Ø¡A¤£¬O±ø¥ó¡COthers¡]§Y¯f±w¤¤³~°h¥X¤H¼Æ¡^¤]¤£¥i¯à¬O¯f±wµo²{¨S¦³¬õ¸~¡B±À½×¤£¦b822¹êÅç²Õ¤º´N¦Û¦æ´N°h¥X¹êÅç¤F¡C¦U¦ì¡A³o¬O¨ÅÀù±ß´Áªº¯f±w¡A°h¥X¹êÅç«á¥hþ¸Ì¡H¦^®a§j§N®ð¶Ü¡HÁöµMSAE¬Ý¨Ó»´·L¡A¦ý¬O³o³Ì«á²Ö¿nªºOthers¬Ý¨Ó·|¶W¹L10% ITT¡A³oÓ¯f±wdrop-rate¬O»Ýnª`·Nªº¡C¯f±w¬°¤°»ò°h¥X¹êÅç¡G¬O¾A¥Î¯f¯gn×¥¿¡HÁÙ¬O¥ý«e¯f±w¤w¥ÎÀøªk§«Ãª§K¬Ì¨t²Îªí²{¦Ó¶·¿z¿ï¡H¦]¨S¦³¶i¤@¨B¸ê°T¡A³oÃ䤣°µÁr´ú¡C - ²{¦b¤]¨S¦³´£«e¸Ñª¼³o¨Æ¤F¡A©Ò¥H¹êÅç¤@©w·|¶]§¹¡A©Ò¦³¯f±wªº¬ö¿ý³£·|²£¥Í¡A¦U¦ì¤]¤£¥Î²q¦ó®É·|¸Ñª¼¤F¡A¨C¦ì¨ü¸ÕªÌªº§K¬Ì¤ÏÀ³¤Î¸~½F¦ó®É´_µo¡]©ÎªÌ¤£´_µo¡^¡A³£¬O¹êÅçn»`¶°ªº¸ê®Æ¡A¨S»`¶°§¹«ç»ò¤½§G©O¡H - ¦³ºô¤Í°Ý¬°¦ó¬O¬Ýmedian¦Ó«Daverage¡H¡K¡K³o¡A¬OºD¨Ò¡C·Q¹³¦pªG§A¬OÀù¯g¯f±w¡Amedian OSÁÙ¬Oaveraged OS¹ï§A¤ñ¸û¦³·N¸q¡H¡]¸U¤@¤§«e¨ü¸ÕªÌ¤¤²V¤F¤@¦ì´^¯ª¶i¨Ó©Ô°ªaveraged OS¡K¡K.¡^¦ý²{¦b¬Ý§K¬ÌÀøªk¡A°£¤Fmedian¤§¥~¡AFDA¥DnÁ٬ݬO§_¦³ªø§À®ÄÀ³¡C¤ñ¦pmedian OS¬O15Ó¤ë¡A¦ý¬O¹êÅçµ²ªG¦³30%ªº¯f±wOS³£ªø¹F30Ó¤ë¥H¤W¡A¨º»ò³oªø§À®ÄÀ³´N«ÜÅå¤H¤F¡C¦]¦¹«ÂÐ¥ý«e©Òz¡A¹êÅç¤@©w·|¶]§¹¡A¬Ý¬Ý¬O§_¦³ªø§À®ÄÀ³¥X²{¡A¥H¤Îªø§À®ÄÀ³¬O§_¾A¥Î©ó¯S©w¦¸±Ú¸s¡B¦]¦¹Àø®Ä§ó¦nµ¥µ¥¡C - ªk»¡¸ê®Æ¤£¬O¼g¤F¶Ü¡H¹w¦ôÁ{§Éªì¨B¸ê®Æ (topline) ¤½§G¬O¦b1H2016¡C¤§«eÁÙ¦³¤H²qtopline¬O¬Æ»òÀY±ø¤j¨Æ¡BÀ禬¸¤Ñ¡K¡K ¤£¬Oªº¡Atopline¬O«üªì¨B¸ê®Æ¤ÀªR¡A¤ñ¦p©ú¦~¤W¥b¦~¤½¥¬µ²ºâ¨ì2015¦~©³©Ò¦³¯f±wªºOS, PFS, PD/PR/CRµ¥µ¥¡C - Topline§¹¤F¤§«áÁÙ·|¦³§¹¾ã³ø§i¡A¤j·§ÁÙnµ¥¤»¨ì¤EÓ¤ë¡A§â©Ò¦³²Ó³¡¸ê®Æ³q³q¾ã²z§¹¦¨¤§«á¡A¨ÃÂk¯Ç¥i¯àªº¯f±w¦¸¸s²Õ»POS/PFS¤§¶¡ªºÃö«Y¡A¬O§_¦³¨ä¥L¥ý´ÁÀø®Ä«ü¼Ðµ¥µ¥¡]¤ñ¦p¦b²Ä¥|°w©Î²Ä¤°w´N¤w¨Ï§K¬Ì¨t²Î²£¥Í°O¾Ð®Ä¯q¡A¬G¦Ó·í®ÉªºSD´N¥i¥H·í¦¨¬OOS surrogateµ¥µ¥¡^¡A³Ì«áÂk¯Ç¥X¨Ó¹ï¤U¤@¶¥¬qÁ{§É¹êÅç×¥¿©Î±ý±´°Qªº¤è¦V¡C±`±`±¡ªp¬O¡Gtoplineªì¨B³ø§i¥X¨Ó¬Ý¨ì´X¶µ¤j«ü¼ÐªºÁͶաA¦ýµ¥§¹¾ã³ø§i¥X¨Ó«á§ó¶i¤@¨B¾\Ū¡A«oµo²{¨Ã¤£¬O³o»ò¦^¨Æ¡A¯S§O¬O¤¤³~¯f±wdrop-out rate¹L°ªªº®ÉÔ¡C©Ò¥Htoplineªºµ²ªG¸ò³Ì²×§¹¾ã³ø§i¬O¦³¥i¯à¦³¥X¤Jªº¡C³oÃä¼È¤£Âب¥¡C - §K¬ÌÀøªkPD¹L°ª¡B©ÎªÌµLCR/§CPR«Ü¥¿±`°Ú¡I¦]¬°RECIST 1.1¬O¥H¸~½F¤j¤p¨Ó§P©w¯f±¡¶i®i¡A¦ý¬O§K¬ÌÀøªk±`±`·|¥X²{¸~½F²ÓM³QT cell®û¼í¡B©ÎªÌnecrosisµo¥Í¤Ï¦Ó¨Ï¸~½FÅܤjªº±¡ªp¥X²{¡CPD/low PR/low CR¤@ÂI³£¤£©_©Ç¡A¦]¬°¹êÅç§P©w¤´¬O¥H¸~½F¤Ø¤o¨Ó¬Ý¡A822¦n¹³¨S¦³»²¥Hbiopsy °µ¸~½F©â¼Ë¡H©ÎªÌ¦³°lÂÜIgG/IgMªº¦å²Gªí²{¶Ü¡H¤£¹Lbiopsy¦b¸~½F¨ú¼Ë¤]¦³°ÝÃD¡A³o¬O«á¸Ü¡C¥i¯àºn°ÝÃD¬O¡G822¨ì©³¯à¤£¯à©µªøOS§a¡H¨ä¦¸¡A´Nºâ¸~½FÅܤj¡A¯f¤HªºQoL (Quality of Life)¦³§ïµ½¶Ü¡]QoL¦n¹³¤]¨S¦³¦C¬°°lÂÜ«ü¼Ð¡^¡H¤ñ¦p¸~½F¦]¬°T cell®û¼í¦ÓÅܤj¡A¦ý¬O¨ä¹ê¸~½F¤º³¡Àù¯g²ÓM¤w¸g³Q²M°£¤j¥b¡H - ³Ì«á¤@ÓÃöÁä°ÝÃD¡G¦pªGPD 229/others 37@Jan 2015¡A¦U¦ìı±oFDA¦³¥i¯à®³¥xÆW¹êÅç¸ê®Æ§KÁ{§É¤T´Áª½±µ³q¹L¬ü°ê¤W¥«¶Ü¡H¡@ASCO è觹¡A§K¬ÌÀøªk¬O«¤¤¤§«¡A°Ñ¦Ò¤@¤U³o½gªºresponse rate§a¡C¡@Cancer treatment breakthrough cure!¡@http://rt.com/news/263881-cancer-treatment-breakthrough-cure/ PS.·Q·Q¡AÁÙ¬O§Ô¤£¦í¤pÂW¤@¤U¦n¤F¡C¦pªGPD 229/others 37ªº½T¬O¯f±w´_µo/°h¥Xªº¼Æ¦r¡A¨º§Ú¹ï³Á§J±iÁÙ¯u¬O¤j¥´§é¦©¡K¡K¡C¦pªG¯E¹©¦b¬ü°ê±¾µP¡A§ÚµLªk·Q¹³¤½¥q¹êÅ祼¸Ñª¼´N¤½¶}¯f±w´_µo¼Æ¦r¡ADMC¡]Data Monitor Committee¡^·|«ç»òײz³o¶¡¤½¥q¡K¡K¡CþºÞ§A¬Æ»òlocal read/central read¡A¼Æ¦r¥»¨Ó´N¥u¯à¦³central read¡A´N¬O¥Ñ²Ä¤T¤è¿W¥ß¾÷ºc»{©wªº´_µo¯f±w¡CÁÙ¦Û¤v¥ýÁ¿¤@ÓPD¥X¨Ó¡A¦A¥Ñ¤½Ãö±»¹¢»¡¨º¬Olocal read¤£¬Ocentral readù¡K¡K¡C |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/2 ¤W¤È 09:31:35²Ä 784 ½g¦^À³
|
ªÑ²¼³]½è¥X¥h´N¬O§â¿ú®³¤@¨Ç¦^¨Ó ÃØ»P¥X¥h ¥H«áªÑ²¼ªº¬y¦V´N¤£¥Î¥æ«Ý¤F |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2015/6/2 ¤W¤È 09:18:25²Ä 783 ½g¦^À³
|
½è³]ÃØ»P¥X¥h ±Ó·P ¬O¥Nªí¥X²æªÑ²¼¨ì¥«³õ???? |
|
|
·|û¡G¦n¤ßªº¯Q¾~10137878 µoªí®É¶¡:2015/6/2 ¤W¤È 09:06:14²Ä 782 ½g¦^À³
|
³Ìªñ¸g²z¤H°Ê§@ÀWÀW ¬ãµoªø½è³]335±i ¥t¤@¦ì¸g²z¤H°t°¸¤]±N¤â¤¤ªÑ²¼¥þ¼ÆÃØ»P¥X¥h ¦b¦¹®É¶¡ÂI¦³¨Ç±Ó·P |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2015/6/2 ¤W¤È 04:19:42²Ä 781 ½g¦^À³
|
¥i½Ð¦³n°Ñ¥[ªÑªF·|ªº¤j¤j¦A¸ò¤½¥q´£°Ý½T©w¤@¤U.. ·íªì3´ÁÁ{§É³]p½µP¨ú¨Mªº¤¤¶¡ÂIPFS(¨Ò3Ó¤ë.5Ó¤ë.3¦~.¨º´N¬OPFS 5) «DÁ`¥§¡Èªº¤¤¶¡ÂIPFSªº³]p¦³ÅܶÜ? ¦]§Ú«çºâPFS³£¤£·|¤Óªø,¤½¥q¦ü¥G¥unĹ¥«±ªºÃĦӤw~Â檺½µP¨ú¤¤¶¡Èªº³]p,¤½¥qªº§Q°ò¨ì©³¬O¤°?¤@®É·d¤£¤Ó²M·¡~ ¦]§Ú©ú±ß¤£·|¦b¥xÆW,½Ð¦U¦ì¤j¤jÀ°¦£°Ý¤½¥q~ÁÂÁÂ~ |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2015/6/2 ¤W¤È 03:17:23²Ä 780 ½g¦^À³
|
¦pªG·Ó±i¸³ÂI¦W¦¡ªº¨ú¤¤¶¡ÂI(È)¦Ó«D¥§¡¤¤¶¡ÂI(È) ¦]¬°¦ü¥G²Ä¤@Ó¥[¤Jªº¯f±w¦b¹L¤F¦w¥þ´Á«á¤]¤£·|¹ïPFS¦³¤Ó¤j¼vÅT ¨º¬O¤£¬O¶V±ß¸Ñª¼¶V¦n?¦A¥[±i¸³»¡ªº³Ì¨Î½µP®É¾÷?¨ú¤¤¶¡ÂI? |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2015/6/2 ¤W¤È 02:35:58²Ä 779 ½g¦^À³
|
è©¿µM·Q¨ì¤§«e±i¸³¨ü³X¸ê®Æ §â¥¦Â½¥X¨Ó~ ¦ý¥i¯à¸ò¥Ø«eÅýªO¤WºÃ´bªº229 ¦³ÂI¤£¬Û¤z~ Q7:·íªì¯E¹©¦b³]p³onªº®ÉÔ,¥L¹ïÀù¥½¯f¤Hªº¦s¬¡²v©M¤£´_µo®É¶¡¬O«ç³]pªº? A7:§ÚÌ·íªì¬O¥Î¶PÀùµÓ§@¤ñ¸û,¥L̦s¬¡²v¬O±q¤@¦~¥b¨ì¨â¦~¥b ´_µo¬O6Ó¤ë¨ì9Ó¤ë,§Ṳ́]¬OÂæ³]pªº,©Ò¥H®Ú¾ÚÂæ§ÚÌ»Ýn284Ó¤H°µÁ{§É. §Ú̦b°µ³o©Ò¿×¤@¦~¥b¨ì¨â¦~.6Ó¤ë¨ì9Ó¤ë,ºÙ°µ¤¤¶¡ÂI¦s¬¡²v ¤j®a³£¥H¬°¬O¥§¡ÂI,°²³]»¡¦³3Ó¤H,³o¤H¬¡3Ó¤ë,³o¤H¬¡5Ó¤ë,¨ºÓ¤H¬¡3¦~ ¨º¥¦¤¤¶¡È´N¬O5Ó¤ë ¤]´N¬O¬Ý¤¤¶¡³oÓ¤H¬¡´XÓ¤ë´N¬O´XÓ¤ë. ©Ò¥H¤£¬O»¡¤H¼Æ¶V¤Ö¶V¦n,Á|Ó¨Ò¤l °²³]§ÚÌnªº284Ó¤H,´_µoªº¦³60Ó¤H,¥i¬O¨º60Ó¤H¸Ìªº¤¤¶¡ÂI¦³31Ó¤H³£¬O5Ó¤ë ³Ñ¤Uªº³£«Üªø,¥i¬O¤¤¶¡ÈÁÙ¬O5Ó¤ë ©Ò¥H¦bÁ{§É¸Ñª¼«e§ÚÌ«ç»ò¥i¯àª¾¹Dµ²ªG,¥~¬É¹ï¨ä¤¤³ø§iªºµ²ªG³£¬O²q´ú,¤£¨ì³Ì«á¤@¨è¬O¤£·|¦³µª®×ªº. ¦U¦ì¤j¤j,±i¸³·N«ä¦n¹³»¡PFS¤£¬O¨ú¥ý¨Ó«á¨ìªº¯f¨Ò¥§¡«áªº¤¤¶¡È¬O¶Ü? ¨ºÂæPFSn¶W¹L¶PÀù¥¬O¨S°ÝÃD,¦ý¦³¥i¯à¨ì20Ó¤ë¥H¤W¶Ü?ÁÙ¬O¦³Ãø«×? ªÑªF·|¥i¦V¤½¥q½T©wPFS¤¤¶¡Èªººâªk¶Ü? ©çÁÛ«á,¦]¹ê¦b¤£¬O¥»¬ì,Y¬O·Pı§Ú¦³¦b¶Ã,¨º.....§O²z§Ú~ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤W¤È 12:47:37²Ä 778 ½g¦^À³
|
µ½¤H¤j 1§A±À¦ô¨ºÓ¯«¯µ¼Æ¦r¬O¶}ª¼¼Æ¬O¦X²z±À½× 2¤]¥i¯à¬O®É®tªºÃö«Y¡A¯«¯µ¼Æ¦r¤]³\¬O«ü9¨ì12¤ë ¶¡¤~·|¹F°}ªº¼Æ¦r¡A¤£¬O«ü¤@¤ë®Éµo¥Íªº¼Æ¦r 3¤p¤ß¤£nÅý2010¦~¡A2011¦~¦¬®×¬ù30¦ìªº ¨ü¸Õ§j¤fï±Æ¶¤±Æ®É±Æ¦b¤¤¶¡¡A¦o̸g¾ú¤F2012,2013,2014,2015¤w¶W¹L40Ó¤ë¡A ¤p¤ß¤£nÅý¨º¨Ç°í±jªº°ü¤k±Æ¦b¤¤¶¡ 4´c¤Æ¤£µ¥©ó¦º¤`¡A¦oÌÁٯଡ«Ü¤[¡Aµ¥«Ý ²Ä¤G¥NªºÃÄ¥X²{ |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/2 ¤W¤È 12:02:24²Ä 777 ½g¦^À³
|
¥xÁÞ¤j, §Ú¤]ºâ¹L¦¬®×Á`¤H¼Æ349¤H, ¸ÕÅç²Õ233¤H, ¹ï·Ó²Õ116¤H, Á`´c¤Æ¤H¼Æ284¤H, ¸ÕÅç²Õ´c¤Æ¤H¼Æ174¤H, ¹ï·Ó²Õ´c¤Æ¤H¼Æ110¤H, ·Ó¥ò´º¤jªº¥d¤è¤À°tªkºâ¥Xªº¼ÆÈ 20.74>10.8 P<0.001 ¨ú±oTFDAÃÄÃÒ¨S°ÝÃD. §ÚJ§è229¬O°µÂ²³øªºû¤u±N129»~¥´¦¨229? ·Ó²z±À½×¤£¬O»~¥´, ¦]¬°229¬Oì¨Ó342ªº²Îp¸ÕÅç²Õmedian PFSªºÃöÁä¼Æ¦r(229-114=115). §Ú²q229¬O¤@Ó²z½×¤S²z·Qªº¸Ñª¼ÃöÁä¼Æ¦r, 342¤H°Ñ»PÁ{§É¸ÕÅç¦Ü¹F¨ì«ö·Óij©wªº±ø¥ó¦Ó²×¤î¥ÎÃÄ, ¤¤³~³£¨S¦³¤H¦]¬G¥D°ÊÂ÷¶}¸ÕÅç. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/2 ¤W¤È 12:00:29²Ä 776 ½g¦^À³
|
¦pªG¤£¤p¤ßÅý¹êÅç²Õ¦´Á2012¦~«e¦¬®×ªº66¤H¤¤¤@¥b¦b§j¤fï±Æ¶¤®É±Æ¦b¤¤¦ì¼Æ¡A¨º¨Ç°í±jªº°ü¤k¼µ¨ì³Ì«á¤~´c¤Æ¡A¨Ã¥B¸g¾ú¤F2013¦~¡A2014¦~¡A2015¦~ ¤w¶W¹L30Ó¤ë¡A¤p¤ß¤£nÅý¦o̱ƶ¤±Æ¤¤¶¡ |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/1 ¤U¤È 11:10:15²Ä 775 ½g¦^À³
|
¤p§Ì¨S¦³¼g¦n¡A¥HPjm¤j»~·|§Úªº·N«ä¡A°k©R»¡¬O«üY¤£¬Û«H±i/¯Î/¤¨¤T¥¨ÀYªº¸Ü´N»°ºò°k©R ¨Ã«D¬O«ü¥»¤H¤£¬Ý¦n¯Eô¡A¥Ø«e¤Ï¦Ó¬O«H¤ß¤Q¨¬¡A°¨¤OÉqÉq°Õ ¤]·PÁ¤j¤á¤H®aÀ°¦£»¡©ú~~ ¦V«e¦æ¤j»¡ªº¤]«Ü¦³¹D²z¡A¦ý¦pªG»¡¬O¦]¬°central read»Plocal read®t²§, 229»P142®t¤F(229-142)/229=38% Y¬O¥Î120ºâ¡A(229-120)/229=48%, «o¤]¥¼§K®t²§¤j¹LÀY¤F§a ¤p©_¤jªº»¡©ú¦³¦p¯«¨Ó¤@µ§¡Acliff¤j±M·~¸ÑÄÀ¤]¥O¤HÀò¯q¨}¦h ¥ò´º¤j¡ALÂå¥Í¡Aµo¨¥¤H...³£¸Ô¹ê´yz¤F©ÒÀò±o¨ìªº¸ê°T ¯E§b¤j«ÈÆ[¥B¤¤ªÖªº´yz¤F¨âªÌ¶¡ªº¥Ù¬Þ¡A´N¬O"¨âÃä½×z¦ü¥G³£¦³ÄY«°ÝÃD" ======================================================================================= 1. ¦pªG¬O±ø¥ó»¡ a. ¨ºµo¨¥¤H¤ÎÂå®v¤£¬O¦³¬G·N»~¾É¤§¶û? (©~µM´±A¯«¤H¯ÅªºCliff¤Î¥ò´º¤j) b. ¨ºOther 37 ¬O¬Æ»òªFªF? (¤jÁx§ârabbit ¤j³£·S¤õ¤F) 2. ¦pªG¬O¹ê»Ú¤H¼Æ»¡ a. ¤£²Å3¤ë»¡ªk, ¥i¯à¦³«H¥Î¯}²£¦M¾÷? (©~µM¹GÅó¤j,§â°k©R¨âÓ¦r³£»¡¥X¤f) b. ¤£²Å¤@´Á¼Æ¾Ú»P²³¦hÅK¤f¤Î¥ý¤H¹Ú¹Ò (À³¸Ó°Û¹Ú¿ô®É¤À, ¤£¬O§Ñ±¡¤ô) ===================================================================================== §Ú»{¦Pµ½¤H¤j¦p¹êªº§â©ÒÆ[¹î¨ìªº²{¶H»¡¥X¨Ó¡A³o¤£¬O©È¤£©Èªº°ÝÃD¡A ¦]¬°«H¥õ²£¥Í¤O¶q¡A¦pªG³s«H¥õ³£°Ê·n¤F¡A¤S¦ó¨Óªº¤O¶q¡C PÈ<0.001©Î³\¬O·sÃįà§_³q¹LFDA¤W¥«ªº«nÃöÁä¡A¦ý¬O¯à¤W¥««o¤£¥Nªí¥i¥H½æ±o¦n ¦³Ó«OÄÖ²y»¡²×©ó¥i¥H½æ¤F¡A¤@¦~¤j®aºâºâ¥u¯àÁÈ3¤¸EPS,´Nºâ¦³150¤¸ªÑ»ù¡A¥»¯q¤ñ50¿ÁÙ¬O¤Ó¶Q¤F Á`¤§ÁÙ¬On¨Ó¬ÝPFS, ¹ï·Ó²Õ114¤H¦pªG¦³14¤H°h¥X¡A¨ä¾l¥þ³¡´_µo¡A´N¬O114-14=100´_µo Y¤w¦³229¤H´_µo¡A«h¹êÅç²Õ¦³229-100=119¤H´_µo¡A¹êÅç²Õ¥Î228¤Hºâ¡A822 PFS³Ì¦h¤]´N¬O15¥ª¥k¡A ¦Ó¥B»P¤@´ÁMSKCCªºµ²ªG¸¨®t¤Ó¤j¡AµLªk¸ÑÄÀ |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/1 ¤U¤È 10:51:38²Ä 774 ½g¦^À³
|
ÁÂÁÂCliff¤jªº»¡©ú¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤U¤È 10:46:09²Ä 773 ½g¦^À³
|
¬Æ¦Ü¶W¶V¹ï·Ó²Õ«Ü¦h¡A½Ð°Ý¹êÅç²Õ¦pªG ´c¤Æ¤H¼Æ¶V¨Ó¶V¦h¬O§_ PÈ·|¶V¨Ó¶V¤j PFS·|¶V¨Ó¶V¤p «H¿à°Ï¶¡·|¶V¨Ó¶V¯¶(ªí¥Ü¥i«H«×¶V°ª) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤U¤È 10:32:23²Ä 772 ½g¦^À³
|
±µÄò §Ú¤£·|¦bªÑªF·|°Ý¤j®a·Q°Ýªº°ÝÃD §Ú¥u·Q°Ý:·í¹ï·Ó²Õ´c¤Æ¤H¼Æ¨ì¤F·¥¡A ¹êÅç²Õ´c¤Æ¤H¼Æ¦pªG¶V¨Ó¶V¦h¡A¬Æ¦Ü¶W¶V ¹ï·Ó²Õ«Ü¦h¡A¨Ò¦p¹ï·Ó²Õ ¤H¤ô |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/1 ¤U¤È 10:29:23²Ä 771 ½g¦^À³
|
ªü¤å¤j¤§«eªº¹w¦ô: ¦¬®×349¤H¤¤,°²³]¹ï·Ó²Õ¬O116¤H "Others: 37"§ÚÓ¤H»{¬°¤j³¡¥÷¬O¹ï·Ó²Õ,°²³]¦³26¤H¬O¹ï·Ó²Õ,¦]¦¹¹ï·Ó²Õ¹ê»Ú¤H¼Æ³Ñ90¤H. ¥Ñ©ó¹ï·Ó²Õ¤¤¦³31¦ì¬O2014¦~¤~¦¬®×,¦pªG¥HPFS 6~9Ó¤ë,À³¸ÓÁÙ¦³³¡¥÷¤H¥¼´_µo,¦]¦¹§Ú§ì¦bPD229¤¤,¹ï·Ó²Õ¥u¦û80¤H. ¦]¦¹,¦pªGLocal Read PD:229, 80%·|CentralRead PD, ¹êÅç²ÕCentral Read PD=229*0.8-80=104, PFS¬ù20 ¦pªG100% CentralRead PD, ¹êÅç²ÕCentral Read PD=229-80=141, PFS¬ù12 XXXXXXXXXXXXXXXXXXXX ¦pªG«O¦u¹w¦ô, ¬Ý¨ÓPFS12¸ò±i¸³¤§«eªk»¡ªº»¡ªk¤ñ¹ï·Ó²Õ¦n50-100% (PFS 9-12), ¦n¹³¬O®t¤£¦h«¨.§Ú¬Ý¤j®aÁÙ¬O¥ý¥Î³o¼Ëªº¼Æ¦r¨Ó¬Ý³oÁûÃĦn¤F. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤U¤È 10:18:52²Ä 770 ½g¦^À³
|
µ½¤H¤j 1±i¸³¬O°ò·þ±Ð®{¡AŪªº¬O¸t¸g¡A ¸t¸g¤£·|±Ð¤H»¡ÁÀ 2¥ò´º¤j¤w¸g¼Ò¹L¹ï·Ó²Õ110¡A¹êÅç²Õ174¡A PÈÁÙ¬O¤p©ó0.001,PFS¤]¬Û·í¾_¾Ù¡A ³oӼƾڤj®a¤£Ãö¤ß¤Ï¦Ó¥hÃö¤ß¹êÅç²Õ119, 129,139,149,159,169¯u¬O·Q¤£³z¡A 174³£¨S¦b©ÈÁÙ©È119 |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2015/6/1 ¤U¤È 09:59:13²Ä 769 ½g¦^À³
|
¤½¶}»¡©ú®Ñp.31: °Ñ¥[¬ü°ê¨p¥ßÀù¯g¤¤¤ßMSKCC(Memorial Sloan-Kettering Cancer Center)OBI-822Á{§É¤@´Á¸ÕÅç³£ÄÝ©óÂಾ©Ê¨ÅÀù¦Ó¨Ã«D°·±d¤H; 1. Ãø¹D³o¤@¬q¬O°²ªº? °Ñ¥[Á{§É¤@´Á¸ÕÅ窺¯f¤H¬Oªì´Á¨ÅÀù? ¤~·|¦³20¤H¦s¬¡¶W¹L4¦~, 13¤H¦s¬¡¶W¹L9¦~. 2. ¤@´ÁÁ{§Éµ²ªGªº¼Æ¾Ú, MSKCC³y°²? MSKCC¬O¾ú¥v±y¤[, ¦³¦W¤S¦³ÀY¦³ÁyªºÀù¯gÂå°|©MÀù¯g¬ã¨s¤¤¤ß, ´±³y°²¼Æ¾Ú? ÁÙ¯à¦s¬¡©ó¥@, ¤Ó¯«©_¤F! 3. ¤@´Á¥ÎªºÃĬOOPT-822, ¤G/¤T´Á¥ÎªºÃĬOOBI-822, ¤GªÌ¤£¦P¦W, Ãø¹D¦¨¤À¤]¤£¤@¼Ë? ¤@ºØ¬O¥P¤¦, ¤@ºØ¬O aÃÄ? 4. ¯Î°|ªø²¦¥Í¬ã¨sÁÞ¬ì¾Ç, µo©ú»Ã¯À¤@Á禡¤Æ¾Ç¦X¦¨ÁÞ¤À¤l, »s¦¨ÁÞ¤À¤l¬Ì], ¦]¦¹ºaÀò¥H¦â¦C¨Uº¸¤Ò¤Æ¾Ç¼ú, Ãø¹D³oÓ¼ú¥u¬Oµê¦W? ¹ï¤HÃþ¨S¦³¹êÈ°^Äm? 5. ¤¨¦ÑÁ󪺿ú¬O¤Ñ¤W±¼¤U¨Ó, §O¤HÀˤ£¨ì, ³q³q¸¨¶i¥Lªº¤j¥¬³U, ©Ò¥H¥Lªº¤j¤â¤@´§, 30»õ¥x¹ô³Ð¥ßð¼ú, ¬O¬°¤F¥L©M®a±Úªº¦W§Q? ©Î¬O¦³¤ß¬°¥xÆW¤Î¥@¤H°µÂI¦³·N¸qªº¨Æ? ¥L¥þ¤O¤ä«ù¥xÆWªº¥Í§Þ²£·~, ¤×¨ä¬O¯E¹©©M¤¤¸Î, ¤£¥u¨S½æ¹L¯E¹©ªºªÑ²¼, ÁÙ¨C¦¸°Ñ»P²{ª÷¼W¸ê, 3/31~5/26¤Sªá6»õ¦h¶R¶i1880±i, ¦pªGOBI-822¬OaÃÄ, ¥L¤£»Ý¦VªÑªFt³d? 6. ±i¸³¥êÄ×¥i¥HµL¼~µL¼{ªº¹C¤sª±¤ô¨É¨ü¤H¥Í, ¦ó¥²¨º»ò¨¯Wªº±a»â¤G®a¤½¥q¬ãµoÀù¯g·sÃÄ©M³Ð¥ß·sÃļt, ¬O¬°¤FÁȤj¿úµ¹¤l®]¨É¥Î? ÁÙ¬O¦³²z·Q©M©êt, ·Q±ÏÀù¯g¯f¤H? ¦pªGOBI-822¬OaÃÄ, ®£©È¦³Ãöªù¤§¸·? ¤£¥u¤£¯àÁȤj¿ú,, ¥i¯à·S¨Ó¤@¨¯ä¦W, ³Q½|±oÅéµL§¹½§, ¦óW°µ¦¹¶Ì¨Æ? 7. PD: 229ªº·ªi¤£¤p!!! ·|¤£·|°µÂ²³øªºû¤u±N129»~¥´¦¨229??? ¦b¸Ñª¼«e, PDªº¤H¼Æ¤£©y¤½¶}¬L¥Ü, ©Ò¥HºM°£P.22? 8. ¦pªGPD: 229¬OÁ`´c¤Æ¤H¼Æ229¤H? ¸ÕÅç²Õ´c¤Æªº¤H¼Æ¤w¸g¹L¥b(ì¨Óªº228¤H), ¥i¥H¸Ñª¼²Îpmedian PFS, ¬°¦óÁÙn©ì¨º»ò¤[ªá¿úÄ~ÄòÁ{§É¸ÕÅç? ¡uFor the majority of the trials, most will have a concordant conclusion, but 10% to 20% of trials could reach different conclusions.¡v ·Ó¦r½Ķ¡u¤j¦h¼ÆªºÁ{§É¸ÕÅç, ¤j³¡¤À±N·|¦³¤@Ó¨ó½Õªºµ²½×, ¦ý¬O¤´¦³10%¦Ü20%ªºÁ{§É¸ÕÅç¥i¯à±o¨ì¤£¦Pªºµ²½×.¡v ¥H¤W¯ÂÄÝÓ¤HJ§è, ¬Ý¹L´N§Ñ, |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/1 ¤U¤È 09:49:47²Ä 768 ½g¦^À³
|
229 (LR) * 0.8= 183 (CR) 2015/1 °²³]20%®t²§ 8 ¤ë¦¬®×§¹¥¼¹F142, °²³]=135 (¦pªG³s¦¬®×§¹¥¼¹F142³£¤£¥i«H, §ë°) 183 -135 = 48 (±q8¤ë¨ì1¤ë, ¤Ó¤ë¼W¥[ 48¤H) 48/5 = 9.6 (°²³]¥§¡¨CÓ¤ë¼W¥[ 9.6¤H) 289-135 = 154 (¥h¦~8¤ë¨ì¸Ñª¼¤j·§¯Ê154¤H) 154/9.6 = 16 ¤ë 2014-8¤ë + 16¤ë= 2015 12¤ë (©Ò¥H¤µ¦~8¤ë¬Ý¬Ý¬O§_2015 12¤ë¬O§_³Ì¨Î®É¾÷ (¦n¹³¤ÛÅ¥¤@ª½¦³¤H»¡¦~©³) ³Ü¾K¤F, ¿ù»~¦Ê¥X, ¤£n·í¯u |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2015/6/1 ¤U¤È 09:06:26²Ä 767 ½g¦^À³
|
¦U¦ì¯E¤Í¤j¤j ¥H¥Ø«e¬J¦³¤§¸ê®Æ(2015.1)·íµM¬O¬Û«H±i¸³ªk»¡¤WªºÁ¿ªk¡F´_µoªÌ¥¼¶W¹L142¤H¡C PD229/37³o¤]¬O¤½¥q©Ò¤½¥¬¡A©Ò¥H³o¬O¥i¤½¶}ªº¼Æ¦r¡AªÑªF¦³ºÃ°Ý´£¥X·íµM¥²¶·»¡²M·¡Á¿©ú¥Õ ·íµM§Ṳ́]¬Û«HPD229¬OºÃ¦ü¥¼¸gCentral read½T»{¤§¼Æ¦r¡A¤£ºÞ¬OLÂå¥Í©Î¬O¤½Ãö©Ò»¡¡C °ÝÃD¬O±i¸³©Ò»¡¤§´_µoªÌ¥¼¶W¹L142¤H(©Î¬O¦³¤j¤j¤£¤p¤ßÅ¥¨ì120¤H)¡A»PPD229¥[Á`142+229=371¡A120+229=349³o¼Æ¦r©|¥¼¥]§t37¤Î2015.5¤~¥ÎÃħ¹¦¨ªÌ¡A³£¤w¶W¥X즬®×¤H¼Æ349¤H¡A©Ò¥H¬O·¥¬°¥Ù¬Þ¡C °ß¤@¥i¦X²z¸ÑÄÀ¡G¦Ü2015.1®É¤w§¹¦¨¥ÎÃĪÌLocal read PD¦@229¤H¡A¸gCentral read½T»{¤w´_µoªÌ¥¼¹F142¤H¡C³o¨Ç´_µoªÌ¹êÅç²Õ¤j·§«Ü¤Ö¡A¦]¬°¹ï·Ó²Õ CyclophosphamideªºPFS / OS¥i¯à¬°3.5Ó¤ë/ < 12Ó¤ë¡A©Ò¥H³o37¤H¤¤¥i¯à¦³¹ï·Ó²Õ¦]¦º¤`¦Ó°h¥X¡A¦Ó³o37¥i¯à¤]¥]§t¦b142¤H·í¤¤¡A³o¼Ë¤]¥i¶¡±µÃҹꤽ¥q©Ò»¡´_µo¤H¼Æ¤Ó¤Ö¡A¸Ñª¼ÁÙ¦¤§»¡ªk¡C·íµM³o229-142=87¤H¤§Local read PD¡A©¹«á¤]¦³¥i¯à¦¨¬°Central read PD¡C |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/1 ¤U¤È 09:04:00²Ä 766 ½g¦^À³
|
§Úı±on¤½§i´c¤Æ¤H¼Æ ÅýªÑ»ù³z©ú §ë¸ê¤H¦³ª¾ªºÅv§Q |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤U¤È 08:59:15²Ä 765 ½g¦^À³
|
¦U¦ì¤j¤j 1¥Ø«e¦³¤TºØ»¡ªk¡A§Úªº»{ª¾¬O ¯«¯µ¤H¤j¡A¦Ñ¥v¤j³o¤@²Õ»P¥ò´º¤j ³o¨â²Õ©R¤¤¾÷²v³Ì°ª 2§Ú·P¨ì¦n©_ªº¬O°Ý¦P¤@Ó¤H«o¦³¨âºØµª®× 3§Ú¤£»{¬°±i¸³·|»¡ÁÀ¡A¤j®a³£ª¾¹D¬ü°ê¥ß°êºë¯«´N¬O±Ð¨|¤p«Ä¸Û«H¸Û¹ê¡A§Æ±æ°Ý²M·¡¦A¦³°Ê§@¡A¶Ë®`¤½¥q¦Û¤v¤]·|¤º¶Ë¡A«Øij§ï¶iµo¨¥¤H¨î«×³oÓ¥i¥H´£¡A n¤½¥q«ö´Á¤½§i´c¤Æ¤H¼Æ¡A¨Ã¤£¦Xªk²z¡A¥H¤W¨}µ½ªº«Øij |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/1 ¤U¤È 08:27:35²Ä 764 ½g¦^À³
|
«D±`©êºp ¤W¤å¤¤¡uÁÙ¦³¯E§b¤j5/29¶Kªº¨º¤@¬qì¤å³Ì«á¤@¥y¡G¡uFor the majority of the trials, most will have a concordant conclusion, but 10% to 20% of trials could reach different conclusions.¡vÁöµMlocal read»Pcentral read¤§¶¡ªº§PŪ®t²§¥i°ª¹F22-25¢M¡A¦ý³Ì«á¨âªÌµ²½×®t¶Z«hÁY¤p¬°10-20¢M¡C¡vÓ¤H¸ÑŪ¿ù»~¡A¤£°µ§ó¥¿¤F¡A¾ã¥y§R°£¡C |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/6/1 ¤U¤È 08:16:46²Ä 763 ½g¦^À³
|
¡u´c¤Æ¹F229¦ì´Nºâ«ÜÁV¤F¡A«ç»òÁÙ¤£¸Ñª¼¡H¡v¡A³o¤S¤£¬Oì¥ýªºpµe®Ñ¤º®e¡A¤@ª½³o¼Ë·Q·íµM«Ü¦h¦a¤èªº«ä¦Ò´N·|¥´µ²¡C 342/289/142¤£¬OªÅ¥Þ¨Ó·¡A·íµM§Ú¤£ª¾¹D¼Ö³z·|¤£·|¥¿¦n¶}¥X¯E§b¤j»¡ªº¨º¨Ç¼Æ¦r¡A¦ý¬O³o¤T²Õ¼Æ¦r¨ä¨Ó¦³¦Û¡Aµ´«DªÅ¥Þ¨Ó·¡C¡]¥H«eR¤jªº¹Ú·Ç«×¦p¦ó¡H¡^ 229¦ì·í¤¤¹êÅç²Õ»P¹ï·Ó²Õ¤À¥¬ªº±¡§ÎµL¤H¥iª¾¡A¤S¦p¦ó¥hµûÂ_229¦ì´c¤Æ¬O¦³¦hÁV¡H ²Ê¦ô¤§¤U¦ü¥G¤ñ¤@´Á¸ÕÅ窺µ²ªG¬°®t¡A¦^·¹¤@¤U¤@´Áªº¦¬®×¡A27¦ì¤¤15¦ì¬ONED¡A12¦ì¬OStable Disease¡]SD¡^¡A¨S¦³PRªº¡Aºâ¬O¯f±¡¤ñ¸ûéwªº±wªÌ¡A¤G/¤T´ÁY¦¬¨ì¤ñ¸û½ÆÂøªº±wªÌ¡]¤G/¤T´Á¦¬¤FCR/PR/SD¡^¡A±EÀu±E¦H«ÜÃø¤ñ¸û¡AÂå¾Ç¤W³q±`¥H¡u±±¨î¦b¬Û¦Pªº±ø¥ó¤U¡v¤¬¬Û¤ñ¸û¤~¬O¥¿³~¡A¨Ò¦p822¸ÕÅ礤ªº¹êÅç²Õ»P¹ï·Ó²Õ¤¬¬Û¤ñ¸û¤~¦³·N¸q¡A¦Ó«D®³¥h¸ò§OªºÃĤñPFS/OSªøµu¡A³o¬O°ò¥»Æ[©À¡C ÁÙ¦³Early Termination Per Protocol¨ä¹ê´N¬O·Ópµe®Ñ¦Ó¨¥¡A¤w¸g°µ¥X°^Ämªº©Î²×¤îªvÀøªºÓ®×¼Æ¡A¥]§t´c¤Æªº¡BªvÀø¹Lµ{¤¤Ãh¥¥ªº©Î¥ô¦ó²z¥Ñ¡A¦bSlide No.22¤¤§i¶D¤j®a¨ä¤¤PDªÌ¦³229¦ì¡A¨ä¥Lì¦]ªÌ¦³37¦ì¡A³o¥i¬O8th DSMB meeting ´¦ÅSªº¡C¦Ü©óLocal read¡H®³¤@ÓLocal Read¸ê®Æ¥h¸ò®ü¥~ªk¤H»¡©ú¡H¦X²z¶Ü¡H¦pªGÀ³¸Ó¥Z¥XCentral Readªº¼Æ¦r¡A¨º´Nµoӧ󥿼Ʀr§Y¥i¡A«o¾ãÓºM°£¡H ÁÙ¦³¯E§b¤j5/29¶Kªº¨º¤@¬qì¤å³Ì«á¤@¥y¡G¡uFor the majority of the trials, most will have a concordant conclusion, but 10% to 20% of trials could reach different conclusions.¡vÁöµMlocal read»Pcentral read¤§¶¡ªº§PŪ®t²§¥i°ª¹F22-25¢M¡A¦ý³Ì«á¨âªÌµ²½×®t¶Z«hÁY¤p¬°10-20¢M¡C Intent-to-treat ¡]ITT¡^349¦ì¡A«üªº¬O¦¬¶i¨Ó¤w§@ÀH¾÷¤À°tªºÓ®×¼Æ¡A¤£ºÞ¬O¥Î¯uÃĩΦw¼¢¾¯¡C Modified ITT¡GITT¤¤¦Ü¤Ö±µ¨ü¹L1¾¯¯uÃĩΦw¼¢¾¯ªºÓ®×¼Æ¡C Evaluable population¡GITT¤¤¦Ü¤Ö±µ¨ü¹L4¾¯¯uÃĩΦw¼¢¾¯ªºÓ®×¼Æ¡A¥Î©ó¡K ¡K¡K ¤@¥¹¬ö¿ý¨ì289¦ìªºPFSȮɡA´N¥i°õ¦æ³Ì«á¤ÀªR¡C¨º»ò²{¦b229¦ì´c¤Æ¡A´N¸Ñª¼¡H·Q·Q¡C ³o¨ÇºØºØ¡A¦n¤ï¥h¬Ý¤@¬Ý¡A¨S¬Ý¹L¤@¨Ç¸ê®Æ¡A½M²q«Ü²Öªº¡KR¤j³£·t¥Ü/©ú¥Ü¨º»ò¦h¦¸¤F,¥h¬Ý¬Ý«á¦A²q·|¤£·|¦n¤@ÂI¡K ¨ä¹ê¤]¤£¥Î¦A²q¡A«á¤ÑÅ¥¡u¯«©ú¡v±i¸³»¡´N¦n¡A¥L»¡¤Fºâ¡C ¤p©_¤j¡G n§P©w¬OPD/CR/PR¡An®Ú¾ÚICH RECIST1.1ª©ªºÁc½Æ§P©w¼Ð·Ç¡A¤£¬O¥u¬Ý³æ¤@¯f¨_¦Ó¤w¡A¦¬®×®ÉÁÙ¦³¤é«á¨C¦¸¦^°|ªº¼v¹³°lÂܳ£n°µ¯Ý/¸¡/°©¬Öªº¹q¸£Â_¼h¡A´ú¶q¡u¥i´ú¶qªº¡v¡B¡uµLªk´ú¶qªº¡v¯f¨_¤j¤pªº¤Ø¤o¡Aþ¨Ç¬O¡u¥i´ú¶qªº¡v¡B¡uµLªk´ú¶qªº¡v¦U¦³©w¸q¡C ¡u¥i´ú¶qªº¡v¡G¦b¹q¸£¹q¼h¤Wºë½T¶q¥X¯f¨_¦Ü¤Ö¦³¤@Ó¤Á±ªºª½®|¬O10mmªÌ¡F©Î¬O®{¤â¥Î´ú®|Âù¸}³Wª½±µ¶q¯f¨_¹Fª½®|10mm¥H¤WªÌ¡A©Î¦bX-ray¤W¦Ü¤Öª½®|20mm¥H¤WªÌ¡A©Î¬O´c©Ê²O¤Úµ²¡K¡]¸¨¸¨ªø¡A²¤¤F¡^ ¡uµLªk´ú¶qªº¡v¡G¹³¸¡¤ô¡B¤ß¥]/¦Ø½¤¿n¤ô¡B¸£½¤¯fÅÜ¡B¨Å©Ðµoª¢µ¥µ¥¡C¡]²¤¡^ §â¡u¥i´ú¶qªº¡v¡u¥Ø¼Ð¯f¨_¡v¡]target lesion¡^ªºª½®|Á`©M¡]sum of the diameter¡^»P¦¬®×®Éªºª½®|Á`©M°µ¤ñ¸û¡A¼W¤j¦h¤Ö©Î´î¤Ö¦h¤Ö¨Ó§P©w¬OPD/CR/PR¡C ¡u«D¥Ø¼Ð¯f¨_¡v¡]non-target lesion¡^«h¥i¥H©w©Ê±Ôz¡C¡]¡K«D±M·~¤Hû¨ì¦¹´N¦n¡K¡^ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤U¤È 08:06:26²Ä 762 ½g¦^À³
|
±µÄò ³y¦¨Local read »PCentral readªº¤ñ²v®t²§«Ü ¹³¤¤Â媺¦W¨¥:ÃĤ£º\¯t¡A³Ö¯e¥±...¡A ¯fn¦n¤§«e¦³®É·|¦³Ä±±o¯f§óÄY«ªº¤ÏÀ³ °Ñ¦Ò¸ê°T:±q²Ä¤@©¡ÁÞ¼ú½ÍÀù¯g§K¬ÌÀøªkªº®i±æ¡A§ë¸ê¯E¹©ªºªÑªF³o½g¤å³¹«Øijn¾\Ū |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤U¤È 07:45:24²Ä 761 ½g¦^À³
|
¥ò´º¤j¡A¦U¦ì¤j¤j ©TºA¸~½Fµû¦ô¥HRECIST criteria¬°¥D¡A¦ýWolchokÂå¥Í´£¥Xn¥ÎirRC¨Óµû¦ô¤~¦X²z¡A¦]¬°¸~½F¹ï§K¬ÌÀøªk¦³¥|ºØ¤ÏÀ³ 1ÁY¤p 2¤j¤pªø´Áéw 3 ²£¥Í·s¯f¨_«áÁY¤p 4Åܤj«áÁY¤p ³o·|¤£·|¬Olocal read»Pcentral read ªºì¦] |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/1 ¤U¤È 06:33:18²Ä 760 ½g¦^À³
|
¨âÃä½×z¦ü¥G³£¦³ÄY«°ÝÃD 1. ¦pªG¬O±ø¥ó»¡ a. ¨ºµo¨¥¤H¤ÎÂå®v¤£¬O¦³¬G·N»~¾É¤§¶û? (©~µM´±A¯«¤H¯ÅªºCliff¤Î¥ò´º¤j) b. ¨ºOther 37 ¬O¬Æ»òªFªF? (¤jÁx§ârabbit ¤j³£·S¤õ¤F) 2. ¦pªG¬O¹ê»Ú¤H¼Æ»¡ a. ¤£²Å3¤ë»¡ªk, ¥i¯à¦³«H¥Î¯}²£¦M¾÷? (©~µM¹GÅó¤j,§â°k©R¨âÓ¦r³£»¡¥X¤f) b. ¤£²Å¤@´Á¼Æ¾Ú»P²³¦hÅK¤f¤Î¥ý¤H¹Ú¹Ò (À³¸Ó°Û¹Ú¿ô®É¤À, ¤£¬O§Ñ±¡¤ô) ¥Ø«e¥u¦³¤p©_¤jªº¯«¸ÑÄÀ, (¦pªGì¨Ó¬O5cm, §Ö³tÁY¤p¦¨2cm, ºCºCµyªø³Ì«á°±¯d¦b3cm¤£°Ê, ³o¼Ë50% ºâPD??) Åý§Ú¤Ö³Ü¨âªM |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/6/1 ¤U¤È 06:21:38²Ä 759 ½g¦^À³
|
¦³¤H¦n¹³¬Ý¤£¤ÓÀ´§O¤Hªº·N«ä. |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/1 ¤U¤È 05:56:36²Ä 758 ½g¦^À³
|
«¢¡AÁÙ¦³¤HÀH«KÁ|ӼƦr¡An¤H»°§Ö°k©R §An«ç¼Ë»{ª¾¬O§A®aªº¨Æ n¤H»°§Ö°k©R¡A§K¤F§a |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/1 ¤U¤È 05:02:16²Ä 757 ½g¦^À³
|
¥úÀY¤jôÁÙ¦b¶R¡A¤O®¼ªº¨M¤ß¤£®e©¿µø(ÁÙ¬OÀ³¸Ó»¡"ªÎ¤ô¤£¸¨¥~¤H¥Ð"?) Á`¤§¡AI«á¤@©w¦³¥O¤H¿³¾Äªº§Q¦hn¥X²{¡A³Ì§Ö6/3¨£¯u³¹ ¤£ºÞlocal read, central read³£¤£¯à¥R¤À¸ÑÄÀ142»P229, ¥u¦³¸Ñª¼±ø¥ó229¤~¯à²Å¦X±i¸³3¤ë¤WÂd«eªk»¡·|¤W»¡ªº "´_µo¤H¼Æ¥¼¹L¥b"¡A°£«D¤£¬Û«H±i¸³·í®É»¡ªº ¦]¬°PD¬O«ü¸~½F¤j¤p¤ñ¥ý«e¤j¶W¹L25%¡A¦pªG²{¦b¤w¸g229¤Hªº¸Ü¡A»°ºò²M¥ú«ùªÑ¤£n¦A¼µ¤F ºâ°_¨Ó822PFS³Ì¦h¥u¦³15¡A²{¦bÁÙ¦³340¥i¥H°k©R |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2015/6/1 ¤U¤È 03:19:14²Ä 756 ½g¦^À³
|
¦P¤@°ÝÃD½×¤F2¤Ñ¤S¦^¨ììÂI YºÃ¦ü229¸gCENTRAL READ½T»{«á¬°¥¼º¡142,¥t87¬O«Ý½T»{,³o¤~¦X¥GÅÞ¿è ¦pªG229+37¤Î142¬O¤@°_¦P®É¦s¦b´N¬O408,¤w¶W¹L349¤F ¨º¸Ñª¼,ÁÙ¦±o«Ü,¤S¬Û¥Ù¬Þ¤F? ´N¤@¥y¸Ü,¸ÑÄÀ¤£²M,³oºØ¤½¥qû¤uÁÙ¯à¸u¶Ü? |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/1 ¤U¤È 02:22:56²Ä 755 ½g¦^À³
|
rabbit¤j ¾Üµ½©T°õ, ¤£°Ê¦p¤s ¤p§Ì¤]·q§A¤@ªM ps. ¤£¹L¤pª¯¥p¨Óªº¥i¯à¬O¤µ±ß¤j¼Ö³z¸Ñª¼¼Æ¦r, 34,22,8,9,14,2 |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/1 ¤U¤È 02:09:35²Ä 754 ½g¦^À³
|
¤p©_¤j, ¦³³Ð·N ¤p§Ì·q§A¤@ªM ¥H«e¤@ª½¤£À´"ºÉ«H®Ñ, ¤£¦pµL®Ñ", ²{¦b¦³ÂI·Pı |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/1 ¤U¤È 01:54:26²Ä 753 ½g¦^À³
|
¤p©_¤j ·PÁ¡I ³oÀ³¸Ó¬O³Ì²×ªO ¤]¬O²Å¦X¨Æ¹êªº»¡ªk 40%ªº»~®t¡A¤@®ÉÁÙ¯uªº«ÜÃø»{¦P |
|
|
·|û¡G¤p³ì10135960 µoªí®É¶¡:2015/6/1 ¤U¤È 01:46:28²Ä 752 ½g¦^À³
|
¦U¦ì¤j¤j ªÑ»ù·|»¡¸Ü,Y³o¼Æ¦r¯uªº«Ü¤£§Q¸Ñª¼,¦b§ë¼v¤ù©ñ¤W«e´NÀ³¸Ó¦³¤@°ï¤H¥X³õ, ¼í®õ¥þ´±®³ªÑªFªº¿ú¤@ª½¶R¶i,·Q¥²¦³¥«³õ¤W¥¼ª¾ªº²z¥Ñ,¦ý²z¥ÑÀ³¬O¥¿±¤~¬O. ¤¨¦ÑÁóÀ³¤£·|®³¦Û¤vªº¦WÁn¥hÀ°¦³°ÝÃDªº¤½¥qÅ@½L |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/6/1 ¤U¤È 01:37:50²Ä 751 ½g¦^À³
|
±i¸³¨S¦³¤f»~¡A¤½Ãö©MLÂå®vªº³o´X¤Ñµo¨¥¤]¤w¸g¹L¤½¥q°ª¼h±ÂÅv¡A³oP22ªº¤º®e¤½¥q¤W¤W¤U¤U³£¤w¸gª¾¾å(³£°µ¥XÀɮשñ¦bªÑ¥«Æ[´ú¯¸¤F)¡A¦ýû¤u³£¤£¥H¬°·N¡A³oPD=229ªºlocal read¹ïÁ{§É¸ÕÅç¶È¨Ñ°Ñ¦Ò¡A¯u¥¿ÃöÁä©Êªº¼Æ¦rCentral Read¤~¬O¨M©w©Êªº¼Æ¦r¡A¦Ó³o¼Æ¦r¬O¤£¯à³zÅSªº¡A¥i¯à¥u¦³¤TÓ·í®aª¾¹D¡C ³o¼Ë¤lªº¸ÑÄÀ¡AºÃÂI³Ì¤Ö¡A¥Ù¬Þ³Ì¤Ö¡A°ß¤@Ãø¥H¸ÑÄÀªº¬O¡A¬°¦ó¦b2015¦~1¤ë¡Alocal read ©MCentral Read¦³ªñ40%ªº®t²§¡H¬O822ªºÀø®Ä¹Lµ{Åý«Ü¦hÁ{§ÉÂå®vÃø¥HÂ_©w±wªÌ¦ó®É¸Ó§PÂ_¬°´_µo©Î´c¤Æ¡H¸~½F¸gªvÀø«áÁY´î¤F¦ý¹L¤F¤@°}¤l¤Sµy·Lªø¤j¡A¦ý¤]¥u¬O°±¯d¦b¤@Ó©T©wªº½d³ò¡AÀHµÛ¤@Ó¤ë¤@Ӥ몺±½ºË¨Ã¨S¦³«ùÄòÂX±i¡A¸Ó§PÂ_¬°´c¤Æ©Î´_µo¶Ü¡H ¥H¤W¬O¤È¥ð©¿µM·Q¨ìªº¡A¬Ý¬Ý´N¦n¡A6/3´Nª¾¹Dµª®×¤F¡C |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/1 ¤U¤È 01:36:36²Ä 750 ½g¦^À³
|
¯E¹©³£¨S¦A©Ô¦^ Ãø¹D¤@ª½º¦¤U¥h |
|
|
·|û¡Gªü¤å10138375 µoªí®É¶¡:2015/6/1 ¤U¤È 01:34:14²Ä 749 ½g¦^À³
|
½Ð°Ý¥ò´º¤j "L Âå®v§iª¾ : ¨º¥y¸Ü¤£¬O¸Ñª¼±ø¥ó , ´N¬O«ü2015/1 PD ¦³229¤H, °h¥XªÌ¦³37¤H ¥L»¡ : n¸Ñª¼ ÁÙ¤[ªº«Ü" ¥Ø«e¤´¦b"¸ÕÅç"¤¤ªº¥u³Ñ349-229-37=83¤H,¨º¬°¤°»ò"n¸Ñª¼ ÁÙ¤[ªº«Ü"? L Âå®v¦³»¡ì¦]¶Ü? ¬O¦]¬°PD¤H¼Æ¤Ó¦h,¥u¯à½ä³o83¤H¯à©Ô¥X«Üªøªº¥¼´_µo´Á,µM«á¦A¥Ñ³o¨Ç¤H§ä¥X¦@³q©Ê,ÁY¤pÃÄ«~¾A¥Î½d³ò? |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/1 ¤U¤È 01:08:50²Ä 748 ½g¦^À³
|
¤S³´¤J¤@¤ù¯íµM¡Aª½¨ì6/3 |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/1 ¤U¤È 01:00:13²Ä 747 ½g¦^À³
|
¥ò´º¤j ¤F¸Ñ¡A·PÁ¡I |
|
|
·|û¡G·¬¬õ10136923 µoªí®É¶¡:2015/6/1 ¤U¤È 12:57:54²Ä 746 ½g¦^À³
|
ºÃ¼{´NÃøº¦¡¦§À½L??? |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/1 ¤U¤È 12:57:02²Ä 745 ½g¦^À³
|
JM¤j: L Âå®v§iª¾ : ¨º¥y¸Ü¤£¬O¸Ñª¼±ø¥ó , ´N¬O«ü2015/1 PD ¦³229¤H, °h¥XªÌ¦³37¤H ¥L»¡ : n¸Ñª¼ ÁÙ¤[ªº«Ü |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/6/1 ¤U¤È 12:39:32²Ä 744 ½g¦^À³
|
¥ò´º¤j ¡§local read ¦³229¤H¡A«öÁ{§Ép¹º¡A´£«eµ²§ô°h¥Xp¹ºªÌ¦³37¤H¡¨ ³o¥y¸Ü¯à§_¶i¤@¨B¶}¥Ü «ö¦r±¡A²Ê²L¤F¸Ñpd229/others37 ¤¤¶¡ªº¡§/¡¨ ¬O¡§©Î¡¨ªº·N«ä¡A·N§YA©Î¡]/¡^B·í¤¤ªº¥ô¤@¸IIJ¨ì¡A¹êÅç§Y´£«eµ²§ô¡C ·Ð½Ð¸Ñª¼ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/6/1 ¤U¤È 12:35:25²Ä 743 ½g¦^À³
|
¤]³\¨S¦³¨º¼Ëªº°ª«×´¼¼z¥h¤À¿ëPD229¨s³º¬OÁ{§É¸ÕÅç²×¤îªº±ø¥ó¡A©Î¬OLocal Read229¤H?¦bºÃ¼{¯ÉÂZ¤ßÀY¤§»Ú¡A§Úªº¤¤¤ß«ä·Q©l²×¥u¦³¤@Ó¤£´¿ÅܹL¡A¨º´N¬O±i¸³«ü¥X¥h¦~©³¥¼´_µo(events)¥¼¹F142¤H¦]¦¹§K°µ´Á¤¤¤ÀªR¡A¦Ó¥Lªº¼Æ¾Ú¬OCentarl readµ¹ªº¡C°£«D³o¶µ¨Æ¹ê¦³»~¡A§_«h§ÚÄ@¿ï¾Ü¤@¸ô¬Û«H¤½¥q¨ì©³¡A«á¤Ñµª®×´N¯à´¦¾å¡C |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/6/1 ¤U¤È 12:25:18²Ä 742 ½g¦^À³
|
¥Lªí¥Ü: Local Read ¦³229¤H, «öÁ{§Épµe , ´£«eµ²§ô°h¥XpµeªÌ¦³37¤H ---------------- ¤£ª¾¬O§_¬O¸Ñª¼±ø¥ó¬OLocal Read 229¤H, ¦Ó¤£¬O¤µ¦~¤@¤ëªº±¡ªp |
|
|
·|û¡G±i¥ò´º10140184 µoªí®É¶¡:2015/6/1 ¤U¤È 12:07:49²Ä 741 ½g¦^À³
|
¨ß¤j: ¶g¤é¦³¹q¸ß L Âå®v ¡§Early Termination Per Protocol PD:229/Others:37 ¡¨ ³o¥yªº·N«ä ¥Lªí¥Ü: Local Read ¦³229¤H, «öÁ{§Épµe , ´£«eµ²§ô°h¥XpµeªÌ¦³37¤H ¥H¤W ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡Grabbit10136567 µoªí®É¶¡:2015/6/1 ¤U¤È 12:00:51²Ä 740 ½g¦^À³
|
§Ú¤S°µ¤F¤@Ó¹Ú: ¦³¤@°¦ª¯¥p¤F¤@±i¯Èµ¹§Ú¡A"åù¯S±F ¼Ú»ó®÷¤K¾j¾j"¡A ¸Ì±¦³¨Ç¼Æ¦r¡A 342 289 142 ´N¬O¨S¦³ 229 37 µM«á§Ú´N¿ô¨Ó §Ú·Q§Ú¥H«á¤£·|¦A°µ¨ì³oÓ¹Ú¡A ³Á§J±iªº¤»¤ë¤T¤é¦^ÂЩγ\¥i¥H¨M©w§Úªº¹Ú¨ì©³¬O¯uÁÙ¬O°²¡C ¦P¤@¦æ¤å¦r¡APD229 ¬O±ø¥ó? Others 37 ¤]¬O±ø¥ó? 37 ºØ´£«eµ²§ôªº¨ä¥L±ø¥ó¶Ü? §Ú«Ü§Æ±æ§ÚªºÅÞ¿è¬O¿ùªº |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/6/1 ¤W¤È 11:21:15²Ä 739 ½g¦^À³
|
¬O±ø¥ó©Î¹ê»Ú¤H¼Æ, ¦³³o»òÃø¦^µª°Ú [¤Ñ¤è©]ÃÓ] ¬Y¤½¥q¤½§i¤W¤ëÀ禬20»õ ½Ð°Ýµo¨¥¤H: À禬¬O¥x¹ôÁÙ¬O¬üª÷? µo¨¥¤H: ¤½¥qÀ禬«üªº¬O¦X¨ÖÀ禬 ½Ð°Ýµo¨¥¤H: ¨º¨ì©³¬O¥x¹ôÁÙ¬O¬üª÷? µo¨¥¤H: ¯B°Ê¶×²v, ©Ò¥Hpºâ¼ÆÈ·|¤£¦P |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤W¤È 11:17:56²Ä 738 ½g¦^À³
|
¤é¦³©Ò«ä¡A©]¦³©Ò¹Ú¡A¬Q±ß¹Ú¨ì¤@º¸Ö¡A¶È¨Ñ°Ñ¦Ò ¤A¥¼¶}µP¥ò©u¬î Ãzµo·sÃĤþ¥Ó¦~ ®Û«a¥[°ÃÂù³ß¦Ü ÁÞÃÄ©µ¦~´I¶Q¬K |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/1 ¤W¤È 11:11:22²Ä 737 ½g¦^À³
|
¤£¹LÁÙ¬Oµ¥6¤ë3¤é¦b»¡ §Ú¦b¥[½X |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2015/6/1 ¤W¤È 11:09:10²Ä 736 ½g¦^À³
|
«D±`·PÁ¦U¦ì¤j¤j,Ó¤H³o2¤Ñ¤ÏÂЫä¦Ò229¤Î142,,Á`µoı¬O¥Ù¬Þªº,¬Ýªk¸ò¦U¦ì¤@¼Ë¬O²×¤î¸ÕÅ窺±ø¥ó,²{¦b¤S¦³ÂI¼ÖÆ[¤F. |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/6/1 ¤W¤È 11:03:46²Ä 735 ½g¦^À³
|
¬°¦ó¤µ¤ÑªÑ¥«¶^¤Ï¦Ó¯Eô°f¶Õ¦bº¦¡A¦Ó¥B¤w¸g±q¶^¯}300®É¤Ï¦Ó¶}©lºCºCªºº¦¡A°½°½ªºº¦ ¥Î¤@¥y¤j¤å»¨ªº¸Ö¨Óªí¥Ü¡G §º¡PĬ¸ý¡m´f±R¬K¦¿±ß´º¤Gº¡n ¦Ë¥~®çªá¤T¨âªK¡A¬K¦¿¤ô·xÀn¥ýª¾¡C蒌»Uº¡¦aĪªÞµu¡A¥¿¬Oªe³b±ý¤W®É ·N«ä¬O»¡¡APD=229À³¸Ó¬O«ü¸Ñª¼±ø¥ó¡A ¦]¬°¦pªG¤w¸g´_µo229ªº¸Ü¡AªÑ»ù¦´N¶^¯}300,200..·d¤£¦n¸òÂûÀn·í¥S§ÌªÑ¤F ¥«³õ¤W¦³¤H¤@©w¤ñ§A§Ú¦ª¾¹D¡A©Ò¥H¥ý¤U¥h¶R¡A¦Ó¥B¥ú©ú¥¿¤jªº¶R¡C¨Ò¦p®}³\¤G¤H»P¶|®õ¥þ.... °O±o¥h¦~ªÑªF·|®É¡A¦pªG¦³°ÝÃD»Ýn½Ð±Ð¤½¥q¡AªÑªF·|¦³µo¨¥±ø¡A¯E¤Í¥i¥H§â°ÝÃD¼g¤U¨Ó¡A¤½¥q·|¤@¤@¶i¦æ¦^µª ¦n¹³¤£·|¦³¤½¥q¤£¦^µªªº³oºØ±¡§Î¡AÓ¤H«D±`¬Û«H±i¸³/¤¨¦Ñ¤j/¯Î¦Ñ¤j¤]³£¬O¥¿¬£¤H¤h ¤£µM´N¤£·|Åó±ø±ø¤F, Ó¤H·N¨£¡A½Ð¦Û¦æ§PÂ_~~ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/6/1 ¤W¤È 10:49:19²Ä 734 ½g¦^À³
|
¦U¦ì¤j¤j ·PÁÂ28¤é¨ì31¤é¦U¦ì¤j¤j´£¨Ñ¤£¦PÆ[ÂI¡A³Ì«á¯u¥¿ªº¸ÑŪ¡A¦³«Ý«á¤ÑªÑªF·|¨Ó½T»{¡A¦b³o¬q®É¶¡¸Ì¡A¦]¥Xªù¦b¥~¡A¤À¨Éªº¶K¤å¸û¹s¹s¸¨¸¨¡A³£¬O¦Û¤v¥DÆ[¬ã§P»P²q´ú¡Aťť´Nºâ¤F¡A·í°Ñ¦Ò´N¦n¡A¤£n¤Ó¬Û«H |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2015/6/1 ¤W¤È 10:45:15²Ä 733 ½g¦^À³
|
¯E¹©³Ìªñ«Ü±j¶Õ C. 229 / Others: 37¥u¬Op¹º¤¤±j¨î¤¤¤î¸ÕÅç,¥ß¨è¸Ñª¼ªº±ø¥ó |
|
|
·|û¡Gªü¤å10138375 µoªí®É¶¡:2015/6/1 ¤W¤È 10:38:18²Ä 732 ½g¦^À³
|
"Early Termination Per Protocol¡GPD: 229 / Others: 37" ¦³3ºØ¥i¯à: A. 229¤H¬OCentral Read PD, ¦Ó¥B¥t¦³37¤H¦]¨ä¥L¦]¯À¤¤¤î¸ÕÅç B. 229¤H¬OLocal Read PD, ¦Ó¥B¥t¦³37¤H¦]¨ä¥L¦]¯À¤¤¤î¸ÕÅç C. 229 / Others: 37¥u¬Op¹º¤¤±j¨î¤¤¤î¸ÕÅç,¥ß¨è¸Ñª¼ªº±ø¥ó §ÚÓ¤H»{¬°¬OC,229´N¬O쥻¹wp¦¬®×342¤H,¹ï·Ó²Õ114¤H¥þ³¡PD,¦A¥[¤W¹êÅç²Õè¦n¹L¥bªº115 ¦Ü©óB,¦]Local Read PD,¦ÓEarly Termination.¦pªGCentral Read»{¬°¤£¬OPD,¨º«ç»ò³B²z? ¦pªG9°wÁÙ¨S¥´§¹,¦]Local Read PD¦Ó°±¤î¥´°w,«ç»ò¦³¿ìªk¦AÄ~Äò? Aªº¾÷²v§ó§C.¦pªG¤£©¯¦¨¯u,¨º±i¸³´N«H¥Î¯}²£. ÁöµM§ÚÓ¤H»{¬°A,Bªº¾÷²v¤£°ª,¦ý¦pªG¯u¬O¦p¦¹,PFS¥i¯à¬O¦h¤Ö? §Ú¨S¦³¥P¤H¤J¹Ú«üÂI,¤]¤£·|µeKaplan-Meier¦±½u,©Ò¥H§Ú¥Î³Ì²Âªº¤Ï±Àªk. ¥ý°²³]PFS¤À§O¬°30,24,18,12,¦A¤Ï±À³o4ºØ°²³],¦b2014/12E®É,¹êÅç²Õ¤j·§ªº´_µo¤H¼Æ. ¤À¬°6Ó¶¥¬q ¦¬®× ¹êÅç²Õ ¥§¡¤ë PFS30 PFS24 PFS18 PFS12 2011/10~2011/12 47 32 37 60%,19 70%,22 80%,26 90%,29 2012/01~2012/06 23 15 33 55%,8 65%,10 75%,11 85%,13 2012/07~2012/12 29 20 27 45%,9 55%,11 65%,13 75%,15 2013/01~2013/06 99 66 21 30%,20 45%,30 55%,36 65%,43 2013/07~2013/12 60 40 15 15%,6 30%,12 40%,16 55%,22 2014/01~2014/07 91 60 9 5%,3 10%,6 25%,15 35%,21 ¨Ì·Ó¤Wªí,¦pªGPFS¬°30,24,18,12, ¨º»ò¨ì2014/12E¹êÅç²Õ´_µo¤H¼ÆÀ³¸Ó¬ù¬°,65,91,117,143 ¦¬®×349¤H¤¤,°²³]¹ï·Ó²Õ¬O116¤H "Others: 37"§ÚÓ¤H»{¬°¤j³¡¥÷¬O¹ï·Ó²Õ,°²³]¦³26¤H¬O¹ï·Ó²Õ,¦]¦¹¹ï·Ó²Õ¹ê»Ú¤H¼Æ³Ñ90¤H. ¥Ñ©ó¹ï·Ó²Õ¤¤¦³31¦ì¬O2014¦~¤~¦¬®×,¦pªG¥HPFS 6~9Ó¤ë,À³¸ÓÁÙ¦³³¡¥÷¤H¥¼´_µo,¦]¦¹§Ú§ì¦bPD229¤¤,¹ï·Ó²Õ¥u¦û80¤H. ¦]¦¹,¦pªGLocal Read PD:229, 80%·|CentralRead PD, ¹êÅç²ÕCentral Read PD=229*0.8-80=104, PFS¬ù20 ¦pªG100% CentralRead PD, ¹êÅç²ÕCentral Read PD=229-80=141, PFS¬ù12 ¤Ï±ÀªkÀ³¸Ó¤ñ¸û¾A¦X©ó¨S¦³³]¸ê®Æ.¸Ñª¼®É¦³³]¸ê®Æ,À³¸Ó¬O¥ÎKaplan-Meier¦±½u. ¦ý¦b¨S¦³¥P¤H«üÂI¦U´_µo¯f¤Hªº¸ê®Æ¤U,§ÚÓ¤Hı±o¥Î°²³]¸ê®Æ¨ÓµeKaplan-Meier¦±½u»~®t¤Ó¤j. Ó¤HJ¶Ã¤ÀªR,¦p¦³¤£§´,½Ð¨£½Ì |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2015/5/31 ¤U¤È 08:26:55²Ä 731 ½g¦^À³
|
"¯à·í¨ì¤W¥«Âd¤½¥qªºµo¨¥¤H¡B°ÆÁ`¡B¸³¡BÁ`¡A ³q±`³£¤w¦³¬Û·í¸ê¾ú¥\¤O¡C(¥i¥H§â§ë¸ê¤HÄF±o¹Î¹ÎÂà ! )" »¡ªº¦n,³o¬O¯uªº,¤½¥q¤è±¬O"¥ýª¾",¤×¨ä¦bt±ªº°T®§¤W§ó¬O¦p¦¹ »¡¦nÅ¥ÂI¬O¬°¤F"¤½¥q§Q¯q" ¥u¤£¹L³o§Q¯q¬O¤½¥q¼Æ¦³³o°T®§ªº§Q¯q ¤½¥qªº¤@¯ë§ë¸êªÌ©Î¬O»È¦æ´£¨Ñ¿Ä¸êªº ³£¬O°T®§"«áª¾«áıªº¤H" Ó¤H¬O±q¨Æ°]°È¤u§@ ³oÃþ¨Æ ¼K¼K¼K ±`·Fªº ¤W¯Z¤u§@¤Wªº»Ýn µoªí¤U¨Ç·PIJ ´Á«Ý¤Î§Æ±æ²`«H ³oôÀ³¤£¬O |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/5/31 ¤U¤È 08:04:12²Ä 730 ½g¦^À³
|
è¤~¬Ý¤F ¯E¹©ªÑªF±`·| ªº ¶}·|ijµ{¡C ´N Cliff¤j©Ò´£¡A¤À¦¨¤G¤j¶ô¡A´£¥X®É¾÷¦p¤U : (¦]¬°§Ú¨S¦³¥X®u¡A¦³«ô°U¨ä¥¦ªB¤Í´£¡AY¨S¦³³Q´£¥X¡A¨ä¥¦¯E¤Í¥ç¥i¹B¥Î) Cliff´£²Ä¤@¤j¶ô¡APD229»¡³Ì¡B®ü¥~ªk»¡·|ºM¤å¡B¡B¡Bµ¥¡A ¦b±`·|¡A´£¥X®É¾÷¬° : ¤G¡B³ø§i¨Æ¶µ (1)¤@¡³¤T¦~«× Àç·~³ø§i¡C ¦b¦¹³ø§i§¹²¦«á¡A§Y¥i¥H±q®eªºµo¨¥¡A½ÐCEO°w¹ï¤Wz°ÝÃD¡A¤©¥H¸Ñ»¡¡C Cliff´£²Ä¤G¤j¶ô¡A¸ê°T¹ïµ¥¤½§i¡B¡B¡Bµ¥¡A ¦b±`·|¡A´£¥X®É¾÷¬° : ¤¡BÁ{®É°Êij °ò¥»¤W§Úı±o¤½¥q¤£·|»¡¡@¡§¤Ï¹ï¡¨¡A ¦ý¥i¯à·|»¡¡G (¥ç§Y¤j®a¼ôª¾ªº ©x¤è¦^ÂÐ) ¤½¥q©Ò¦³¶i«×¡A³£¨Ì·Ó¥DºÞ¾÷Ãö³W©w¡A¤½§i©ó ¡§¤½¶}¸ê°TÆ[´ú¯¸¡¨¡A ¨ä¥¦¸ê°T¡A¬ÒÄÝ©ó´CÅé©Î¬ã¨s¤HûÁr´ú¡A¤½¥q¤£«Kµû½×¡C Cliff¤j©Ò¨¥ªº²Ä¤G¶ô«Øij¨Æ¶µ(1)¡A¤j·§´N¬O±o¨ì¤Wzªº¦^ÂСC ¦Ó«Øij¨Æ¶µ(2)¡A©Ò±o¨ìªº¦^ÂСA¤j·§´N¬O : ¨Mij¥[±jµo¨¥¤H¥H¤ÎIR¥\¯à¡C ¦ý¡A±`·|¤§«áÁÙ¬O¤@¼Ë ¡§¥Ö¡¨¡C²¦³º¤U¦¸¨£±¡A´N¬O2016¦~6¤ë¤F¡C (¤p)ªÑªF¡A¸¾¤ü§p¤é¤]²ö¥i©`¦ó¤]¡C ¦pªG¡An°µ¦¨¦³®Ä¤Oªº¨Mij : ¨Ò¦p ( ª`·N¡A¶È¬OÁ|¨Ò ) (1)¨C¤G©P©ó¯E¹©©xºô¤½§i ¡§´_µo¤H¼Æ¡¨ ¡C (2)±µ¨ìªÑªF¸ß°Ý¸ê®Æ¡Aµo¨¥Åé¨t¶·©ó¤Ó¤u§@¤é¤º¦^ÂСC ³o¼Ëªº¨Mij¬O¦³®Ä¤O¡A¥B¤½¥q¹H¤Ï®É±o¾Ú¥HÁ|µo¡C ¦ý¬O·Q¨Ó·Q¥h¡A¤]¬O¤£§´¡C¦]¬° : ¨ä¥¦(¥Í§Þ)¤½¥q¡A¤]¨S¦³³Q¦Û¤vªºªÑªF¡A¨î¨ì¦º¦ºªº¸j¦í¦Û®a¤½¥q¡C ·í´£¥X¦p¦¹±jµw¦³®Ä¤O¨Mij®É¡A(¦¹¨Mij¤£¨£±o¬O ¦X²z ¯¸±o¦í¸}) ¼í®õ¤j·§´N·|¥X± ¡§ªÑÅvÀu¶Õ¡¨ ¤Ï¹ï¤F¡C ¦Ó¦^ÂЪѪF¸ß°Ý¤@¨Æ¡A¨ä¹ê¤]«Ü§xÂZ¤W¥«¤½¥qªº¡C ¬Û·í³¡¥÷(©Îª½¥Õ¡A¤j³¡¥÷)ªº ´²¤á´£°Ý¡A±`¬O«ÜµLÍùÀY©Î¤£²z©Êªº¡C ÅýÀu¨q±q·~¤Hû¡Aªá¤j¶q®É¶¡¦b¦^ÂÐ ¡§µLÍùÀY©Î¤£²z©Ê¡¨ °ÝÃD¡A ¹ê¦b¤£¬O ¡§¨þÅ@¯E¹©¡¨ ªº´£Ä³¡C ¨º»ò¡A¤S¥Ñ½Ö¨Ó¥ý¿z¿ïµô§P¡A¨º¨Ç´£°Ý¬O¶·¦^ÂЪº ? (¤S¡A¸ê°T¹ïµ¥°ÝÃD ? ) ¨âÃø ~ ~ ¥i¯àµL¸Ñ ¡C «ä¦Ò¤¤ ! ÃD¥~½g : ¤G©P«e©M Faith¤jªº²á¤Ñ¤å³¹¡A¨ä¹ê¦³²á¨ì¡Acall³X¤½¥qªºªº¤èªk¡A °µ¨¬¥\½Ò¡A¦h¤è¦h¾÷ºc¨DÃҽбСA¥æ¤eÅÞ¿è¤ñ¹ï¡B¡B¡B (¼K~¤£§j¤û¡A »»·Q·í¦~§Ú±oª¾ xxx¤½¥qªº Á{§É¹êÅç¡A¬O¦b¥x¤jÂ媺xxx¥DªvÂå®v¡A ÁÙ´¿¸g±¾¸¹¥h¬Ý³o¦ìÂå®v¡A¥u¬°²áÓ5¤ÀÄÁ ! ²{¦b·Q¨Ó¡A¯u¬O¦³¤@ÂI ·ö¨g! ) ¦b¤Wz«eÃD (¥\½Ò¡B¦h¤è¡B¡B¡B)¡ACEO¤½¥q¬£©¹©¹¤]Ä@·N©M§Ú̦h½Í¤@¨ÇªF¦è¡C ¨Ò¦p: ·í§Ú̸ÛÀµ»¡¥X¤w«ô³X¹LX°|ªø¡AX¥Dªv¥D¥ô¡A¤½¥q¬£¤]·|¸ûÄ@·N¦hÁ¿¤@¨ÇªF¦è¡A ¥B¸û¤£·|°äÄê§Ṳ́F¡C (¤½¥q¤@¯ë¤£·|©p¥u°Ý¤@¥y¡A´N¥D°Ê»¡¥X®zÂI¦b¨º¸Ì) µy·Lªø¤j¤§«á¡A¤~ºCºC§ó²`«×ÅéÅç¡A§ë¸êªº¸g¨å¦W¨¥: ¡§§ë¸ê¤@©w¥ý¬Ý¤HCEOµ¥¡¨ ¯à·í¨ì¤W¥«Âd¤½¥qªºµo¨¥¤H¡B°ÆÁ`¡B¸³¡BÁ`¡A ³q±`³£¤w¦³¬Û·í¸ê¾ú¥\¤O¡C(¥i¥H§â§ë¸ê¤HÄF±o¹Î¹ÎÂà ! ) ©Ò¥H§Ṳ́@©w¤]nCALL³X¹L´X¤Q®a¤½¥q¥H¤W¡A¤~¯àºCºCÅé·|¡A¤ñ¸û¡A ¤½¥q¬£ªº¸Û«H¼ÖÆ[«O¦u¡B¡B¡Bµ¥¦UºØ¯S½è¡C 4/16§Ú¥h°Ñ¥[¤ý«~ªºªÑªF·| («¢~ ·í¤ÑÄ«ªG§Y®É³ø¤Þ¥Îªº·Ó¤ù´N¬OÀ¹³Ó¯q©M¤pªÑªF§Úªº´¤¤â) À¹³Ó¯qªÑªF·|09:00¶}³õ¥Õ : ¤µ¤Ñ¸Ô²Ó¦^µª©Ò¦³ªÑªF°ÝÃD¨ìº¡·N¬°¤î¡C¨º©Èn¨ì¤U¤È¤T¡B¥|ÂI¡C µM«á¡A¥ú²Ä¤@®×ªº³ø§i¨Æ¶µ¡A´N³QÅF¤F2¤p®É¥H¤W !! (¹¦w°ÝÃD¡AªÑ»ù¤j¶^¡B¡B) ²Ä¤@®×´N2¤p®É¥H¤W¡A¤´¬O@¤ßÅý¤pªÑªFºÉ±¡´£°Ý ! ªÑªF·|«á(ÁÙì°£®§ªÑ»ù)¡Aº¦¤Fªñ40¤¸¡A¥~¸ê¥Ñ½æ¶W ¡÷ Âন³sÄò¶R¶W¡C °µ¨¬¥\½Ò«á ¡÷ »P¤½¥q¬£²`½Í´X¦¸«á¡A¦LÃÒ¨ä©Ò¨¥ ¡÷ ¦A¨M©w¬O§_«©ã§ë¸ê¤]¡C |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/5/31 ¤U¤È 07:43:36²Ä 729 ½g¦^À³
|
»¡¯uªº¥´¦º§Ú¤]¤£·|¬Û«H³o»ò«nªºªk»¡·|±i¸³·|»¡¥X¸ò¨Æ¹ê¦³³o»ò¤j®t²§ªº¼Æ¦r,¤j®an§Ë²M·¡¨º®É«áªÑ»ùÁÙ¦³±µªñ400¤¸¼Ú.¦pªG¯uªº1¤ë´N¦³229ªºPD¼Æ¦r,¨º¤j®a³£¥i¥H¥h§i¤½¥q¤F.³£¥i¥H½ÐÀ˽ըӬd¤½¥q¤º³¡¦³¨S¦³¤H§Q¥Îµ¹¿ù»~ªº°T®§¨Ó°ª½æªÑ²¼¤F. |
|
|
·|û¡G¤j¤á¤H®a10140174 µoªí®É¶¡:2015/5/31 ¤U¤È 07:23:13²Ä 728 ½g¦^À³
|
§Úı±o229 /37´N¬OÁ{§É¤¤¤îªº±ø¥ó©Ô. 37´N¬O«ü¨ä¥L«DPDªº°Æ§@¥Î. ¦]¬°´N¬O¨S¦³¨ì37©Ò¥HÁ{§É³£ÁÙ¦b¶i¦æ,¥Nªí822ªºt§@¥Î¤£¤j.§Úı±o´N¬O³oÓ·N«ä.¤£µM¦³¤Ó¦h¤£¦X²z¤§³B¤F. |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2015/5/31 ¤U¤È 06:38:00²Ä 727 ½g¦^À³
|
¦^ÂÐ Cliff ¤j : ¦¬¨ì±zªº°T®§¡C «ä¦Ò²Õ´¤¤¡C·PÁ ! ±zÁÙ¯u¬O ¦Pµ¥«ÕÀq ~ ~ ~ ( ¹ê±¡¬O¤w»PªB¤Í»¡¦n¤À¤u¡A¤À§O¥X®u¯E¹©&¤¤¸ÎªÑªF·|¡A¦A¥æ´«¸ê°T¤] ~ ~ ) ©IÆ~¥þ³¡ ¡§¯E¤Í¡¨(©Îºô¤ÍµLªk¥X®u¡AÂા±zÌn¥X®uªºªB¤Í )¡AªÑªF±`·|¨S¦³¨º»òÄYµÂªº ~ ~ ·í¦³ªÑªF´£¥X ¡§«Ø³]©Ê½èªº¡¨ °Êij¡A¤£§«¤j®a´N ¡§¼ö¯P¹ª´x¡¨ ªþij¤@¤U¡A¤£n·í¾À¤WÆ[ !! ¤£¶ÈµL¶Ë¤j¶®¡A¥B¤j¦³À°§U ! |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/5/31 ¤U¤È 06:22:29²Ä 726 ½g¦^À³
|
¦pªGearly termination per protocol pd229¡K ¥u¬O¦r±ªº·N«ä¡A¬Oì¨Ó¸ÕÅçp¹º¹w³]ªº±ø¥ó¡A ¦n¹³¹q¸£µ{¦¡¤ºªºdefault È ¨ºLÂå®v¡A¤½Ãö§õ¸g²z¤£´N§j½K¤@¦À¬K¤ô ®`¤j®a¾á¤ß¡A¤S½èºÃ±i¸³¸Û«H ü¡A¯u¬OµL¨¥ |
|
|
·|û¡G¤po10135877 µoªí®É¶¡:2015/5/31 ¤U¤È 06:12:18²Ä 725 ½g¦^À³
|
«D±`»{¦P¦Ñ¥vªº¬Ýªk, PD Y¦³¼ÆÈ¥u¦³°ª¼h¤~ª¾¹D§a¦Ó¥B¬O±K¦Ó¤£«Åªº,Y³sL Âå®v³£ª¾¹D¤F,¨º³o®ø®§¦¦b¯E¹©¶Ç¶}¤F,¨º¯E¹©ªº°ª¶¥¸g²z©Mû¤u̦´N½æ¤F¤j³¡¥÷ªÑ²¼¤F. ©Ò¥HPD229À³¬O¸Ñª¼±ø¥ó¤£¬O²{ªp |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/5/31 ¤U¤È 06:01:47²Ä 724 ½g¦^À³
|
¦U¦ì¤j¤j¡A §Ú¤@ª½Ä±±oPD=229¬O¥u¸Ñª¼±ø¥ó¡Aì¦]¦p¤U: 1.3¤ëªk»¡·|±i¸³»¡´_µo¤H¼Æ¥¼¹F¤@¥b(142¤H?)¡A¦ó¥H´XÓ¤ë«á¨³³t¨ì¹F229¤H´_µo¡A¥Î¼Ò«¬ºâ¤£¤j¥i¯à ¼Ò«¬ºâ«Ü²³æ¡A¨Ì·Ó¹êÅç®É¶¡¨Ó¬Ý¨ì¥h¦~©³©Ò¦³¤H¥§¡¬ù¸g¹L18Ó¤ë¸ÕÅç¡A¦A5Ó¤ë´Á¶¡ ¹ï·Ó²ÕÀ³¸Ó¼W¥[¤H¼Æ¤£¦h(°²³]PFS¥u¦³6~9¡A¼W¥[20¤Hªº¸Ü)¡A¹êÅç²Õn¼W¥[229-142-20=67¤H "µuµu4Ó¦h¤ë¼W¥[¬ù67/233,±Nªñ30%¹êÅç²Õ¤H¼Æ¡A822 PFS®Ú¥»¥u¦³¤£¨ì8Ó¤ë®É¶¡¤~¦³¥i¯à" 4/(8*2)=25%, ¤À¥Àn¤p©ó8,³oÓȤ~·|±q25%-->30% 2.¦ýY822 PFS<8, ®Ú¥»¤£¥i¯à¦b2014/12¥u¦³142¤H´_µo¡A§e²{¥Ù¬Þ¤£¦XÅÞ¿è¡A©Ò¥H¤£¦¨¥ß 3.¦A¨Ó»¡229³oӼƦrªº¶ø§®¡A°O±o·íªìn¦¬342¤H¡A¹êÅç²Õ228¤H¡A¹ï·Ó²Õ114¤H ¥Ñ©ó¹êÅç±ÄÂùª¼³]p, ¤°»ò±¡ªp¤U¥²¶·¸Ñª¼©O? °²³]¹ï·Ó²Õ¥þ³¡´_µo¡A¹êÅç²Õ¶W¹L¤@¥bªº¤H´_µo¡A³o¼Ë¬O¤£¬O´N¥i¥H¦w¥þ¸Ñª¼ ³oÓ®ÉÔ¹êÅç²Õ228/2+1=115¤H¡A¹ï·Ó²Õ114¤H¡A¨âÓ¦Xp¬O229¤H 4.¤Wz3, ¦pªG¤p©ó229¤H´_µon¸Ñª¼¡A¨Ò¦p¥u¦³220¤H«Å¥¬¸Ñª¼¡A¹ï·Ó²ÕY¥þ¼Æ114¤H´_µo ¹êÅç²Õ¥u¦³220-114=106¤H´_µo¡A¥¼¹F¹êÅç²Õ¤H¼Æ1/2, ¦p¦ó¯à»PK-M 0.5¬Û¥æ(¥ý¤£p³]¸ê®Æ³oÓ±¡ªp) ¦U¦ì¤j¤j·Q·Q¬O§_¦³¹D²z©O¡H ¤j®aÀ³¸Ó¥i¥H©ñ¤ß¤F§a~~ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/5/31 ¤U¤È 05:57:39²Ä 723 ½g¦^À³
|
·PÁ¦ѥv¤j¡AÁ|ÃÒ¦³¤O¡AT¶ë¹y¶}¡I |
|
|
·|û¡GµØ10139344 µoªí®É¶¡:2015/5/31 ¤U¤È 05:38:27²Ä 722 ½g¦^À³
|
¦P·N¦Ñ¥v¤jªº»¡ªk, http://www.ct-toolkit.ac.uk/routemap/temporary-halt-or-early-termination http://ec.europa.eu/health/files/eudralex/vol-10/2011_c172_01/2011_c172_01_en.pdf --> item 122 |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/31 ¤U¤È 05:34:05²Ä 721 ½g¦^À³
|
¥v¥S ÁÂÁ±z »P¤p§Ì·Qªk¤£¿Ñ¦Ó¦X ¤p§Ì¹ê¦b¸g¾ú¤Ó¦hÃþ¦üª¬ªp ³ø¯ÈÀY±ø¤º¡ã½Ö·|¤£¬Û«H¡ãµ²ªG¬O¯QÀs ¤p§Ì¦¹¦¸°í«ù¬Û«H±i¸³ LÂå¥Í¤]¨S¿ù¡A¥v¥S¤w»¡©ú Cliff¤j ÁÂÁ±z¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/31 ¤U¤È 05:27:48²Ä 720 ½g¦^À³
|
¦Ñ¥v¤j¤j ³o´N¬O§Ú·Qnªº¨ãÅé¦õÃÒ¡A·PÁ§A§ä¥X¨Ó´£¨Ñ¤j®a°Ñ¦Ò¡A¥»¶K¤åÀ±¨¬¬Ã¶Q¡A«nªº¸ê°T¸Ñ¶}¦U¦ì¤j¤j¤ß¤¤ªººÃ´b¡Aºâ¬O¥\¼w¤@¥ó¡A¦pªG229¯u¬O¸Ñª¼¤H¼Æ¡A²{¦b¥unµ¥¹ï·Ó²Õ110¥X²{¡A´N¥i¤½§i¸Ñª¼¡A¶}¨Ó¶ý¯ªÅÒnÀ³Åç¤F¡C |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2015/5/31 ¤U¤È 05:27:12²Ä 719 ½g¦^À³
|
¹ï¤£°_¦³º|¦r ¾ãÓpµe´£«e²×¤î The DSMB (will or will not)monitor effectiveness outcomes to determine relative risk/benefit, futility, or for early termination due to overwhelming effectiveness. |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2015/5/31 ¤U¤È 05:08:48²Ä 718 ½g¦^À³
|
¥xÁÞ¥SFaith¥S ¦b¤U«D±`»{¦P¯«¯µ¤Hªº¨£¸Ñ¡A±N§ÚŪ¨ìªº¸ê®Æ»P¥S¤À¨É ·OÀÙ¤j¾ÇÁ©v¦¨§U²z±Ð±Â¦³^¤å²³øÀÉ"Á{§É¸ÕÅçpµe¼¶¼g¡B¬ã¨s³]p»P°õ¦æ" http://rnd-epage.tccn.edu.tw/ezfiles/7/1007/img/52/shia.pdf P19¼g¨ìSequential Design¡G The design allows for 1.Early termination for overwhelming efficacy or lack of it or harm 2.Study modifications (e.g., dropping treatment groups) 3.Sample size adjustment P21¼g¨ìUsually involve an independent Data and Safety Monitoring Board(DSMB) P31¼g¨ìAnalysis Population¡GIntent-to-treat Population (ITT Population) ºò±µµÛP32¼g¨ìAnalysis Population¡GPer-protocol Population (PP Population)¡AAt least 70% of the scheduled study medication was taken °]¹Îªk¤HÂå¾Ç«~¸ÕÅ礤¤ßhttp://www2.cde.org.tw/FAQ/IND/Pages/%e7%b5%b1%e8%a8%88.aspx Àø®Ä¤Î¦w¥þ¤ÀªR¸sÅ餧¼f¬d«ÂI¬°¦ó¡H 1.¤ÀªR¸sÅ骺©w¸q¡C pµe®Ñ¤¤»Ý²M·¡©w¸q¦U¤ÀªR¸sÅé¦p·N¹ÏªvÀø¸sÅé (Intent-to-treat, ITT population)¡A¨Ìpµe®Ñ¸sÅé (Per-Protocol, PP population) µ¥©Ò²[»\¤§¨ü¸ÕªÌ½d³ò¡C *****½Ðª`·NPer-Protocol=PP population***** ¦¨¤j³Õ¤h½×¤å"²Ä¤G´ÁÁ{§É¸ÕÅç¤U¤G¤¸¸ÕÅç«ü¼Ð¤§ÁY´î¤G¶¥¬q¸ÕÅç³]p"ªº^¤åºKn Moreover, this dissertation extends curtailed sampling procedure for bivariate endpoints to allow for early termination once the treatment shows lack of efficacy or safety, or very effective and safe. The early termination of clinical trials, for either benefit or harm, often generates undue enthusiasm or alarm. http://www.ncbi.nlm.nih.gov/pubmed/8205706 early termination¬O±`¥ÎÁ{§É¥Î»y¡A³s¤é¤åªºÁ{§É³ø§i¤]¬Oª½±µ¥Î¤W^¤åearly termination¡A¦Ó¤£¬O¥Î¤ù°²¦W JUPITER ÇV¡B17802 ¤H¡B°·±dÇQ¨k¤k¡BLDL Chol 130 mg/L¥¼満¡BCRP2.0 mg/L ¥H¤WÇN¡Brosvastatin 20 mg ÇyªA¥Î¡B1¦~«áLDL Chol 50%¡BCRP 40%´î¤Ö¡B¤¤¥¡値2¦~ÇUªvÀøÇN¡Bcomposite outcome 40%´î¤Ö¡C¨}Æêµ²ªGÆòÇNÇFÇOÆêÆìÆùÇOÇN¡Bearly terminationÇOÇQÇJÇM¡Bµ²ªGÆò¹L¤jµû価(over exaggerate) ÇNÆèÇrÇOÆêÆì§å§PÆèÇq¡C ¤©©wÆýÇFDZÇïÇÓÇç数ÇR届ÆñÇQÆêÆìÇHÇR¬ã¨sÇy²×¤FÇ@ÇrÆùÇOÇyearly terminationÇOÆêÆê¡B¤jÆóÆõ¤GºØÃþÆèÇr Early termination for benefitÇV¡A°°¶§©ÊÇ@ÇQÇvÇH£\ǤÇåÆãÇU¦M険©ÊÇy¤Wª@ÆûÇBÇr(³o½g¤å³¹¦b°Q½×ÀH¾÷¤À¬£ªº¸ÕÅ笰¦ó¦³¤£¦Pµ²ªGªº¤TÓ²z¥Ñ) FAME2¸Õ験 ºò«æ¦å¦æ¦A«ØÇN®tÆòÇKÆó¡Bearly termination for benefitÇOÇQÇJÇF early termination¬O"¤@Ó¦Wµü"¡A¤£¬O"¤@ӧήeµü+¤@Ó¦Wµü" ¦ÓPer-Protocol=PP population ©Ò¥HEarly Termination Per Protocol´N¬O¯«¯¦¤H»¡ªº"¾ãÓpµe´£«e²×¤îªº±ø¥ó¬OPP population¤¤ PD= 229" 쥻¸Ñª¼±ø¥ó¬OÁ`´_µo284¤H¡A¦ý¦]¬°"µ¥¨ì´_µo¤H¼Æ³o»ò¦h¹ê¦b«ÜÃøµ¥¨ì"¡A©Ò¥H¯E¹©´£°ªÁ{§É³]pªº¨â²ÕÀø®Ä®t§O£G(§Æþ¦r¥À)¡A³o¼Ë´N¥i¥H°§C¸Ñª¼ªùÂe¡A³o©Mªk»¡·|¤W±i¸³ªº¦^µª¬Û²Å ¾ãÓpµe´£«e²×¤î The DSMB monitor effectiveness outcomes to determine relativerisk/benefit, futility, or for early termination due to overwhelming effectiveness. P22¬Oµ¹®ü¥~ªk¤H¬Ýªº¡A¶¶¨ä»y·NŪ¨ì¤U¨Ó ¥ý»¡©úIntent-to-treat Population¬O349¤H ±µ¤U¨ÓEarly Termination Per Protocol PD229 ¯E¹©«ç»ò¥i¯à"¤½¶}"¸ò®ü¥~ªk¤H»¡¡A§Ú̲{¦bPD229¤H¤F¡A¦³¹H±`²z¡A«D±`¹HI±`²z ªk¤H«äºû¥u·|Ãö¤ß¯E¹©¦ó®É¸Ñª¼¡A¦ó®É¨ú±oÃÄÃÒ¡A¾P°â¼ç¤O¡AÀ禬»PEPS ¥L̤~¤£²z§APD¦h¤Ö¤H ©Ò¥H¯E¹©·Q»¡ªº¬O¸Ñª¼±ø¥ó¡A³o¼Ëªk¤H¤~·|¥h±Àºâ¦ó®É¥i¯à¨ú±oÃÄÃÒ¡A¸Ó¦p¦óµ¹§é²{²v¡A¸Ó¦p¦óµû»ù²{¦bªº¯E¹© ¤j®a·N¥~ªº¬OLÂå®v»¡ªºPD229¡A§Úªº·N¨£¦p¤U 1.LÂå®vÀ³¸Ó¬O¥h¦~10¤ë¤~¶i¤J¯E¹©¡A¥L½T¹êª¾¹DPD¼Æ¦r¡H§Ú¤ñ¸û¬Û«H¥u¦³¤j·í®a¤G·í®a¤T·í®aª¾¹D¡AÁÙ¬O¦]¬°´X¦ì¤jô®³P22¶¥h½Ð±ÐLÂå®vPD229ªº·N«ä¡A²³¯E¤Í¥´¹q¸Ü¥h°Ý§õ¸g²z¡A¦ý¦]¬°·í®aªº¥X°êªk»¡¡A©ó¬OLÂå®v¥u¬O«ö·Ó¥L±M·~¸gÅç¨Ó¸ÑÄÀPD229ªº¥i¯à±¡§Î¡H 2.¦]¬°§Ú¤£¬Û«H±i¸³·|¤f»~¡A¥[¤W³o»ò¦h¦ì«e½ú³£¦³¥P¤H«üÂI¤@¤ë´_µo¤H¼Æ¤£¨ì120¤H¡A¦pªGLÂå®v¯uªº´x´¤PD¼Æ¦r¡A¦Ó¦¹PD¼Æ¦r¬O229¡A³o©M¤@¦~¨Ó¤Ó¦h«e½ú´£¨Ñªº°T®§¤£²Å¡A¦Ó¥B¤]·|¤Þµo¸Û«H°ÝÃD(§Ú¿ýµÅ¥¤Ó¦h¦¸¤F¡A§Ú¤£¬Û«H¤f»~)¡A¦Ó¥B¤]µLªk¸ÑÄÀµu´Á¶¡"²§±`¤j¶q´_µo"¡A¤]µLªk¸ÑÄÀ¤¨¥ý¥Í¤j¶R2000±i¡A¤]µLªk¦X²z¸ÑÄÀ®ü¥~ªk»¡P22ªº»y·N...... 3.¦pªGLÂå®v¥u¬O¦b¸ÑÄÀPD229¡A¦ý¥L¨S¦³½T¹ê´x´¤PD¼Æ¦r¡A¥H¤W³\¦h¤£¦X²z¤§³B´N¥þ³¡¦X²z¤F¡A¦Ó±i¸³¤´µM¬O¯«©ú¡A822¤´Â¬O¥P¤¦¡A¤¨¥ý¥Í¦]ª¾¹DXX©Ò¥H¶R2000±i....... ©Î³\ªÑªF·|¤W¡A±i¸³Â²³æ¤@¥y¡A"PD229¬O¹wq¸Ñª¼ªº±ø¥ó"¡AµM«á¤j®a³£¯º¶}¤F |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2015/5/31 ¤U¤È 05:07:12²Ä 717 ½g¦^À³
|
«æ´M«¼C¤j¡I ´£®×¤è¦¡»Ýn¦³¸gÅ窺±z¨ó§U¡A¦b·|«áªº´£°Ý¤£¨ã¬ù§ô®Ä¤O¡A¦b·|¤¤ªºÁ{®É°Êij´£®×¡Aµ{§Ç¾Þ§@§Ú«Ü¤£¼_¼ô¡A¥[¤W¤p§Ì¤á¸¹¶W¹L60XX¸¹¡A¤S¬O©`¦Ì©@«ùªÑ¡A©ÈÃa¤F¤@¼Î¦n¨Æ¡A´X¸g¦Ò¶q«Øij¥Ñ±z¦b²{³õÁ{®É°Êij´£®×¸û¬°¾A¦X¡AÁÙ±æ²{³õ²³¤Hªþij¡A¤£n·í¾À¤WÆ[¡C èè¤wúd±z¦A½Ð¥Ü¡A³s±o¤T¸tÚÞ¡A¡]Ãö¸t¡^«Ò§gn±z06/03§ï°Ñ¥[¯E¹©¡A±æ±z¥H²³¥Í¬°©À¡A¬O©¯¡C ¤å½Z¡G ¥H¤U³¡¥÷·q½Ð±i¸³»¡©ú¡G I´º¡G 2015/05/25 17:54 ¤¤¥¡ªÀ¡G¯E¹© ¡u¥»¤½¥q¨üÁÜ°Ñ¥[104/05/26-104/05/29¤¸´IÃÒ¨éÁ|¿ì¤§»´ä¤Î·s¥[©Y®ü¥~ªk¤H»¡©ú·|¡v¦P¤@®É¶¡¦b¡u¤½¶}¸ê°TÆ[´ú¯¸¡v¤¤´£¨Ñ¤F¸Óªk»¡·|²³øÀɤU¸ü¡C¨ä¤¤Slide No.22´£¨ì¡G ¡uClinical Trial Safety Monitoring Update¡v¡G¡uEarly Termination Per Protocol¡GPD: 229 / Others: 37¡v 1.½Ð°Ý¡uPD¡G229¡v»P¡uOthers: 37¡v©Ò«ü¦ó¸q¡H¥Ø«e¬°¤îÁ`´c¤Æ¤H¼Æ¬O¦h¤Ö¡H 2.YPD¡G229¬O2015/01/10 the 8th DSMB·|ij©Òª¾ªº´c¤Æ¤H¼Æ¡A½Ð°Ý»P03/03¤WÂdªk»¡·|¤W©Ò´¦ÅS³¡¥÷¦³µL½Ä¬ð©Î´¦ÅS¤£¨¬¤§³B¡H 3.¤Wz»´ä¤Î·s¥[©Y®ü¥~ªk¤H»¡©ú·|²³øÀɮסASlide No.22¬ðµM©ó05/26¤U¤È¤T®É¾l³QºM°£¡A«o¥¼¨£¤½¥q¦³¶i¤@¨Bªº»¡©ú¡A¥O²³¦h§ë¸ê¤H·P¨ì¹Lµ{²ÊÁW»P¤£¸Ñ¡C ¥H¤U³¡¥÷¬°«Øij¨Æ¶µ¡G 1.«Øij¶Q¤½¥q¦b¸ê°T´£¨Ñ¤è±¡AµL½×¹ï«Ýªk¤H»PÓ§O§ë¸ê¤H¡A³£¯à°µ¨ì¤@µø¦P¤¯¡C ¡]2015/01/10 the 8th DSMB·|ij¤¤PD¡G229ªº°T®§¡A¥¼¦b2015/03/03°ê¤º¤WÂdªk»¡·|¤W´¦ÅS¡A«o¦b2015/05/26ªº®ü¥~ªk¤H»¡©ú·|ªºÂ²³ø¤º®e¥X²{¡H¡^ 2. ¦³·P©ó¥Ø«e¶Q¤½¥q¦bµo¨¥¤H¥\¯à¤è±¦³«Ý¥[±j¡A¶À¸g²zµn°O¬°µo¨¥¤H¡A¦ý´X¥GµLªkÁpµ¸¤W¡F¦ü¥G¨S¦³±M¤H±M½ut³d§ë¸ê¤Hªº¹q¸Ü´£°Ý¡A§Y¨ÏÂà±µ¦Ü¤½Ãö³æ¦ì¤]±`±`¦]¬°¨Æ¯A±M·~¡A³Qn¨D¯d¤U¹q¸Üµ¥«Ý¦^À³«o¤S¥Û¨I¤j®ü¨S¦³¤U¤å¡C¥t¥~®Ñ±¡]e-mail¡^´£°ÝªÌ¤]À³³]¦³´Á¡]¤é¡^¦^ÂЪº¾÷¨î¡A«Ø½Ð¤½¥q½Õ¾ã±j¤Æ¥H¤Wªº¥\¯à«á¡A©ó¤½¶}¸ê°TÆ[´ú¯¸©Î¤½¥qºô¯¸¤½§i¾ã¦X«áªº·s±¹¬I¡A¥H¬L¤½«H¡C ¥H¤W¤º®e¤À¦¨n¨D»¡©ú¤Î«Øij¨Æ¶µ¨â³¡¥÷¡AÅý«¼C¤j²ÎÄw¡Aµø´£¥X®É¾÷¤£¦P¡]Á{®É°Êij©Î·|«á®y½Í¡^¦Ó¨Ï¥Î¡C |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/31 ¤U¤È 04:58:09²Ä 716 ½g¦^À³
|
ÁÙ¦³¡Aª½±µ°Ý²Ä6¦¸²Ä5¦¸DSMB·|ijªº¦P¤@±i²³ø¤º®e´Nª¾¹D°Õ 1.¦pªG«e¤@¦¸ ·|ij¤¤ªºearly termination per protocol ¬O142¡A¦¹¦¸¬O229 ´N¦p¤j®a©Ò»¡ 2.¦ý¦pªG«e¤@¦¸¬O284¡A1¤ë³o¦¸¬O229©O¡H |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/31 ¤U¤È 04:46:39²Ä 715 ½g¦^À³
|
¤£¹ï§r¡I¦pªG early termination pro -ptotocol PD229¬O¦p±zÌ©Ò»¡ ¨º±i¸³3¤ë3¤é»¡ªº´N³£n±À½ «ç»ò¿ì¡H¤p§ÌÁÙ¬O¬Û«H±i¸³C¡I¡]½Ðª`·N¡A±i¸³»¡¡A´_µo¤H¼Æ¤ñ¹w´Á¤Ö«Ü¦h¡^ ¥H¤U¬O3¤ë3¤é °ÝÃD±i¸³¦^µª¤@¤p¬q ¡u·íªì³]p¦]¬°¬OFirst In Class ¡A¨S¦³¥ô¦óBenchmark¡A¦]¦¹§ÚÌ¥ÎSurrogate(¥N²z)²£«~--HerceptinªºPerformance¨Ó°µBenchmark¡A·íªìHerceptin¹ï¨ÅÀù¥½´Á¯f¤HªºPFS¬O6~9Ó¤ë¡A§Ú̬O¥H§ïµ½50%¨Ó³]pÁ{§É¡A³]p¥X¨Óªº¯f¤H¬O284Ó¯f¤H¡A°µ¥X¨ÓªºPFS¤~¦³²Îp¤Wªº·N¸q¡A«á¨Ó¦bÁ{§É¹êÅ礦~«áµo²{¡A´_µo¤H¼Æ¸û·íªì¹wpªºn¤Ö«Ü¦h¡C ³o¸Ì¦³¤@ÓSignificant«Ü«nªº·N¸q¡A¤H¼Æ¤Ön¦p¦ó¤~¯à¹F¨ì²Îpªº·N¸q¡H»Ýn¿ï©w¤@ӳ̦nªº¸Ñª¼®É¶¡ÂI¡C¬O¤£¬Onµ¥¨ì284¤H¡H°²³]»¡Àø®Än100%§ï¶i¡A¤H¼Æ±N¤j¤j´î¤Ö¡A¥i¯à120¤H§Y¥i(³o¬OMichael°²³]ªº)¡An50%§ï¶i¡A¤H¼Æ¥i¯àn180¤H(³o¤]¬O°²³]ªº)¡A¤¤¶¡ªº®³®º¡A¬O¸gÀç¹Î¶¤·|½Õ¾ã¡A¦Ó¨S¦³¸Ñª¼«e¬O¤£¯à³zÅSªº¡C¡v ±Û«a¤j ·PÁ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/31 ¤U¤È 04:42:06²Ä 714 ½g¦^À³
|
PD229¦p§â¦o©î¦¨¹êÅç²Õ¡A¹ï·Ó²Õ¬ù²¤·|Åܦ¨ PD119,PD100 ¤j®a§âµJÂIfocus on PD119,§Ñ¤FPD100,³o¬O¤@Ó¤ñ¸û¨â²Õªº¹êÅç¡A«ç»ò¥i¥H¥uÃö¤ßPD119,¤£Ãö¤ßPD100,»¡¥Õ¤F¯E¹©¦bµ¥PD100Åܦ¨PD110,¦Ü©óPD119Åܦ¨129,139³£¤£¼vÅT¨äÀø®Äªº¼ç¤O¡A¤£½× PÈ,PFS,©Î¸û¥i·sªº°Ï¶¡ ¥X¥~®È¹C¡A¦h¦¸¤À¨É¡A¦Ü¬°©êºp |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2015/5/31 ¤U¤È 04:23:25²Ä 713 ½g¦^À³
|
2015¦~1¤ë¥X²{¤FPD=229³oӼƦr¡A¦¤w¬O¤@Өƹê¡A¥u¬O§Ṳ́£ª¾¹D¦Ó¤w¡A¤½¥q¨S¦³¹ï¥~´¦ÅS¡A¦ý¤]¦Ñ¯«¦b¦bªº¶}ªk»¡·|¡A«ÅºÙÁ{§É¤@¤Á¶¶§Q¡A«ÅºÙ¦~©³©ú¦~ªì¤~·|¶i¦æ¸Ñª¼(³Ì·sªº»¡ªk¬O8¤ë¶}±M®a·|ijµû¦ô¸Ñª¼®É¶¡)¡AÁ{§É¹êÅç¤w³]p´c¤Æ284¤H®É¡AµLÛ¦p¦ó¤@©w¶}ª¼¡A¦]¦¹¤µ¦~8¤ë«eÁ`´c¤Æ¤H¼Æ¤£·|¤j©ó284¤H¡A¦ü¥G´c¤Æªº³t«×»·§C©ó¥h¦~¤U¥b¦~¡C ½T»{¦³¨âºØ´c¤Æ¼Æ¦r¡A¤@Ó¬O¿W¥ß¤¤¤ß¡A¤@Ó¬OÁ{§ÉÂå®v§PŪ¡A¤j³¡¤À±¡ªp³o¨âӼƦr¤£À³¸Ó®t¶Z¤Ó¤j¡A¦ý229»P¤£¨ì142¥i¬O®t¤F¬ù40%¡A¥Ø«en§¹¥þ¬Û«H229©Î¤£¨ì142³£¦U¦³¬°Ãø¤§³B¡A¨º¦pªG±i¸³¬O¹ïªº¡A¤½Ãö»PLÂå®v¤]¬O¹ïªº©O¡H ¦pªG6/3ªÑªF·|±i¸³¦^µª¡A³o¨âӼƦr³£¬O¨Æ¹ê©O¡H |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/5/31 ¤U¤È 04:16:26²Ä 712 ½g¦^À³
|
¥i¯à¬O½L«á°t¹ï¤Î«ü©w¤H¥æ©ö¡A¦³®ÉÔ¬O¤jªÑªF©Î¤j¤á¬°¤F¸`µ|¡A±NÓ¤H¦W¤U«ùªÑÂà¨ì§ë¸ê¤½¥q¡AÂରªk¤H©Î¥~¸ê¤§«á¥i°§C¾A¥Îµ|²v¡C |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2015/5/31 ¤U¤È 03:36:27²Ä 711 ½g¦^À³
|
¯E¤ÍÌ ¤p§ÌÁÙ¬Oı±o«Ü¯Ç´e¡A§Ú§â©_¼¯ªÑ¥«--°]¸g·s»D¦@13¶¡A¥þ³¡³£§ä¤F£¸¹M Ãö©ó¥~¸ê¶R¯E¹©ªº¤½§i¡A´N§ä¨ì5¤ë28¤é©M5¤ë29¤éªº¨âµ§ 5¤ë28¤é¶R1361¡A¥H¤Uªº¼ÐÃD¬O¥Îªñ3¤é¡A¤]´N¬O27-29³o3¤Ñ¡A¦@¶R¤F1474±i¡A¦ý§Ú°lÂÜÄw½X±®É§¹¥þ¬Ý¤£¥X¨Ó ³o¬O«ç»ò¦^¨Æ¨à¡HÁÂÁ ¥xÆW©±ÀY¥«³õ¥~¸êªñ3¤é«ùªÑ¼W´î«e30¦W 2015/05/29 17:30 ¹d¦ëºô ¥x¥_¸ê®Æ¤¤¤ß ¡»¶R¶W¡@ ¥N½X¡@ªÑ²¼¦WºÙ¡@¶R¶W±i¼Æ¡@«ù¦³±i¼Æ¡@«ùªÑ²v%¡@ 4174¡@¯E¹©¡@¡@¡@¡@¡@1474¡@¡@ 13419¡@¡@ 7.86¡@ ÁÙ¦³¡An°ÝPD,½Ð°O±o°Ý§¹¾ãªº¥y¤l |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/31 ¤U¤È 02:13:42²Ä 710 ½g¦^À³
|
¯E§b¤j 121¤Hªºì¦]¬OÓ¤H¨Ì¾Ú¤@´ÁÁ{§ÉÁ`¦s¬¡´Á¶W¹L¤E¦~¡A¤£¦Ò¼{¾¯¶q»P°w¦¸¤U¡A¬ù48%,233*0.52=121,¶V¹L121¤~¯à¬Ý¨ì±mi¡AÁ`¦s¬¡´Á°£¤T¥i¬ù²¤±o¨ìPFS,9¦~*12=108Ó¤ë¡A 108/3=36, «O¦u¤@ÂI¦A¥´¤K§é¡A36*0.8=28.8¡A«Ü±µªñ¥ò´º¤jªº29Ó¤ë¡C¥H¤W¦sÄݲq´ú¡A¥i¯à²q¿ù¡C¤£ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/31 ¤U¤È 02:02:33²Ä 709 ½g¦^À³
|
D§b¤j °²¦p¤@¤ëCR event¹F180¡A¦©°£¹ï·Ó²Õ90¤H¡A¹êÅç²Õ¬ù90¤H¡A¨â²Õ¤H¼Æ©|¤£¨¬¡A¹êÅç²Õn¶W¹L121¤H¤~¯à¹F¨ì¸û¨ÎªºPFS¡A¹ï·Ó²Õ¬ù¹F110¤Hµ¥¤~·|¦³¸û¦nªº¶}ª¼¾÷·| |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/5/31 ¤U¤È 01:20:05²Ä 708 ½g¦^À³
|
½Ð±Ð¦U¦ì¤j¤j (1)§Ú¬O¤£·|ºâPFS ¥HCentral Read (CR) ¨Ó»¡ ¦pªG§âì¥ý¤j®a°í«Hªº2015/1 CR Event <142 ¼È®É×¥¿¦¨2014/8 CR Event <142 (¯f¤H¦¬§¹8¤ë¥¼¹F142) ¨º¬O§_¥i¥H§â¥ý«e¦U¤j¤j¹w¦ôªºPFSÈ, ª½±µ´î5? (2) ¦pªG8¤ëCR È142, ¨Ì¦¬®×¤H¼Æ¤ñ¨Ò, ¨ì2015/1 , CRÈY¤É¨ì180~200 ¥ª¥k¬O§_Äݩ󥿱`²z¸Ñ? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/31 ¤U¤È 12:10:41²Ä 707 ½g¦^À³
|
±µÄò¸É¥R ¬JµM¥ò´º¤j¤w¼ÒÀÀ¦ôp¥X«GÄRªºPÈ»PPFS¤U ¤j®a´N¤£¥²¤Ó¾á¤ß¹êÅç²Õ´c¤Æ¤H¼Æ¼W¥[¡A¼W¥[ ¤~¯àÅý§j¤fï±Æ¶¤¡A¤~¯à´ç¹L¦MÀI°Ï¡A¤~¯à¹F¨ì«H¿à°Ï¶¡¡A¤~¯àºÉ§Ö¤W¥«¤Î±ÂÅvª÷¡AÀ禬¤J±b |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2015/5/31 ¤W¤È 11:57:26²Ä 706 ½g¦^À³
|
¥ò´º¤j §A»¡ªº¨S¿ù¡Aµo¨¥¤H¤£¬O¨CÓ°ÝÃD³£¦³¨D¥²À³¡AÀ³Åé¶q¤½¥q¡A¥t¥~¡AªºÁ{§É¸ÕÅç¦]¦³Û²z³W½d¡A¯S§O¬OÂùª¼³]p¡A¤£¨ì¶}ª¼¤£¯à¤½¶}¡A¤]¤£¯à³z©ú¡A³o¬O°ò¥»±`ÃÑ¡A¯E¹©¤£·|¥Õ¥Ø¨ì§i¶D®ü¥~±M·~§ë¸ê¾÷ºc¹êÅç²Õ PD¤H¼Æ«Ü¦h¡AÅwªï¨Ó§ë¸ê¡A»¡¤£©wPD229ÁôÂìO¥¿± ·N¸q¡A¥]¬APFS,PÈ¡A«H¿à°Ï¶¡ |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/5/31 ¤W¤È 11:23:38²Ä 705 ½g¦^À³
|
°ò¨Èªº¨Ò¤lÅý¤j®a²£¥Í¤F¤£«H¥ô·P¡A¦U¦ì¤j¤j¥iª¾°ò¨ÈªºÁ{§É¸ÕÅç³]p©M¯E¹©ªº®t²§©Ê?°ò¨È¬O¥Ñ¿W¥ß¼fij©eû·|°w¹ï PI-88 ²Ä¤T´ÁÁ{§É¸ÕÅ礤º¥ý´_µoªº 136 Ó¯f¨Ò¡]¬ù¦ûÁ`¤ÀªR¯f¨Ò¼Æ¤§ 60%¡^¶i¦æ¸ê®Æ¸Ñ±K¤Î¤ÀªR¡C ¦]¦¹¡A´_µoªº¤H¼Æ¬O´X¥G½T©w«á¤~°e¥h§P§O¬O§_¹F¨ì²ÎpÅãµÛ¤ÀªR¡CµM¦Ó¯E¹©´Á¤¤¤ÀªRªº¼Ð·Ç¬O´_µo(events)¤H¼Æ¥¼¹F142¤H¡AÃöÁä¦b´_µo¤H¼Æn¥ý©w®×¡A¦pªG¤w¸g¶W¹L142¤H©w®×«á¬O¤£¬O´N¸Ó±Ò°Ê´Á¤¤¤ÀªR¤F?¹ê»Ú¤W³Ì«á¨Ã¨S¦³´Á¤¤¤ÀªR(¥¼¹F142¤H)¡A°ò¨È°e¥h¿W¥ß¤¤¤ß¼fij¬O¦b½T©w¬O§_¹F¨ì²Îp¤ÀªRªºÀø®Ä¦Ó¤£¬O½T©w´_µo¤H¼Æ¡C |
|
|
·|û¡G´µ¤p¤å10139040 µoªí®É¶¡:2015/5/31 ¤W¤È 10:40:14²Ä 704 ½g¦^À³
|
¬Ý¨ìFaith¤jpo¤å4174ªñ¤T¤é¥~¸ê¶R¶W¤@¤d¦h±i, »P¦L¶H¤£²Å, ¥J²Ó¬Ý¤F¤@¤U, ¶R¶W¤@¤d¦h±i¬O¥H«ù¦³±i¼Æ¤ñ¸û ¦ý5/28¶R½æ¶W±i¼Æ«o¥u¦³3±i, ½Ð±Ð¦U¦ì¤j¤j³y¦¨³oºØ¸¨®tªºì¦]¬O? ¤é´Á ¶R¶i±i¼Æ ½æ¥X±i¼Æ ¶R½æ¶W±i¼Æ «ù¦³±i¼Æ «ùªÑ²v% ¥þÅé¥~¸ê©|¥i§ë¸ê±i¼Æ µo¦æ±i¼Æ 05/29 57 10 47 13,419 7.86 157,237 170,267 05/28 17 14 3 13,372 7.83 157,284 170,267 05/27 2 37 -35 11,909 6.99 158,358 170,267 |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2015/5/31 ¤W¤È 10:32:24²Ä 703 ½g¦^À³
|
¸É¥R¤@ÂI¡Aµo¨¥³æ¦ì§õ¤p©jªí¥Ü¡A±i¸³ªº¼Æ¾Ú¬O¿W¥ß¤¤¤ßµ¹ªº¡A¦Ó¤£¬OLocal Read¡C |
|
|
·|û¡G¯E§b10139724 µoªí®É¶¡:2015/5/31 ¤W¤È 10:21:59²Ä 702 ½g¦^À³
|
§Ú¦A¬Ý¤F¤@¹MQ&A Michael¡Gµª®×¨ä¹ê¥u¦³¤@Ó¦r¡A¦ý§Ún¥Î¤@¤j¬q¸Ü¨Ó»¡©ú¡C·íªì¹w©w´Á¤¤¤ÀªR¬O¥H´_µo¤H¼Æªº¤@¥b142¤H¬°¤ÀªR¼Ð·Ç¡A«e¨âÓ¤ë´_µo¤H¼Æ¤´¥¼¹F´Á¤¤¤ÀªR¼Ð·Ç¡A¦Ó¥B¤w¸g¦¬§¹©Ò¦³ªº¯f¤H¡A¦]¦¹´Á¤¤¤ÀªR¤w¸g¨S¦³·N¸q¡A¨ú®ø¤F¡C Michael¡G³Ì«á¤@Ó¯f¤H¥h¦~8¤ë¦¬ ¦pªG»¡¤H¼Æ¤´¥¼¹F®É¸õ°w·Qªº¬O2014/6 ¤ë, ¯f¤H¨Ã¥¼¦¬§¹ |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2015/5/31 ¤W¤È 10:14:43²Ä 701 ½g¦^À³
|
ºÃ¦ü®×¨Ò¡Alocal¥§¡¦³20%¥ª¥k°ª¦ô §Úı±o³o¥§¡¼Æ¨S·N¸q¡A ¨ä¹ê§ë¸êªÌÀ³¸Ó¥Î§óÄY®æªº¼Ð·Ç¨ÓÀ˵ø »Ý¦Ò¼{¸U¤@ºÃ¦ü®×¨Ò§P©w¤U¨Ó´X¥G¥þ¼Æ¤¤¼Ð ¨ºn¦p¦ó¦]À³ ©Ò¥HªÑªF·|±i¸³¦³³d¥ô ¹ïpd229»¡²M·¡Á¿©ú¥Õ |
|
|
|